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Abstract 
Due to the expansion of the pharmaceutical industry, the increase in demand and 
current inadequate removal methods, pharmaceutical waste has been increasing in 
concentration in environmental waters. It is unknown what the chronic effects this 
waste could have on humans and so more adequate removal methods are necessary. In 
this research project the zeolite ZSM-5’s effectiveness at removing the analgesics 
paracetamol, aspirin and ibuprofen lysine from aqueous solution was investigated. 
ZSM-5’s Si:Al ratio and charge balancing cation were also altered to ascertain the 
effects these attributes had on its ability to remove the analgesics from aqueous 
solution. Its ability to remove low concentrations of paracetamol from solution was 
also investigated. Ion exchange reactions were performed on commercial ZSM-5 
ammonium with a Si:Al ratio of 30:1, this being the baseline zeolite for this research, 
changing the charge balancing cations to iron and sodium respectively. SEM-EDX 
spectroscopy was ran to ensure the ion exchanges had been successful. Then 
adsorption reactions using 0.005M paracetamol, 0.005M aspirin and 0.002M 
ibuprofen lysine were performed on commercial ZSM-5 ammonium with a 30:1 Si:Al 
ratio and one with a 200-400:1 Si:Al ratio as well as the iron ion exchanged ZSM-5 
30:1 ratio and the sodium ion exchanged ZSM-5 30:1 ratio. Using HPLC and powder 
XRD analysis it was found that the optimum form of ZSM-5 for the adsorption of 
paracetamol and ibuprofen lysine was the commercial ZSM-5 ammonium with the 
30:1 ratio, found to be due to its increased number of ammonium cations present 
relative to the other forms, and commercial ZSM-5 ammonium with a Si:Al ratio of 
200-400:1 the optimum form for the adsorption of aspirin, found to be due to its 
hydrophobicity. At halved and quartered batch concentrations for paracetamol 
commercial ZSM-5 ammonium 30:1 was found to have a much lower ability to 
adsorb paracetamol, adsorbing only 3.62% at max at the halved concentration, 
relatively small when compared to its maximum of 64.39% at normal concentration.  
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Glossary 
Si:Al  Silicon: Aluminium 
ZSM-5  Zeolite Socony Mobil-5 
SBU   Secondary building units 
S4R  Single four ring 
S6R  Single six ring 
S8R  Single eight ring 
D4R  Double four ring 
D8R  Double eight ring 
HSAB  Hard soft acid base 
XRD   X-Ray diffraction 
HPLC  High performance liquid chromatography 
UV  Ultra violet 
LC-MS Liquid chromatography – Mass spectroscopy 
LC-IR  Liquid chromatography – Infrared spectroscopy 
LC-NMR Liquid chromatography – Nuclear magnetic resonance 
SEM  Scanning electron microscope 
EDX  Energy dispersive X-Ray spectroscopy 
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Introduction 
 
1.1 – Zeolites and Zeotypes 
 
1.1.1 – Background 
Zeolites have been observed in nature since 1756, when the first one, stillbite, was 
discovered in Sweden by Baron Cronstedt.
[1]
 The term ‘molecular sieve’, coined 
because of zeolite’s ability to selectively take certain molecules into its porous 
structure whilst rejecting others based on their larger molecular dimensions
[2]
, was 
first introduced in 1926 when the sorptive properties of chabazite were attributed to 
its small pores.
[1]
 Through the early 1950s synthetic zeolites were first produced, these 
zeolites were given the prefix of ‘Zeolite’ to differentiate them from their natural 
counterparts. Examples from this time include zeolite A, zeolite X and zeolite Y. The 
first commercially available synthetic zeolite was made in 1953 by the Linde 
Corporation which was called Linde Type A zeolite or, more commonly, zeolite A.
[1,2]
 
 
Zeolites are a class of microporous crystalline aluminosilicates which occur in nature 
and can be synthesised in the laboratory. Zeolites have the general formula of 
Mx/n[(AlO2)x(SiO2)y] .mH2O, where n is the valency of the metal ion M which 
balances the negative charges in the aluminosilicate framework. These minerals have 
three dimensional structures which arise from a framework of [SiO4]
4-
 and [AlO4]
5-
 
tetrahedra that are linked by all their four corners.
[2]
 When these tetrahedra link they 
are governed by Lowenstein’s rule. This rule states that the distribution of tetrahedra 
in a crystal is not entirely random in amorphous and crystalline aluminosilicates and 
that whenever two tetrahedra are linked by one oxygen bridge, the centre of only one 
of them can be occupied by aluminium while the other centre must be occupied by 
silicon. Also, whenever two aluminium ions are neighbours with the same oxygen 
anion, at least one of them must have a coordination number larger than four, either 
five or six, towards oxygen. These rules explain that there is a maximum substitution 
limit of 50% of the silicon in the framework.
[3]
 The frameworks produced by these 
tetrahedra are generally open with channels and cavities, in which cation and water 
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molecules can reside. These cations have a high degree of mobility which give rise to 
easily achievable ion exchange and therefore zeolites are used industrially in ion 
exchange processes. The water molecules also have a large amount of freedom, being 
able to be easily lost and regained by the zeolite without any damage to the 
aluminosilicates framework.
[2]
 
 
The word zeolite has its basis in Greek and means ‘boiling stones’. This is due to the 
noticeable loss of water when zeolites are heated; this property visually illustrates 
how easily water is lost from the pores.
[2]
 Materials that share the properties of 
zeolites, i.e. molecular sieving, easy loss and gain of water, and a similar structure to 
zeolites but that are non-aluminosilicates are known as zeotypes. 
 
1.1.2 – Zeotypes 
Zeotypes share all their major properties with zeolites and only differ in that they 
contain elements other than Si and Al in the tetrahedral framework sites and 
sometimes lack certain properties of zeolites.
[4]
 The synthesis of these materials 
usually follows the logic of replacing one of the elements in a zeolite with another 
similar element to keep consistent properties. The most likely candidates for this 
replacement are elements in the same group as Al and Si on the periodic table such as 
Ga and Ge respectively, or that they share the same oxidation state as one of the two. 
However, the first commercially produced zeotype used neither of these elements.
[4]
 
 
The first accepted zeotype was discovered in 1982, when Union Carbide research 
laboratories reported a family of framework structures based on [AlO4]
5-
 and [PO4]
3-
 
known as aluminium phosphates.
[4]
 This zeotype is more commonly known by the 
acronym AlPO4. 24 compounds of this family have been described and all have the 
composition of χRAl2O3 
.
1.0(±0.2)P2O5 
.γH2O where R is the amine or quaternary 
ammonium species used as a component of the original gel synthesis
[4]
 and the 
quantity of (χ + γ) represents the amount needed to fill the microporous void of the 
final framework
[4]
. The majority of these compounds are three-dimensional structures 
while some of them have P-O-H environments, some are dense phosphate phases and 
some have a layered structure, though this layered structure can sometimes have 
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different Al:P ratios.
[3]
 13 of these compounds are found to be three-dimensional 
while also being classified as molecular sieves. Unfortunately, these compounds lack 
ion exchange properties as the overall framework charge is neutral, due to an Al:P 
ratio of 1:1 and strict alternation of Al and P throughout the framework. Titanium 
silicates represent another possible zeotype and Titanium Silicate-1 (TS-1) was first 
successfully synthesised in 1983. They share similar sorptive properties to their 
corresponding zeolite, in the case of TS-1 this is ZSM-5 as they share the same MFI 
structure, though TS-1 seems to have a lower hydrophilic aspect than ZSM-5. They 
differ from zeolites in that they have an octahedral coordination in their Ti:S 
framework as opposed to a tetrahedral for zeolites.
[5]
 
 
So, overall zeotypes differ from zeolites as they are not specifically aluminosilicates 
and they do not share all their properties. 
 
1.1.3 – Structure 
 As previously mentioned, all zeolites are microporous aluminosilicates with a three-
dimensional framework consisting of [SiO4]
4-
 and [AlO4]
5- 
tetrahedra. These 
tetrahedra are linked together by the vertices forming rings of varying size. Figure 1
[6]
 
shows a comparison of eight membered, ten membered and twelve membered rings. 
The formation of channels and cages has led to over 200 known zeolite framework 
types. The number of cations present is dependent on the ratio between the Al and Si 
in the framework. An increased number of Al
3+
 substituting into the framework over 
Si
4+
 leads to a residual negative charge on the oxygen framework. This negative 
charge leads to increase in cations to balance out the overall charge of the zeolite. The 
number and location of water molecules in the zeolite’s framework depends on a few 
different factors. First the overall structure of the zeolite, the size, shape and number 
of channels present in the zeolite and secondly the number and type of cation located 
in the zeolitic framework. Zeolites that contain no aluminium and only silicon on the 
oxygen framework would be neutral charged and have no cations present. High silica 
zeolites have hydrophobic tendencies when compared to low silica zeolites that 
commonly have hydrophilic tendencies. 
[7] 
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Figure 1. Comparison of the limiting ports of Erionite, ZSM-5 and Faujasite 
[6]
 
 
For the classification of zeolites, the usual process would be to relate them to the 
symmetry of their unit cells. This is troublesome however due their complex structure 
and so a simplified route has been found. The basis for this classification is the 
observation that zeolite structures often have very similar structural sub-units that 
repeat and lack the complexity of the repeating unit cells. These sub units are referred 
to as “secondary building units” (SBU)[4]. Using these SBUs a classification can be 
applied all of the known zeolite framework arrangements. There are eight SBUs total: 
single four ring (S4R), single six ring (S6R), single eight ring (S8R), double four ring 
(D4R), double eight ring (D8R), complex 4-1, complex 5-1 and complex 4-4-1. These 
are illustrated in the Figure 2 below.
[7] 
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Figure 2: A) Single four ring SBU. B) Single six ring SBU. C) Single eight ring SBU. D) 
Double four ring SBU. E) Double eight ring SBU. F) Complex 4-1 SBU. G) Complex 5-1 
SBU. H) Complex 4-4-1 SBU. 
[7] 
 
The SBUs only represents the aluminosilicate skeleton, with the positions of Al, Si 
and O being relative to one another, and excludes the cations and water moieties with 
the pores and cavities within the zeolite framework. The sites for water and cations 
themselves are complex and specific to the zeolite and only fully defined for certain 
zeolites. 
[7] 
 
1.1.4 – Uses 
Due to the unique structure of zeolites they have four main uses: molecular sieve, 
drying agent, ion exchanger and heterogeneous catalyst.
[8, 9, 10]
 Each of these will be 
described in turn. 
 
Molecular Sieve 
Zeolites themselves are not unique in their properties as molecular sieves, other 
compounds such as carbon and porous glass also have sieving properties but they are 
special in that they have highest flexibility of use for these kinds of materials. The 
structure of zeolites is responsible for their sieving properties as they possess a wide 
array of internal channels and cavities. The windows into the pore system are close in 
size to the dimensions of common organic and inorganic molecules and therefore 
H 
B A 
D 
C 
G F 
E 
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zeolites can separate mixtures of molecules, in either gas or liquid phase, as they 
allow molecules of certain sizes and dimensions to pass through. The size of the 
windows in the zeolite are dependent on the SBUs that make up the framework. The 
effective size of these windows is also affected by the nature and number of cations 
present in the pores and whether the zeolite is dehydrated. When water is removed 
from the zeolite the cations can move closer to the framework. This cation movement 
partially blocks access to the interstitial site via the window, reducing the effective 
pore size. The Si:Al ratio will also have an effect as that will limit the number of 
cations in the structure. The amount reduced is dependent on the size of the cation in 
the system, the larger the cation the more the effective pore size is reduced. This has 
been described as the sentinel effect.
[7] 
 
 
 
Drying Agent 
The second use of zeolites are as drying agents in which they are used almost 
universally in laboratories around the world. Bottles of Molecular Sieve 3A, 4A and 
5A
[2]
 can be found in many laboratories and these contain beads made of zeolite A, 
the different notations referring to alternate names for different ion exchanged 
versions.
[2,7]
 These beads are used as general purpose drying agents for purposes such 
as drying gas chromatography columns or drying an air-line for a vacuum. Dried, 
sealed cartridges of zeolites 3A, 4A and clinoptilolite are included in systems where 
water build up would cause malfunctions, these types of systems include vehicle 
braking and air conditioning systems and certain heavy duty transformers with 
hydrocarbon liquids stored inside of them. Another application where the use of 
zeolites is much preferred to the alternative is inside double glazed windows. The 
double-glazing units contain gases such as Ar, SF6 and halocarbons in the cavity 
between the glass panes which improve heat and sound insulation. When molecular 
sieves other than zeolites are used they slowly absorb the gases over time and so 
reducing the windows life span. This is avoided if zeolites 3A and 4A are used as they 
do not absorb these gases. They also remove any residual vapour left behind by the 
sealant used to fix the panes together.
[8]
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Ion Exchangers 
The third use, as ion exchangers, is based upon the property of zeolites which allows 
them to replace the cations held in their pores with cations present in solutions or 
melts. This property has been extensively researched and so modifications to zeolites 
through the changing of their cations have been performed. These modifications lead 
to changes in the catalytic or molecular sieving properties of the modified zeolite. Not 
all zeolites can perform simplistic ion exchange; zeolites that have a high density and 
low porosity, have limited and slow ion exchange properties. Unfortunately, despite 
the ease with zeolites can perform ion exchange their actual practical usefulness in 
this regard is very limited. One major limitation is their lack of compatibility with 
column use; synthetic zeolites usually crystallise with a particle size range of 0.1-1.0 
µ. This size is too small for column use as it does not facilitate a reasonable liquid 
transport through a bed of particles. Synthetic zeolites are usually marketed as crystal 
compacts but they are not attrition resistant under liquid column use. Natural zeolites 
have a much higher compatibility with column use than their synthetic counterparts 
and clinoptilolite has been used in columns worldwide. Another problem with using 
zeolites as ion exchangers arises due to zeolites inherent instability in low pH 
conditions. Zeolites with an Si:Al ratio between 1 and 2 readily lose Al from their 
framework in acid environments and this leads to reduced capacity and eventually 
complete framework collapse. These properties mean that any use as an ion exchanger 
comes with the caveat that any reaction using zeolites must have very specific 
conditions.
[9] 
 
Zeolites have been used as ion exchangers in commercial laundry detergents as a 
replacement for polyphosphates. Polyphosphates were replaced because of their 
negative effect on the environment so less hazardous alternatives were investigated. 
Their use in detergents was to remove Ca
2+
 and Mg
2+
 ions from washing water to 
prevent them from co-precipitating with surfactant molecules. Zeolites were found to 
be a good alternative as they could effectively carry out the same function. Zeolite A 
and zeolite X in a mix were chosen as the best alternative. The sodium form of zeolite 
A was found to remove Ca
2+
 ions extremely well but was found to have much less 
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success when removing Mg
2+
 ions due to poor selectivity.
[8]
 To make up for this the 
sodium form of zeolite X is used in conjunction with zeolite A as it removes the Mg
2+
 
to a satisfactory amount. Zeolite P is sometimes used instead of zeolite A as it has a 
higher affinity for calcium ions than zeolite A but since there is less data on zeolite 
P’s potential risks zeolite A is used more often.[10] Zeolites are also used in the nuclear 
industry to remove radioactive isotopes from radioactive waste water. Spent nuclear 
fuel rods are stored underwater in ponds
[8]
 to allow thermal and radioactive cooling to 
take place before the elements are reprocessed. Unfortunately, this storage leads to a 
build of fission products, especially the radioactive isotopes of 
137
Cs and 
90
Sr/
90
Y, in 
the ponds. This pond water is a major source of medium level radioactive waste and 
so much be processed before it can be released into the environment. Zeolites such as 
clinoptilolite have been used to remove the harmful isotopes from these bodies of 
water. The Sellafield plant removes Cs and Sr isotopes from its liquid effluents via the 
use of clinoptilolite in the SIX GP process, greatly reducing the negative impact upon 
the environment once it is released into the Irish Sea.
[9]
 
 
Catalysts 
The last major use for zeolites, as heterogeneous catalysts, has been one of the major 
branches of research into these materials. Zeolites were first used as catalysts in 1959 
when zeolite Y was used by Union Carbide as an isomerisation catalyst. The more 
important use however came in 1962 when zeolite X was first used as catalyst for 
cracking with zeolite Y now being used in fluid catalytic cracking. It was noted that 
small amounts of zeolites could be incorporated into the silica/alumina or silica/clay 
catalysts used at the time. This catalysis occurs via Brønsted acid sites produced by 
the aluminium sites in the zeolite’s framework. The use of zeolites in petroleum 
cracking greatly increased their efficiency and has secured them a place as a catalyst 
in the petroleum industry. The savings produced from this improvement number in 
the billions of pounds per annum. These savings led to the huge amount of money 
invested into the research of zeolites.
[11] 
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1.1.5 – ZSM-5 
The zeolite ZSM-5 (Zeolite Socony Mobil-5) is a medium pore zeolite with channels 
defined by ten-membered rings which was patented by the Mobil Oil Company in 
1975 and it has been widely used in the petroleum industry as a heterogeneous 
catalyst since. The chemical formula of ZSM-5 is NanAlnSi96-nO192 where n is 
between zero and 27. It has a relatively low aluminium content and therefore has a 
low number of cations present in its pores making it less suited for ion exchange 
reactions when compared to other zeolites. Similarly, its use a drying agent will be 
low as well as it has low water content and its framework has hydrophobic properties 
as opposed to the highly hydrophilic properties of most other zeolites.
[7]
 
 
Due to it having a medium pore size represented by a ten-membered ring, small being 
represented by an eight-membered ring and large being represented by a twelve-
membered ring, ZSM-5 has distinct sorption and diffusion properties. ZSM-5 can be 
considered an end-member of the pentasil family and the structure is formed by the 
stacking of layers with the neighbouring layers being related via inversion. The 
structure contains two types of channels, straight and sinusoidal. The straight channel 
running parallel to [010] formed by ten membered rings with 5.4 X 5.6 Å free 
diameter and the sinusoidal channel runs parallel to the [100] direction having ten 
membered rings with 5.1 X 5.4 Å free diameter and this is known as the MFI 
topology. The sinusoidal channels, which have a near-circular cross-section, run in a 
zig-zag pattern between the straight channel pores, which have an elliptical shape. 
The pore size dictates how large of a molecule the zeolite can adsorb, for example 
adsorption of hydrocarbons by eight membered ring zeolites is limited to normal 
paraffin while the twelve membered ring zeolites can adsorb molecules as large as 
tributylamine, which is 9.1 Å. ZSM-5’s ten membered ring and medium pore size 
means that it can adsorb as large as o- and m-xylene, 1,2,4-trimethylenzene and 
naphthalene all of which have minimum diameters of around 6.9Å, but these all 
adsorb slowly which would indicate some steric hindrance so these molecules would 
indicate the upper boundary. Hydrocarbons like pentamethylbenzene and 1,3,5-
trimethylbenzenene, which have minimum diameters of around 7.8Å, do not adsorb at 
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all and are essentially excluded from the zeolite. ZSM-5’s framework and structure is 
presented in figure 3 below.
 [7,12, 13] 
 
 
Figure 3. A) Structure of ZSM-5 with straight channel pores aligned and cations removed for 
simplicity. B) Structure of ZSM-5 with sinusoidal channel pores aligned and cations removed 
for simplicity.
[13]
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1.2 – Pharmaceuticals  
 
1.2.1 – Levels of Detection 
Over the last few decades the prevalence and production of pharmaceuticals in their 
many forms has increased dramatically due growing public demand. These chemicals 
have gone a long way to increase the quality of life and life expectancy of many. 
However, there has been a negative effect due to this, as the amount of waste from the 
production and use of these chemicals has increased and has accumulated in the 
environment. 
 
Most of these pharmaceuticals and their metabolites are polar and so easily dissolve in 
water, this has led to them being found in concentrations of ng to pg/L in drinking 
water, ng to pg/L in ground water, µg to ng/L in surface water, mg to µg/L in 
wastewater and g to mg/L in domestic and non-domestic sources such as households, 
industries and healthcare establishments
 [14]
. Relatively large amounts have been 
found in the effluent of waste water treatment plants indicating that they are not 
successfully removing all this pharmaceutical waste is not completely removed from 
our water supply. For example the average concentration of ibuprofen in the influent 
of investigated waste water treatment plants was found to be 14.6 µg/L and in the 
effluent it was reduced to 1.96 µg/L.
[15]
 The average concentration of salicylic acid, a 
metabolite of aspirin, found in the influent of investigated waste water treatment 
plants was found to be 212 µg/L and in the effluent it was reduced to 2.50 µg/L.
[15]
 
Though these are large reductions the concentrations going into the water supply are 
still at the µg/L level and though these levels are way below what we expose 
ourselves to through the use of these pharmaceuticals very little is known about the 
long term effects of chronic low level exposure of this waste on humans.  
 
More is known about the impact on aquatic life and bacterial resistances, as impaired 
reproductive and immune systems as well as structural and neurological damage in 
fish and amphibians has been linked to the increase of pharmaceutical waste along 
with increased antibiotic resistance in bacteria
 [16]
. To prevent any more drastic effects 
in the long term effective and easily applicable water purification techniques need to 
be researched to ensure clean water and a healthy environment for the future. It is 
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especially important as the industries that are producing these chemicals and their use 
by the common public continue to increase. 
 
1.2.2 – Environmental Concerns  
With the advancement of the pharmaceutical industry as well as the increase in 
commercial availability of over the counter analgesics, the use of analgesics by the 
mass public has increased. This means that the amount of pharmaceutical waste 
released into the environment due to the production of these chemicals has increased 
and can be found at the highest concentrations in the effluents of sewage treatment 
plant. These pharmaceuticals are being detected in concentrations of µg/L such as 
ibuprofen being 1.96 µg/L. Analgesics and anti-inflammatory drugs waste have been 
found to have some of the highest influent concentrations, being over 292 µg/L, while 
hormones have the lowest at ng/L level.
[15]
 Research comparing the influents and 
effluents of sewage treatment plants near the outflow of pharmaceutical factories has 
shown that the reduction of the pharmaceuticals found was a 100% reduction t the 
highest, varying from chemical to chemical but going as low as 0% uptake for some 
when using activated sludge processes.
[2]
 Additionally most pharmaceuticals do not 
always break down completely in the body and so some of the drug and its 
metabolites are excreted, which in turn enter the water system through the sewage 
plant and other pathways illustrated in figure 4
[17]
. Due to their high use by the general 
public, pharmaceuticals such as analgesics are increasing being introduced into the 
environment in this manner
[14]
. 
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Figure 4. Possible pathways of pharmaceuticals into the environment.
[17]
 
 
The effect on aquatic life has not been investigated thoroughly for all pharmaceuticals 
but the effects of oestrogen hormones on fish has been looked into. Work by Olsen et 
al
[12]
 on the effects and incidence of oestrogenicity, found in the effluent of a Swedish 
sewage treatment plant, on juvenile rainbow trout were investigated. In the effluent of 
the sewage plant they found the synthetic oestrogen used in contraceptives 17α-
ethinyloestradiol, the natural oestrogens oestrone and 17β-oestradiol and the weaker 
non-steroidal oestrogens 4-nonylphenol and bisphenol. All these oestrogens were 
found in ng/L levels but the amount of ethinyloestradiol found exceeded the levels 
shown to oestrogenic to fish by 45 times. 
[18]
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Key to figure,                            Strong Evidence,                             Medium Evidence,                             Weak Evidence                                                                                     
Effects on human health Effects on aquatic organisms 
Runoff 
Digested 
Sludge 
Leakage 
Application of Pharmaceuticals (by doctor’s 
pharmacies, over the counter medication etc.) 
Excretion 
Sewage System 
Sewage Treatment Plants 
Surface Water 
Sediment 
Soil 
Disposal 
Waste 
Landfill 
Drinking Water 
Incineration 
Groundwater 
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When 17β-oestradiol is present in fish it acts as an inducer of vitellogenin, a complex 
precursor protein normally found in the blood of maturing female fish but very low in 
male or juvenile fish and is used in the production of yolk in all oviparous vertebrates. 
However, many other environmental oestrogens, which include alkyl-phenolic 
compounds, phyto-oestrogens, synthetic oestrogens and certain pesticides, have been 
found to also induce vitellogenin synthesis in male and female fish. Due to this the 
presence of vitellogenin in the blood of male or juvenile fish has become a biomarker 
for identifying oestrogenic contamination of an aquatic environment. The research 
was carried out by introducing juvenile rainbow trout downstream of the sewage 
treatment plants effluent and after two weeks samples of their bile and blood plasma 
were analysed using GC/MS for the bile and by ELISA and Western blotting for the 
blood plasma. All the oestrogens mentioned were found in the bile collected and large 
amounts of the vitellogenin was found in the blood plasma. This shows that a widely 
used synthetic oestrogen caused negative effects in the endocrine systems and 
hermaphroditic tendencies in fish exposed to sewage effluent water.
[18]
 Considering 
that analgesics have the second highest incidence in sewage effluents
[19]
 after 
hormones and that mostly their effects on the aquatic environment have not been 
thoroughly investigated, the introduction of a much more efficient removal system 
would be prudent and if successful this research could provide that.  
 
 
1.2.3 – Current Filtering Techniques 
As mentioned before
[15]
 current techniques used for water purification do not 
completely remove pharmaceutical waste. Some of the most common removal 
techniques for organic compounds from wastewater are biological filters and activated 
sludge. Both techniques are similar in that they are both types of secondary 
wastewater treatment techniques that take place during secondary biological treatment 
and they both use two vessels, the first being a reactor containing large amounts of 
micro-organism populations. These micro-organisms oxidise the organic compounds 
so they are easier to remove, this is dependent on the biochemical oxygen demand and 
so oxygen is present in this reactor. The second vessel is a tank that removes the 
micro-organism from the effluent via sedimentation. The removal of organic micro-
organism pollutants from during this process include the adsorption onto microbial 
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flocs and removed in waste sludge, through biological or chemical degradation or 
through transformation and volatilisation during aeration. These mechanisms are 
displayed on Figure 5
[20]
 below but as shown in that diagram, some organic polar 
compounds are left unoxidised and are released into the next step of wastewater 
purification subsequently into the environment.
[20]
  
 
Figure 5. Removal mechanisms for organic micro-pollutants during secondary biological 
treatment.
[20]
. 
 
Most pharmaceuticals are polar molecules designed to dissolve in water and some are 
also designed to be resistant to biological degradation to improve therapeutic 
performance. Therefore, higher concentrations of these pharmaceuticals will be 
released into the environment because they are not fully removed by the wastewater 
purification techniques. However, treatment technologies based on advanced 
oxidation processes
[21, 22, 23]
 or adsorption on to appropriate solid materials such as 
activated carbon cloth
[24, 25]
 have been investigated and suggested as replacements or 
additions to the current system. Unfortunately, advanced oxidation processes are 
expensive and energy consuming, additionally total mineralisation of the pollutants 
cannot be reached. This can result in potentially dangerous products or by-products 
forming. Activated carbon cloth meanwhile has yet to demonstrate its ability to 
remove pharmaceutical waste. All this has led to an increased demand for adsorbent 
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materials that can achieve higher efficacy and better selectivity in the removal of 
pharmaceutical waste compounds in variable conditions. 
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1.3 – Zeolites and Pharmaceutical Waste 
Previous research has proven that zeolites are useful when adsorbing organic 
compounds. Shu et al
[17]
 investigated the use of zeolites in the adsorption of organic 
molecules form an aqueous solution. They used surfactant-modified pillared clays, 
silicalite and zeolite beta with high Si/Al ratios to remove phenol, chlorophenols and 
nitrophenol from an aqueous solution. They found that the surfactant-loaded pillared 
clays had a moderate capacity for the adsorption of the phenol and chlorophenols 
from an aqueous solution but were not seen to be a viable candidate as it had high 
adsorbance capacity for phenol, at low concentrations it fell lower than the silicalites. 
Also, it had the draw-back of discharging surfactant into the aqueous phase during the 
adsorption process. Hydrophobic silicalite, with a high Si/Al ratio, was found to have 
a high capacity for phenols and is efficient even at lower organic concentrations. Its 
capacity for phenols reaches a maximum value at a Si/Al ratio of 563 with further 
increases having no further effect on the adsorption capacity. Silicalites were found to 
be poor at adsorbing larger molecules as their internal pore structure limits access. 
Dealuminated zeolite beta with a Si/Al ratio of 170 however was found to be a good 
choice for an adsorbent for the larger phenols due to its larger pore size but was out 
performed by the silicalite on the smaller phenols, having only 60% the adsorption 
capacity, based on moles, of the silicalite for the smaller phenols. They also found 
that at higher Si/Al ratio that the adsorption capacity of both the silicates and zeolite 
beta were increased becoming comparable, but lower by a factor of two, to the 
capacities of organic resins XAD-2, XAD-4 and XAD-7 which were designed to 
adsorb organics from an aqueous solution. Overall this research shows that zeolites 
have been proven useful in the removal of small to large organic molecules from 
aqueous solution, thus adding credence to their use in this research.
[17]
 
 
 
Khodaverdi at al
[26]
 investigated the use of synthetic zeolites in adsorbing and then 
releasing anti-inflammatory drugs for use in modified-release drug delivery systems 
for the gastrointestinal tract. For a carrier to be ideal it must release the adsorbed drug 
into the intestine, which is the main area for absorption. They used zeolite X and Y as 
the carriers and sodium diclofenac and piroxicam as the drug molecules. They heated 
the zeolites for 48 hours to ensure the absence of water in the zeolites. Two methods 
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for loading the drugs onto the zeolites were used and analysed them using weight 
measurement, spectroscopy FTIR, thermogravimetry and scanning electron 
microscopy to confirm the drug loading into the zeolite. Simulated gastric fluid and 
simulated intestinal fluid were synthesised and used to determine how much of the 
drug the zeolites would desorb at the specific sites within the body. They found that 
the zeolites adsorbed over 90% of the drugs loaded onto them. The pure drugs without 
the zeolites were found to release around 90% of their concentration in the simulated 
gastric fluid within the first 15 minutes whereas the drugs adsorbed into the zeolites 
released a much smaller amount, around 10-20%, in the same time frame. However, 
they found that in the simulated intestinal fluid that the drug release from the zeolites 
was quite slow but a continuous process. They concluded that this was favourable as a 
drug delivery system as a large concentration of the drugs being released into the 
stomach caused irritation in the stomach lining, and that the overall performance for 
the release of diclofenac and piroxicam in the simulated gastric fluids and slow 
release in the simulated intestinal fluid was higher for zeolite Y compared to zeolite 
X. This research shows that synthetic zeolites can be used to adsorb anti-
inflammatory drugs so theoretically so could ZSM-5.
[26] 
 
Research by Rakic et al
[27]
 attempted to adsorb the following pharmaceuticals and 
pharmaceutical metabolites, salicylic acid, acetylsalicylic acid and atenolol from 
aqueous solutions onto clinoptilolite, which has been modified with sorbed metallic 
cations Cu(II), Zn(II), Ni(II) and Mn(II) as they will form stable complexes with N- 
and O-donor groups (following the Hard-Soft Acid-Base theory (HSAB theory)) that 
are present in the pharmaceuticals investigated. The HASB theory applies to Lewis 
acids and bases and explains the stability of compounds and the viability of reaction 
pathways. It assigns the terms hard or soft and acid or base to chemical species and if 
their ability to react together is shown in a like for like system. This means hard acids 
react well with hard bases and vice versa. This is important when designing reactions 
as it can help indicate what reactions will work well and can also help indicate the 
solubility of different compounds in water or mobile phases for analytical techniques 
such as high performance liquid chromatography. They also used the natural clays, 
kaolin and bentonite (pure or ion-exchanged by octadecyl dimethyl benzyl ammonium 
chloride), as adsorbents as well. All three of these are naturally occurring materials. 
The adsorption was observed at 30
o
C (303.5K) by titration microcalorimetry which 
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was employed to obtain the heats evolved because of adsorption. These evolved heats 
were found to be directly linked to the strength of the interaction between the 
adsorbate and adsorbent and therefore the affinity of the pharmaceuticals used for the 
adsorbents were reflected by the evolved heats. They used volumetric experiments to 
indicate the adsorption capacities of the adsorbents used towards specific 
pharmaceuticals used. Their results showed that all the adsorbents investigated had 
affinities for the adsorption of the chosen pharmaceuticals with the maximal 
adsorption capacities within the range of 10
-5
-10
-6
 mol/g. Their data also showed that 
the adsorption capacities of the adsorbents used could be tailored by applying 
modification procedures but that these procedures did not affect their structural 
characteristics. Overall they demonstrated that the removal of salicylic acid, 
acetylsalicylic acid and atenolol from aqueous solutions by aqueous phase adsorption 
was found to be highly dependent on the nature of the adsorbate. The presence of 
some organic functional groups appear to play an important part in the mechanism of 
adsorption of the specific adsorbate. Parameters such as hydrophobicity and the 
physical states of the adsorbate molecules in the aqueous solution are also 
important.
[27] 
These results and their analysis show that the use of natural zeolites can 
be effective in the removal of salicylic acid, acetylsalicylic acid and atenolol from 
aqueous solution via adsorption and so the removal of the drugs investigated in this 
research from aqueous solution could be viable using ZSM-5.
 
 
Zeolites can be used to adsorb other groups of pharmaceutical apart from analgesics. 
Martucci et al
[28]
 studied the sorption capacities of dilute solutions of drugs onto 
hydrophobic zeolites. They investigated the removal of the three drugs, erythromycin 
(an antibiotic), carbamazepine (an analgesic) and levofloxacin (an antibiotic) from a 
solution in water using the three synthetic zeolites Y, mordenite and ZSM-5. They 
added the zeolites to solutions of the pharmaceuticals in water and measured their 
concentration at different times to find out at what point an equilibrium is reached. 
They then determined the maximum adsorbance capacity of the zeolite by introducing 
a zeolite into a pharmaceutical aqueous solution until equilibrium is reached, they 
then separate the zeolite and solution and take the solution off the be tested using high 
pressure liquid chromatography/mass spectrometry. They then took the zeolite and 
introduced it to a fresh aqueous solution and the process repeated. Once the 
concentration of the solution ceased to change then maximum adsorbance had been 
20 
 
reached. Powder X-Ray diffraction patterns were collected and the presence of the 
drugs inside the zeolite pores was shown by variations in these unit cell parameters. 
Overall, it was shown that zeolite Y adsorbed high amounts of the three drugs tested 
compared to the other adsorbents. This data was then confirmed by thermogravimetric 
analysis. To test the ability of organophilic zeolites in removing drugs from 
wastewater they took samples of water from the outlet of a wastewater treatment plant 
located in Northern Italy and determined the adsorption of erythromycin, 
carbamazepine and levofloxacin onto zeolite Y. They found that the drugs were 
almost completely adsorbed by zeolite Y thus confirming its viability at removing 
pharmaceutical waste from wastewater.
[28]
 This research shows that not only can 
zeolites be used to adsorb pharmaceuticals from wastewater, in this case antibiotics, 
but that synthetic zeolites can be used for this task. This means that though ZSM-5 
was not useful in the adsorbance of the pharmaceuticals analysed in the paper it can 
be used to remove pharmaceuticals from water. 
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1.4 – Aim of Research 
The aim of this research is to determine ZSM-5’s viability in the removal of 
pharmaceutical waste from aqueous solution, specifically looking into the removal of 
the analgesics paracetamol, aspirin and ibuprofen lysine. Analgesics were chosen to 
be the focus of study because they were found in the effluent of investigated 
wastewater treatment plants in the second highest concentration second only to 
hormones, 20% for analgesics and 30% for hormones.
[18]
 Ibuprofen lysine was 
chosen over ibuprofen as it was slightly more soluble in water and thus easier to 
analyse for the purposes of this research. A synthetic zeolite was chosen due to its 
ability to be mass-produced, any filtration system could have this easily applied to as 
its source is not necessarily finite, and research has been done into the use of 
naturally occurring zeolites and clays, like clinoptilolite and bentonite respectively, 
for the same purpose.
[26]
 ZSM-5 was chosen out of the synthetic zeolites available 
due to a lack of research into its use in this manner, that other similar synthetic 
zeolites such as zeolite X and Y have had research into their use and adsorbents
[27]
 
and that its unique characteristics, like its intermediate pore sizes, might aid in its 
adsorption of the drug molecules of interest. Two Si:Al ratios were chosen for 
investigation because a change in this ratio can lead to changes in the sorptive 
characteristics of the ZSM-5, an increase leading to a lower number of charge 
balancing cations present and higher hydrophobic properties and vice versa. These 
changes could change the sorptive affinity of the drugs investigated for ZSM-5 and 
so should be explored. Similarly, a change in the charge balancing cation can change 
these affinities as well, therefore ion exchanged ZSM-5 shall be used. Iron is being 
used for one of the ion exchanges as it would imbue the ZSM-5 with ferro-magnetic 
properties allowing for easy removal from the water supply once adsorption of the 
drugs have taken place. The uptake levels of the drugs investigated shall be 
characterised by high performance liquid chromatography, powder X-ray diffraction 
and scanning electron microscope with energy dispersive X-ray spectroscopy. 
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2. Methodology 
 
2.1 Experimental 
The chemicals used in this research are the commercially available analgesics 
paracetamol
[28]
, aspirin
[29]
 and ibuprofen lysine
[30]
 all purchased over the counter from 
the pharmacy Boots, commercially available zeolite ZSM-5 ammonium 30:1
[7]
 and 
zeolite ZSM-5 ammonium 200-400:1
[7]
 both purchased directly from the chemical 
supplier Alfa Aesar
[31, 32]
, and iron chloride
[33]
 and sodium chloride
[34]
 both of which 
came from UCLan’s laboratory stores. These chemicals were used for an adsorption 
experiment to determine the sorptive capacity of ZSM-5 with regards to the drugs 
used. First 0.005M, 0.005M and 0.002M aqueous solutions of paracetamol, aspirin 
and ibuprofen lysine respectively are prepared. These concentrations were chosen as 
mM is one order of magnitude higher than the highest concentration found in the 
effluent of wastewater treatment plants investigated by C. Miege
 
et al
[35]
, this increase 
would allow us to investigate whether ZSM-5 would be useful as a drug removal 
agent in the future if concentrations of these chemicals in the water system increase. 
0.005M was found to be the highest concentration where all the solid dissolves in 
solution for paracetamol and aspirin, ibuprofen lysine being less polar than the other 
two analgesics used had its maximum concentration for full solid dissolution being 
found at 0.002M. 0.5g of ZSM-5 is then added to 250ml of the solution being 
analysed and the mixture stirred at room temperature for intervals between 2 and 48 
hours at 400rpm. The solid is recovered using vacuum filtration and analysed using 
powder X-Ray Diffraction (XRD). The concentration of drug remaining in the 
filtrated solution is determined using High Performance Liquid Chromatography 
(HPLC). This basic template was used for all the experiments. To determine the effect 
that the charge balancing cations have on the adsorption reaction a form of ZSM-5 
ammonium with an increased Si:Al ratio of 200-400:1 was used instead of the 30:1 
form. Ion exchange experiments were also carried out on the 30:1 form of ZSM-5 
prior to adsorption. The NH4
+ 
containing ZSM-5 was exchanged with Fe(II) and Na. 
For the ion exchange 10g of the zeolite was stirred overnight in a 500ml 0.1M metal 
ion solution. The zeolite was then filtered, washed and the process repeated a further 3 
times. Successful ion exchange was verified by SEM/EDX and XRD. Finally, the 
concentration of the paracetamol aqueous solution was reduced to verify if ZSM-5 
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could remove drug waste at lower concentrations effectively, these concentrations 
being 0.0025M and 0.00125M, half and a quarter of the original concentration used 
for the aqueous paracetamol solution.  
 
2.2 Setup 
The aqueous solutions of the analgesics were made in 1L batches from store bought 
packs of the drug being analysed. The concentration and mole equations were used to 
calculate the mass of the drug needed. Concentration was calculated using drug mass 
per tablet and not using total tablet mass. This is because the tablets themselves were 
not 100% pure as they have various other chemicals to help with their ingestion and 
stability, and so the percentage impurity (% impurity) was needed. To find this out 
this equation 1 was used. 
𝑊𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑇𝑎𝑏𝑙𝑒𝑡 𝑎𝑠 𝐴𝑑𝑣𝑒𝑟𝑡𝑖𝑠𝑒𝑑 𝑜𝑛 𝑡ℎ𝑒 𝑃𝑎𝑐𝑘𝑎𝑔𝑖𝑛𝑔 (𝑔)
𝐴𝑐𝑡𝑢𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑇𝑎𝑏𝑙𝑒𝑡 (𝑔)
× 100 = % 𝐼𝑚𝑝𝑢𝑟𝑖𝑡𝑦 
Equation 1. Percentage impurity equation. 
This equation is assuming that the weight on the packaging is referring to the weight 
of the drug in the tablet which seems likely as it does not correspond with the overall 
weight of the tablet. This % impurity is then used to work out the mass of tablet 
needed in equation 2. 
𝑀𝑎𝑠𝑠 𝑜𝑓 𝑇𝑎𝑏𝑙𝑒𝑡 𝑁𝑒𝑒𝑑𝑒𝑑 (𝑔) = 𝑀𝑎𝑠𝑠 (𝑔) × 1. (
% 𝐼𝑚𝑝𝑢𝑟𝑖𝑡𝑦
100
) 
Equation 2. Mass of tablet needed equation. 
This will give the concentrations needed. 
 
2.3 High Performance Liquid Chromatography (HPLC) 
 
High performance liquid chromatography (HPLC) is the analytical technique used to 
analyse the liquid filtrate from the ZSM-5 experiments. It was used ascertain the 
concentration of the drug remaining in the solution and therefore how much was 
adsorbed by the zeolite. For this a set of calibration concentrations needed to be made 
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to produce a calibration curve. The peaks produced by the HPLC are specific to the 
chemical producing them and the mobile phase used, i.e. the peak produced by 
paracetamol should always elute at the same time, if the mobile phase used is 
constant for all analyses’. The area of the peaks are proportional to their 
concentration so using set concentrations of the chemical being analysed a plot of 
their areas can be produced. A line of best fit is drawn and the equation for this line 
can be used to determine the concentrations of the drug peaks in the adsorption 
experiments. The calibration standards were produced using serial dilutions and these 
equations: 
𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 (𝑀) =
𝑀𝑜𝑙𝑒𝑠 (𝑚𝑜𝑙)
𝑉𝑜𝑙𝑢𝑚𝑒 (𝐿)
  
𝑀𝑜𝑙𝑒𝑠 (𝑚𝑜𝑙) =
𝑀𝑎𝑠𝑠 (𝑔)
𝑀𝑜𝑙𝑎𝑟 𝑀𝑎𝑠𝑠 (
𝑔
𝑚𝑜𝑙)
 
𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 (𝑀)1𝑉𝑜𝑙𝑢𝑚𝑒 (𝐿)1 = 𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 (𝑀)2𝑉𝑜𝑙𝑢𝑚𝑒 (𝐿)2 
 
A sample of the experiments solution is taken and injected into the HPLC and 
subsequently flows through the system shown in figure 6
[36]
. It passes through the 
column taking a certain amount of time to reach the detector, this time is referred to 
as the elution time. This elution time is dependent on two factors, the affinity of the 
chemical analysed for the mobile phase compared to the stationary phase and the 
chemical being analysed. If the sample has a higher affinity for the mobile phase than 
the stationary phase, then its elution time will be less. The opposite is also true, a 
higher affinity for the stationary phase leads to a longer elution time. The chemical 
being analysed will have a set range for elution times based upon the mobile and 
stationary phases used. This allows for the identity of chemicals to be found if used 
with other techniques as multiple chemicals have overlapping elution time ranges.  
 
The detector used in the HPLC can change what chemicals can be identified as there 
is no perfect universal detector yet available. There are four main types detector that 
differ by taking advantage of different physical or chemical attributes of the analyte 
or the mobile phase. The first and closest to a universal detector are bulk property 
detectors, these measure properties that are common to all analytes by measuring 
differences in the mobile phase with and without the sample, and the refractive index 
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detector is one of the most common bulk property detectors.  Because bulk property 
detectors react to all analytes more emphasis is placed on the selectivity of the 
chromatographic column used, though overall this type of detector is limited in its 
sensitivity due to its bulk identification technique being the equivalent of determining 
the weight of a person by weighing their car before and after they get in to it.
[37] 
 
The second type of detector is the analyte specific property detector; these respond to 
unique characteristics of certain analytes. The most commonly used of this type is the 
Ultra Violet (UV) detector which responds to analytes that absorb UV light at 
particular wavelengths. Though usually specific to analytes with chromophores the 
range of detection for UV detectors can be increased by using low wavelengths, 
<210nm, as almost all organic compounds absorb UV radiation at this wavelength. 
Other types of analyte specific detector include fluorescence, conductivity and 
electrochemical detectors.
[37] 
 
Mobile phase modification detectors are the third type and these change the mobile 
phase post-column to produce a change in the properties of the analyte such as 
creating particles suspended in a gas phase. Detectors that fit into this category 
include evaporative light scattering and corona discharge detectors.
[37] 
 
The final type of detectors use hyphenated techniques; this refers to the use of 
independent analytical technologies alongside a HPLC system. These include mass 
spectrometry (LC-MS), which is the most common, infrared spectrometry (LC-IR) 
and nuclear magnetic resonance (LC-NMR).
[37] 
 
Once identified its concentration can be established though the use of previously 
mentioned calibration curves. These properties are why HPLC has been chosen for 
this analysis. 
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Figure 6. Diagram of HPLC machine.
[36]
 
 
The HPLC used in this work was a Perkin Elmer LC 90 BIO. The Supercosil
TM
 LC-
18 HPLC column with C18 as the matrix active group and a UV detector was used. 
To analyse the three drugs being looked into two different mobile phases and 
wavelengths were required. For the analysis of paracetamol and aspirin the 
wavelength of the machine was set to 254nm and the mobile phase consisted of 
methanol: water: acetic acid with the ratios of 40: 60: 1.6. For ibuprofen lysine, 
however the wavelength was set to 220nm and the mobile phase consisted of water: 
acetonitrile: phosphoric acid with the ratios of 45: 55: 0.045. 
 
2.4 Powder X-Ray Diffraction (XRD) 
 
Powder X-Ray Diffraction (XRD) produces patterns based upon the crystal structure 
of the compound and gives us information on the composition and structure of the 
compound analysed, i.e. the unit cell, its thermal parameters, its particle size and the 
location and nature of its atoms. Any changes in the XRD pattern can be related to a 
change in the structure or in the shape and contents of the unit cell. 
 
Crystalline substances act like three-dimensional diffraction gratings towards X-ray 
wavelengths that are similar to the spacing of planes in crystal lattices XRD is based 
upon the constructive interference of monochromatic waves by a crystalline sample. 
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The X-rays are generated in a cathode ray tube and then, based on the diffractometer, 
sometimes filtered to produce monochromatic radiation, collimated to concentrate 
and then directed towards the sample. The interaction of the incident rays with the 
sample produces constructive interference and a diffracted ray when the conditions 
satisfy Bragg’s law.  
nλ = 2dsinθ 
Equation 3. Bragg’s Law[38]
 
 
Equation 3
[38]
 is Bragg’s Law, where n is the order of reflection and an integer, λ is 
the wavelength of the incident X-rays, d is the interplanar spacing of the crystal and θ 
is the angle of incidence. This law is shown in figure 7
[38]
 and it relates the 
wavelength of the electromagnetic radiation to the diffraction angle and the lattice 
spacing in crystalline samples. The diffracted X-rays are detected, processed and 
counted by the detector. By scanning the sample through a range of angles of 
incidence all the possible directions of the lattice can be attained due to the random 
orientation of the powdered material. The d-spacing of the crystal system can be 
calculated by using the d-spacing equation, though the crystal geometry must be 
known beforehand as the equation differs dependent on them. For example, equation 
4 is the d-spacing equation for cubic crystal systems. 
1
𝑑2
=
ℎ2 + 𝑘2 + 𝑙2
𝑎2
 
Equation 4. d-spacing equation for cubic crystal system.
[39] 
 
In equation 4 h, k and l represent the miller indices, d represents the d-spacing and a 
represents the lattice parameters, there is only one as for cubic they are all equal. 
ZSM-5 is not a cubic crystal system and so this equation does not apply to it. ZSM-
5’s crystal system is orthorhombic and equation 5 is the d-spacing equation for 
orthorhombic, with h, k and l representing the miller indices, d representing the d-
spacing and a, b and c representing the lattice parameters. 
1
𝑑2
=
ℎ2
𝑎2
+
𝑘2
𝑏2
+
𝑙2
𝑐2
 
Equation 5. d-spacing equation for orthorhombic crystal system.
[39]
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The intensity of the peaks in the diffraction patterns can be calculated using equation 
6 where Ihkl is the intensity, K is a proportionality constant, (Lp)hkl is the Lorentz-
Polarisation factor, which contains two parts, the Lorentz factor and the polarisation 
factor, jhkl is the multiplicity of the {hkl} planes, Whkl is the Debye temperature 
correction factor, Ahkl is the absorption factor and Fhkl is the structure factor. 
𝐼ℎ𝑘𝑙 = 𝐾(𝐿𝑝)ℎ𝑘𝑙𝑗ℎ𝑘𝑙𝐹ℎ𝑘𝑙
2 𝑒−2𝑤. 𝐴ℎ𝑘𝑙 
Equation 6. Intensity equation for a diffracted X-ray peak
[40] 
The Lorentz factor is a function of θ and is dependent on the geometry of the 
experiment and the polarisation factor is used to correct for the unpolarised nature of 
the X-rays produced by the X-ray tube. These X-rays are at their most intense when 
either parallel or antiparallel to the incident beam and at their weakest when 
perpendicular. The correction done by these factors is in the form of
1
2
(1 + 𝑐𝑜𝑠22𝜃). 
The multiplicity term, jhkl, takes into account the amount of equivalent reflections that 
can give rise to a single powder line, for example the (122), (212) and (221) 
reflections for a cubic material will all have the same d-spacing and so make a single 
line. The absorption factor is related to the geometry of the experiment and the Debye 
temperature corrects for the thermal motion of the atoms in the crystal, as when they 
vibrate the intensity is reduced. The structure factor of a particular lattice plane is 
shown in equation 7
[40]
, where fi, the atomic scattering factor, is the sum of the 
scattering from each electron and therefore is dependent on the atomic number. 
𝐹ℎ𝑘𝑙 = ∑ ∑ 𝑓𝑖[cos 2𝜋 (ℎ𝑥𝑖 + 𝑘𝑦𝑖 + 𝑙𝑧𝑖) + 𝑖 sin 2𝜋 (ℎ𝑥𝑖 + 𝑘𝑦𝑖 + 𝑙𝑧𝑖)]
𝑛=𝑁
𝑛=1𝑎𝑙𝑙
𝑙𝑎𝑡𝑡𝑖𝑐𝑒
𝑝𝑜𝑖𝑛𝑡𝑠
 
Equation 7. Structure factor equation
[40]
 
 
The powder XRD data were collected on a Bruker D2 phaser using CuKα1α2 radiation 
(λ = 1.5418Å average) operating in θ-θ geometry and equipped with a LynxEye PSD 
detector. The scan range was 5-80
o2θ with a scan time of 20 minutes. Pawley fits 
were performed on the data using the programs TOPAS and Jedit, Pawley fits 
themselves being a process in which observed peaks in a powder pattern are fitted 
29 
 
without a structural model but with 2-theta values that are constrained by the size and 
symmetry of the unit cell and can be used to give an indication of the best fit possible 
from a structural refinement.  
 
 
Figure 7. Bragg’s Law reflection. The diffracted X-rays exhibit constructive interference 
when the distance between paths ABC and A’’C’ differs by an integer number of 
wavelengths (λ).[38] 
 
If the relative intensities of the peaks change then this indicates a change in the 
chemical contents of the unit cell. If this change was shown in a ZSM-5 XRD pattern 
after being introduced to the aqueous drug solutions it would indicate that something 
has been taken up into the zeolite, and when taken in context, that the drug had been 
adsorbed. If for example the peaks were to shift to the left or right this would indicate 
a change in the unit cell, either compressing or expanding it. If the peaks shift to the 
right, towards the higher 2-theta values, then the unit cell would be compressed 
whereas if the peaks shifted towards the left, towards the lower 2-theta values, then 
the unit cell would be stretched though this can be somewhat dependent on the cell 
symmetry. This effect is illustrated by equation 3, Bragg’s Law, the 2-theta value 
being inversely proportional to the d-spacing. Due to ZSM-5 and zeolites in general 
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having a rather high level of flexibility when it comes to their unit cells this could be 
caused by the adsorption of the drug in the solution. This technique shall be used 
alongside HPLC analysis to confirm that the drug being analysed has been taken up 
into the ZSM-5 and not lost in some other fashion. An example of a XRD pattern is 
shown in figure 8, this pattern being from pure ZSM-5 ammonium 30:1. 
 
 
Figure 8. The powder XRD pattern for ZSM-5 ammonium 30:1. 
 
2.5 Scanning Electron Microscope with Energy Dispersive X-Ray Spectroscopy (SEM 
EDX) 
 
Scanning Electron Microscopes (SEM) allows for the production of high resolution 
images of the surface of materials with resolution better than 1 nanometre. An 
electron beam is scanned across a sample’s surface and when the electrons strike the 
sample a variety of signals are generated. The interpretation of these signals is how 
the images produced by an SEM are formed. The three signals most important in an 
SEM and the ones that provide the most information are the secondary electrons, 
backscattered electrons and secondary X-rays. Secondary electrons are emitted from 
the surface of the atoms occupying the top surface of the sample and produce a 
readily interpretable image of the surface, the contrast of which is determined by the 
samples morphology. A high-resolution image can be obtained because of the small 
diameter of the primary electron beam. The backscattered electrons are the primary 
beam electrons that are ‘reflected’ by the atoms in the solid. The contrast in the 
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image produced is determined by the atomic number of the elements in the sample. 
Therefore, the image will show the distribution of different chemical phases in the 
sample, but because these electrons are emitted from a depth in the sample the 
resolution of the image produced is not as good as the one from the secondary 
electrons. 
 
Interaction of the primary electron beam with atoms in the sample causes shell 
transitions which result in the emission of an X-ray. This emitted X-ray has an energy 
that is characteristic of the element that produced it or the parent element. Detection 
and measurement of these X-rays and their energy allows for elemental analysis; this 
is known as Energy Dispersive X-ray Spectroscopy (EDX). It is this aspect of SEM 
EDX that is useful for this research as it is needed to confirm whether the ion 
exchanges performed in the experiments are successful as it will allow us to gauge 
the elemental changes to the ZSM-5 used. 
 
The SEM EDX used for the analysis in this work was a FEI Quanta 200 SEM EDAX. 
The accelerating voltage of the system was 20kV, a spot size of 6 was used for the 
EDX analysis as well as having the sample set at a 10mm working distance inside the 
SEM. Samples were sputter coated with gold before putting them into the SEM to 
make them more conducting.  
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3. Results and Discussion – Adsorptions Using Commercial ZSM-
5 Ammonium 30:1 
3.1 Introduction 
The data presented in this chapter has been taken from the adsorptions of 
paracetamol, aspirin and ibuprofen lysine by the commercial ZSM-5 30:1 used in 
these experiments. The later chapter will go into the data from the adsorptions where 
certain properties of ZSM-5 have been changed such as the Si:Al ratio being 
changed, the charge balancing cation being changed through ion exchange and 
conditions like reduced concentration of the drug in the solution. The ZSM-5 used for 
the experiments in this chapter has a Si:Al ratio of 30:1 and its charge balancing 
cation is ammonium. 
 
3.2 – Paracetamol 
A HPLC calibration curve for aqueous paracetamol was produced for the 
concentrations 0.001M – 0.01M, increasing in 0.001M increments. Table 1 shows the 
results for this curve. The peak area was plotted against the concentration and a line 
of best fit was applied and the first five data points were used for the line equation as 
they produced a straight line with an intercept through zero. This graph is shown in 
figure 9.  
Table 1. Paracetamol HPLC calibration curve. 
Paracetamol 
Standards 
Concentration 
(M) 
Peak Area 
(mVmin) 
Retention Time 
(mins) 
Height 
(mV) 
0.005 517.1415 2.979 2272.58 
0.004 463.3413 2.978 2141.348 
0.003 355.0007 2.975 1746.598 
0.002 248.4916 2.973 1229.889 
0.001 132.6921 2.969 636.163 
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Figure 9. Paracetamol HPLC calibration curve with the equation of the line included. 
 
This calibration curve’s equation was used to calculate the concentration of the 
paracetamol left in the solution after the adsorptions. This calibration curve was used 
for all paracetamol adsorptions presented in this work. Table 2 shows the HPLC data 
produced by the adsorption reactions between 2 and 48 hours. Included are the 
concentration of the drug left in solution, the concentration of the drug that was 
adsorbed and the percentage of the overall concentration that was adsorbed. A plot 
showing concentration adsorbed by the zeolite against contact time is presented in 
figure 10.  
Table 2. HPLC results for the paracetamol adsorptions by ZSM-5 ammonium 30:1. 
Paracetamol 
Concentration 
Left in Solution 
(M) 
Peak 
Area 
(mVmin) 
Contact 
Time 
(Hours) 
Retention 
Time (mins) Height (mV) 
Concentration 
Adsorbed by 
the Zeolite (M) 
% 
Concentration 
Adsorbed 
0.00219 244.2899 2 1.765 1892.936 0.00281 56.1902 
0.00228 254.2914 4 1.779 2057.026 0.00272 54.3966 
0.00230 256.1782 6 1.775 2022.073 0.00270 54.0582 
0.00178 198.5878 8 3.513 1133.016 0.00322 64.3862 
0.00414 461.4787 10 3.690 2175.915 0.00086 17.2406 
0.00221 246.1849 24 1.779 1927.387 0.00279 55.8504 
0.00224 249.8804 48 1.776 1940.49 0.00276 55.1876 
y = 111523x 
R² = 0.9648 
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Figure 10. Graph depicting concentration of paracetamol adsorbed by ZSM-5 ammonium 
30:1 against contact time. 
 
As the data shows it seems that the optimum contact time for the maximum 
adsorption is eight hours, with an adsorption of 0.0032M equating to 64.39% of the 
initial concentration being adsorbed. This then drops drastically between eight and 
ten hours, adsorbing only 0.0009M or 17.24% of the overall concentration at this 
contact time. The retention times for the eight and ten hour adsorptions differ from 
the retention times for the rest of the adsorptions as these were completely redone to 
verify the validity of their concentrations and were ran in a separate batch of mobile 
phase, this different batch is the reason for their differing retention times. The data 
was kept because the concentrations being found were congruent with the previously 
found concentration for these adsorptions. After this the adsorption increases to 
0.0028M or 55.19% adsorbed for 24 and 48 hours. It seems that this is the 
equilibrium concentration adsorbed as two to six hours have similar adsorptions, 
ranging from 54-56% adsorbed. Further research is required to find out the exact 
point at which is starts to desorb the paracetamol between eight and ten hours 
because 8 hours is not necessarily the point at which the concentration adsorbed starts 
to drop but as it stands with a contact time of eight hours ZSM-5 ammonium 30:1 
seems to be suitable for removing paracetamol from an aqueous solution. To confirm 
that the paracetamol has been adsorbed into the pores of ZSM-5 and not absorbed on 
to the surface of the particles powder XRD was performed on the filtered solid after 
adsorption had occurred. As a basis, the commercial ZSM-5 ammonium 30:1 XRD 
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pattern is included in figure 8 and shall have the adsorption patterns overlaid onto it 
in any further XRD patterns in this chapter. 
 
The diffraction patterns for the post adsorption ZSM-5 is shown in figure 11 with the 
post adsorption pattern overlaid onto the pre-adsorption pattern. 
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Figure 11. A) Commercial ZSM-5 Ammonium 30:1 + ZSM-5 30:1 post 2-hour paracetamol 
adsorption. B) Commercial ZSM-5 Ammonium 30:1 + ZSM-5 30:1 post 4-hour paracetamol 
adsorption. C) Commercial ZSM-5 Ammonium 30:1 + ZSM-5 30:1 post 6-hour paracetamol 
adsorption. D) Commercial ZSM-5 Ammonium 30:1 + ZSM-5 30:1 post 8-hour paracetamol 
adsorption. E) Commercial ZSM-5 Ammonium 30:1 + ZSM-5 30:1 post 10-hour paracetamol 
adsorption. F) Commercial ZSM-5 Ammonium 30:1 + ZSM-5 30:1 post 24-hour paracetamol 
adsorption. G) Commercial ZSM-5 Ammonium 30:1 + ZSM-5 30:1 post 48-hour paracetamol 
adsorption. 
 
All seven XRD patterns show some difference when compared to the original, 
commercial ZSM-5. All the patterns have some form of reduction in relative peak 
intensity in multiple peaks within the range of 5
o
-23
o
 2-theta. The biggest difference 
is seen in the first two peaks at 7.91
o
 2-theta and 8.82
o
 2-theta, with the commercial 
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ZSM-5 having peak intensities of 11162 counts per second and 6111 counts per 
second respectively. Post adsorption these peaks were reduced to between 9242-
11052 counts per second and 5030-6121 counts per second with the lowest peaks 
being produced by the 8-hour adsorption and highest being produced by the 24-hour 
adsorption. This change in relative peak intensity indicates that the contents of the 
unit cell have changed in some way which would indicate that the adsorption of the 
paracetamol has been successful. Another indicator is that the post adsorption 
patterns are shifted to the right a small amount, most notable on the 8 hour and 10 
hour adsorptions. The 8-hour adsorption shifts to the right by 0.0606
o
 2-theta and the 
10-hour adsorption by 0.0808
o
 2-theta. This shift towards a higher 2-theta value 
indicates a contraction of the zeolite unit cell is occurring. The zeolite framework has 
a high degree of flexibility and this peak position shift is a further indication that a 
species has been adsorbed into the pores of the zeolite, in this case paracetamol, 
though the relatively low shift indicates that this change is negligible. I have not 
included the 48-hour adsorption XRD pattern into my discussion as I believe this to 
be an outlier result due to its inconsistent data with respect to the rest of the 
paracetamol XRD and HPLC results, going from the trend set by the other data it 
should have a similar XRD pattern to the 2, 4, 6 or 24 hour adsorptions. 
  
The HPLC and XRD data indicate that the paracetamol has been adsorbed by the 
commercial ZSM-5 30:1 and successfully removed from the solution. The data from 
the XRD patterns were used to determine the cell parameters to see how the cell 
structure changed to accommodate the adsorbed paracetamol. The unit cell 
parameters for commercial ZSM-5 30:1 pre-and post paracetamol adsorption were 
determined using Topas and J-edit and shown in table 3. A Pawley fit was done using 
a Chebyshev function background and Pseudo-Voight peak shape function, the zero 
background and unit cell parameters (a, b, c) were refined to determine errors. The 
Pawley fit of the commercial ZSM-5 30:1 pre-adsorption is shown in figure 12, as is 
shown the cif file used
[13]
 is a good fit. 
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Figure 12. Commercial ZSM-5 30:1 Ammonium Pawley fit against its XRD data. 
 
Table 3. Lattice parameters of commercial ZSM-5 30:1 pre-and post paracetamol adsorption 
with errors included in brackets. 
Contact Time with 
Paracetamol 
Solution (Hours) RWP 
a 
(Å) 
b 
(Å) 
c 
(Å) 
0 7.466 20.11848(3) 19.92388(2) 13.41704(2) 
2 7.369 20.12475(3) 19.93059(2) 13.42273(2) 
4 7.479 20.12271(3) 19.92646(2) 13.42233(2) 
6 7.378 20.12378(3) 19.92806(2) 13.42322(2) 
8 7.059 20.12952(3) 19.92966(2) 13.42709(2) 
10 8.192 20.11720(4) 19.92717(3) 13.41934(3) 
24 7.963 20.11900(4) 19.92830(3) 13.42093(3) 
48 7.672 20.18986(9) 19.91643(9) 13.45545(5) 
787674727068666462605856545250484644424038363432302826242220181614121086
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Figure 13. A) Change in lattice parameter a against ZSM-5 30:1 contact time with 
paracetamol. B) Change in lattice parameter b against ZSM-5 30:1 contact time with 
paracetamol. C) Change in lattice parameter c against ZSM-5 30:1 contact time with 
paracetamol. 
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Figure 13 shows the change in the lattice parameters of ZSM-5 pre-and post 
paracetamol adsorption and shows all three lattice parameter size changes are related 
to each other. All three have very similar relative size changes with the only major 
differences being that parameter b has a larger increase in size at 2 hours when 
compared to parameters a and c, and that it has a reduction in size for its 48-hour 
adsorption whereas parameters a and c increase in size at this contact time. Though 
as before the results for the 48-hour adsorption is not being considered with regards 
to the rest of the discussion as it seems to be an outlier with false XRD data. Taking 
that out then the lattice parameter size changes in relation to the amount of 
paracetamol adsorbed by ZSM-5. The concentration adsorbed of paracetamol 
plateaued from 2 to 6 hours and then increased to its most adsorbed at 8 hours, 
similarly the lattice parameters a and c size increased from zero contact hours to 2 
hours and then plateaued until 6 hours before increasing in size to its largest size at 8 
hours, showing an increase of 0.055% for parameter a and a 0.075% increase for 
parameter c, which correlates to 64.39% of the paracetamol being adsorbed by ZSM-
5. Parameter b starts with an increase in size from zero contact hours to 2 seemingly 
much larger than that of parameter a and c, increasing by 0.034%, but is in fact 
similar to the increase for parameter a which is an increase of 0.031%. Parameter c 
has the highest initial increase of 0.042%. After 2 hours parameter b increases in size 
steadily up to 8 hours where it has an increase in size of 0.029% from the norm. All 
three parameters size the drops at 10 hours before increasing in size at 24 hours. 
Paracetamol is 7.8Å X 4.2Å 
[41]
 in size, considering the pore sizes of ZSM-5 are 5.4 
X 5.6Å and 5.1 X 5.5Å it would be logical to conclude that some pore expansion 
would be required for paracetamol to be adsorbed and with the upper limit for 
molecule adsorption size for ZM-5 being 9.1Å
[6]
 it is completely possible for 
paracetamol to be adsorbed. 
 
These changes in size corresponding with the changes in the concentration of 
paracetamol adsorbed indicate that these changes are due to the unit cell expanding to 
accommodate the paracetamol being adsorbed into the pores of ZSM-5, which 
confirms that the paracetamol is being adsorbed by the ZSM-5.  
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3.3 – Ibuprofen Lysine 
Ibuprofen lysine was used instead of ibuprofen as it is more polar and more soluble in 
water making it more suitable for the adsorption experiments. A HPLC calibration 
curve for aqueous ibuprofen lysine was produced for the concentrations 0.001M – 
0.01M, increasing in 0.001M increments. Table 4 shows the results for this curve. 
The peak area was plotted against the concentration and a line of best fit was applied 
an intercept through zero. This graph is shown in figure 14.  
 
Table 4. Ibuprofen lysine HPLC calibration curve. 
Ibuprofen Lysine 
Standards 
Concentrations 
(M) Peak Area (mVmin) 
Retention Time 
(mins) 
Height 
(mV) 
0.01 760.5942 8.795 1837.132 
0.009 707.4346 8.801 1748.334 
0.008 644.6036 8.800 1636.957 
0.007 562.1113 8.807 1463.294 
0.006 493.8933 8.807 1314.598 
0.005 415.9444 8.802 1121.824 
0.004 329.1105 8.808 889.091 
0.003 252.4453 8.816 691.038 
0.002 170.936 8.817 472.958 
0.001 82.3878 8.825 228.722 
 
 
Figure 14. Ibuprofen lysine HPLC calibration curve graph. 
 
This calibration curve’s equation was used to calculate the concentration of the 
ibuprofen lysine left in the solution after the adsorptions. This calibration curve has 
been used for all ibuprofen lysine adsorptions presented in this work. Table 5 shows 
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the HPLC data produced by the adsorption reactions. Included are the concentration 
of the drug left in solution, the concentration of the drug that was adsorbed and the 
percentage of the overall concentration that was adsorbed. The data is plotted in 
figure 15.  
 
Table 5. HPLC results for the ibuprofen lysine adsorptions by ZSM-5 ammonium 30:1 
Ibuprofen 
Lysine 
Samples 
Concentration 
Left in 
Solution (M) 
Peak 
Area 
(mVmin) 
Contact 
Time 
(Hours) 
Retention 
Time 
(mins) 
Height 
(mV) 
Concentration 
Adsorbed by 
the Zeolite (M) 
% 
Concentration 
Adsorbed 
0.00086 68.6539 2 8.377 259.063 0.00114 56.8187 
0.00197 156.9875 4 8.390 809.574 0.00003 1.2595 
0.00225 179.2554 6 8.386 919.555 0.00000* 0.0000 
0.00156 124.3634 8 8.392 641.871 0.00044 21.7791 
0.00211 167.4259 10 9.108 407.518 0.00000* 0.0000 
0.00163 129.6220 24 8.388 668.371 0.00037 18.4716 
0.00223 177.2387 48 8.389 912.151 0.00000* 0.0000 
*These values have been normalised to zero as HPLC data came out with a negative 
concentration 
 
Figure 15. Graph depicting the concentration of ibuprofen lysine adsorbed by ZSM-5 
ammonium 30:1 against contact time. 
 
This data indicates that the optimum time for adsorption is two hours and after that 
the concentration adsorbed drops, going from 56.82% down to at most 21.78% and at 
least no adsorption occurring at all. The HPLC data indicated that the data points 
with stars next to them had a negative concentration being adsorbed, as for this to be 
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true ibuprofen lysine would have to increase in concentration in the solution 
spontaneously. Due to its low concentration and the low relative solubility of 
ibuprofen lysine in general the HPLC machine may have picked up a higher result 
than possible, if only slightly, causing negative results to appear. These adsorptions 
were repeated to check validity and consistent results were produced. For the 
purposes of this research any negative concentration results have been changed to 
indicate that no ibuprofen lysine was adsorbed, though some may have been the 
amount is negligible, and these results will be clearly marked on any tables presented 
in this work. The incongruous retention time of the 10 hour adsorption is due to this 
adsorption being ran in a different batch of mobile phase to the rest of the adsorptions 
and was repeated to confirm its validity. 
 
To ascertain that ibuprofen lysine had been adsorbed into the pores of the zeolite and 
not the surface of the particles XRD was carried out and the data analysed using 
Pawley fits. The post adsorption XRD patterns overlaid onto the commercial ZSM-5 
30:1 XRD pattern, shown in figure 8, are plotted in figure 16 below. 
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Figure 16. A) Commercial ZSM-5 Ammonium 30:1 + ZSM-5 30:1 post 2-hour ibuprofen lysine 
adsorption. B) Commercial ZSM-5 Ammonium 30:1 + ZSM-5 30:1 post 4-hour ibuprofen lysine 
adsorption. C) Commercial ZSM-5 Ammonium 30:1 + ZSM-5 30:1 post 6-hour ibuprofen lysine 
adsorption. D) Commercial ZSM-5 Ammonium 30:1 + ZSM-5 30:1 post 8-hour ibuprofen lysine 
adsorption. F) Commercial ZSM-5 Ammonium 30:1 + ZSM-5 30:1 post 24-hour ibuprofen lysine 
adsorption. G) Commercial ZSM-5 Ammonium 30:1 + ZSM-5 30:1 post 48-hour ibuprofen lysine 
adsorption. 
 
All seven XRD patterns show some difference when compared to the original, 
commercial ZSM-5. All the patterns have some form of reduction in relative peak 
intensity in multiple peaks within the range of 5
o
-23
o
 2-theta and a large overall 
reduction in relative intensity with the 2-hour adsorption. The biggest difference is 
seen in the first two peaks at 7.91
o
 2-theta and 8.82
o
 2-theta, with the commercial 
ZSM-5 having peak intensities of 11162 counts per second and 6111 counts per 
second respectively. Post adsorption these peaks were reduced to 5393 counts per 
second and 3309 counts per second respectively for the 2-hour adsorption and 
between 7162-8636 counts per second and 4244-5042 counts per second for the rest 
of the adsorptions with the lowest peaks being produced by the 10-hour adsorption 
and highest being produced by the 4-hour adsorption for the 7.91
o
 2-theta peak and 
the 8-hour adsorption for the 8.82
o
 2-theta peak. Further noticeable changes in 
relative intensity are shown in the 2-hour adsorption, a reduction from 1555 counts 
per second on the 14.75
o
 2-theta peak to 932 counts per second, from 7062 counts per 
second on the 23.05
o
 2-theta peak to 5034 counts per second and from 3753 counts 
per second on the 23.86
o
 2-theta peak to 2715 counts per second. These changes in 
relative peak intensity indicate that the contents of the unit cell have changed in some 
way which would indicate that the adsorption of the ibuprofen has been successful. 
Another indicator is that the post adsorption patterns are shifted a small amount, most 
notable on the 2-hour adsorption, shifting to the right, and the 6-hour adsorption 
shifting to the left. The 2-hour adsorption shifts to the right by 0.2423
o
 2-theta and 
the 6-hour adsorption shifting to the left by 0.0808
o
 2-theta. This shift towards a 
higher 2-theta value indicates a contraction of the zeolite unit cell is occurring. The 
zeolite framework has a high degree of flexibility and this peak position shift is a 
further indication that a species has been adsorbed into the pores of the zeolite, in this 
case ibuprofen, though the relatively low level of shift occurring indicates that this 
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change is negligible. The biggest change seems to be occurring within the 2-hour 
adsorption pattern, which lines up with the HPLC results as the 2-hour adsorption has 
the highest amount of concentration adsorbed. 
 
The data from the XRD patterns were used to determine the cell parameters to see 
how the cell structure changed to accommodate the adsorbed ibuprofen lysine. The 
unit cell parameters for commercial ZSM-5 30:1 pre-and post ibuprofen adsorption 
were determined using Topas and J-edit and presented in table 6. A Pawley fit was 
done using a Chebyshev function background and Pseudo-Voight peak shape 
function, the zero background and unit cell parameters (a, b, c) were refined to 
determine errors. 
 
Table 6. Lattice parameters of commercial ZSM-5 30:1 pre-and post ibuprofen lysine 
adsorption with errors included in brackets. 
Contact Time with 
Ibuprofen Lysine 
Solution (Hours) RWP 
a 
(Å) 
b 
(Å) 
c 
(Å) 
0 7.466 20.11848(3) 19.92388(2) 13.41704(2) 
2 7.634 20.20457(5) 19.94301(3) 13.43105(3) 
4 6.799 20.12280(3) 19.93512(2) 13.42727(2) 
6 7.170 20.12198(4) 19.93152(2) 13.42720(2) 
8 7.195 20.11385(4) 19.92755(2) 13.42167(2) 
10 7.047 20.14066(4) 19.94453(2) 13.43933(2) 
24 6.847 20.12434(4) 19.93571(2) 13.42845(2) 
48 6.855 20.12592(4) 19.93224(2) 13.42836(2) 
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Figure 17. A) Change in lattice parameter a against ZSM-5 30:1 contact time with ibuprofen 
lysine. B) Change in lattice parameter b against ZSM-5 30:1 contact time with ibuprofen 
lysine. C) Change in lattice parameter c against ZSM-5 30:1 contact time with ibuprofen 
lysine. 
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Figure 17 shows the change in the lattice parameters of ZSM-5 pre-and post 
ibuprofen lysine adsorption and shows all three lattice parameter size changes are 
related to each other in some capacity. All three increase from 0-2 hours a large 
amount, 0.43% for parameter a and 0.10% for parameters b and c. Then all three 
reduce in overall size between 2-8 hours, -0.45% for parameter a, -0.08% for 
parameter b and -0.07% for parameter c. This coincides with the HPLC results as 
56.82% of the concentration was adsorbed from the solution at 2 hours and this was 
reduced to 0% at 6 hours and 21.78% at 8 hours. All three then increase in size from 
8-10 hour and then reduce in size again from 10-48 hours, except for parameter a 
having a slight increase from 24-48 hours. Having an increase in size from 8-10 
seems to indicate that the desorption of ibuprofen lysine caused the lattice parameters 
to increase in size, this is inconsistent with the rest of the data which shows a relative 
reduction in size at 6 hours and 48 hours when the concentration adsorbed is also 0. 
Taking out 10 hours there is a correlation with the HPLC results that a higher 
percentage of concentration leads to a larger size for all 3 lattice parameters. 
Ibuprofen lysine is 8.9Å X 3.8Å
[42] 
in size, the pore sizes of ZSM-5 are 5.4 X 5.6Å 
and 5.1 X 5.5Å so it would be logical to conclude that some pore expansion would 
occur to allow for ibuprofen lysine to be adsorbed and with the upper limit for 
molecule adsorption size for ZM-5 being 9.1Å
[6]
 it is completely possible for 
ibuprofen to be adsorbed, conversely though it may be this large size that is inhibiting 
its adsorption into ZSM-5. Due to this commercial ZSM-5 ammonium 30:1 has been 
found to not be a viable compound for the removal of ibuprofen lysine from aqueous 
solution.  
 
3.4 – Aspirin  
The aspirin solution post adsorption produced HPLC result with two peaks instead of 
one. This indicated that the aspirin degraded into at least two products. For this some 
experimentation was required and it was found out that the first peak corresponded 
with pure acetylsalicylic acid (i.e. aspirin) and salicylic acid. This means that 
sometime while it was in its aqueous form it partially broke down into salicylic acid 
and acetic acid. The mechanism for the degradation of aspirin in aqueous solution is 
shown in figure 18
[43]
. For the HPLC calibration curves for aspirin two were made 
up, one from pure acetylsalicylic acid and one from pure salicylic acid. These are 
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represented in table 7 and figure 19 for acetylsalicylic acid and table 8 and figure 20 
for salicylic acid. The line equation from figure 19 being used to determine the 
concentration of the first HPLC peak, the line equation from figure 20 being used for 
the concentration of the second HPLC peak. 
 
𝐴𝑠𝑝𝑖𝑟𝑖𝑛 + 𝑊𝑎𝑡𝑒𝑟 → 𝑆𝑎𝑙𝑖𝑐𝑦𝑙𝑖𝑐 𝐴𝑐𝑖𝑑 + 𝐴𝑐𝑒𝑡𝑖𝑐 𝐴𝑐𝑖𝑑 
𝐶9𝐻8𝑂4 + 𝐻2𝑂 → 𝐶7𝐻603 + 𝐶2𝐻4𝑂2 
Figure 18. Aspirin degradation mechanism.
[43]
 
Table 7. Acetylsalicylic acid HPLC calibration curve. 
Acetyl Salicylic 
Acid Standards 
Concentration 
(M) 
Peak Area 
(mVmin) 
Retention Time 
(min) 
Height 
(mV) 
0.001 9.9330 6.749 35.479 
0.002 19.8956 6.740 70.903 
0.003 29.4265 6.714 104.295 
0.004 39.1061 6.724 137.71 
0.005 49.0458 6.713 171.942 
0.006 59.0977 6.713 206.907 
0.007 69.3670 6.711 242.319 
0.008 77.6219 6.705 269.304 
0.009 88.4570 7.420 279.23 
0.01 97.5896 7.349 307.972 
 
Figure 19. Acetylsalicylic acid HPLC calibration curve graph.  
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Table 8. Salicylic acid HPLC calibration curve. 
Salicylic Acid 
Standards 
Concentration 
(M) 
Peak Area 
(mVmin) 
Retention Time 
(mins) 
Height 
(mV) 
0.01 86.1949 10.046 223.323 
0.009 73.9693 10.065 201.481 
0.008 74.8316 10.063 189.282 
0.007 68.1971 10.060 166.64 
0.006 53.7704 10.092 140.216 
0.005 45.6968 10.097 118.49 
0.004 40.0593 10.125 98.005 
0.003 29.806 10.169 73.802 
0.002 20.1126 10.212 49.353 
0.001 9.7841 10.287 24.224 
 
 
Figure 20. Salicylic acid HPLC calibration curve graph. 
Using the line equations, the concentrations of the peaks were calculated separately 
and then added together to produce the overall concentration left in the aqueous 
solution and from there the concentration adsorbed by ZSM-5. The results from the 
first HPLC peak are depicted in table 9 and table 10 for the second peak. The 
combined concentration results as well as the concentration adsorbed and percentage 
adsorbed by ZSM-5 are shown in table 11. A graph with combined concentration 
adsorbed against contact time is shown in figure 21.  
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Table 9. Aspirin peak 1 HPLC results 
Aspirin Tablet 
Samples Peak 1 
Concentration 
Left in Solution 
(M) 
Peak Area 
(mVmin) 
Contact Time 
(Hours) 
Retention 
Time (min) 
Height 
(mV) 
0.0020 19.3766 2 8.037 97.393 
0.0019 19.0242 4 8.004 95.762 
0.0021 20.6857 6 8.130 102.869 
0.0002 2.0689 8 7.040 11.487 
0.0012 12.0469 10 4.248 68.765 
0.0014 13.7907 24 8.065 66.972 
0.0013 12.6718 48 8.011 64.19 
Table 10. Aspirin peak 2 HPLC results. 
Aspirin Tablet 
Samples Peak 2 
Concentration 
Left in Solution 
(M) 
Peak Area 
(mVmin) 
Contact Time 
(Hours) 
Retention 
Time (mins) 
Height 
(mV) 
0.0013 11.9075 2 11.806 42.234 
0.0013 11.9620 4 11.766 42.202 
0.0009 8.0997 6 11.935 28.913 
0.0027 24.5764 8 10.635 94.237 
0.0010 8.8900 10 7.058 31.836 
0.0011 9.8382 24 11.898 33.926 
0.0020 17.9634 48 11.77 62.784 
Table 11. Aspirin combined concentrations HPLC results. 
Aspirin Tablet 
Samples 
Combined 
Concentrations 
Left in Solution 
(M) 
Contact 
Time 
Concentration 
Adsorbed by the 
Zeolite % Concentration Adsorbed 
0.0033 2 0.0017 33.9123 
0.0033 4 0.0017 34.5100 
0.0030 6 0.0020 39.7280 
0.0030 8 0.0020 40.9972 
0.0022 10 0.0028 55.5976 
0.0025 24 0.0025 49.9251 
0.0033 48 0.0017 34.0977 
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Figure 21. Graph of aspirin combined concentration adsorbed against contact time. 
 
The HPLC results indicate that the optimum adsorption time is 10 hours with the 
maximum adsorption being 55.60% of the concentration in the solution, the retention 
time for both peaks vary greatly from the rest of the adsorptions as its HPLC analysis 
was ran at a different time using a different batch of mobile phase which caused this 
anomaly, the time between the peaks is consistent though and so the data was kept. 
Overall the adsorption seems to plateau at around 34% with it rising and falling as it 
approaches and passes the optimum adsorption time of 10 hours. Though this is 
lower overall than the adsorption of paracetamol it does indicate that ZSM-5 
ammonium 30:1 is an adequate choice for the removal of aspirin from aqueous 
solution.  
 
Again, to determine of the molecules had been adsorbed in to the pores powder XRD 
was carried out and the data obtained shown in figure 22. 
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Figure 22. A) Commercial ZSM-5 Ammonium 30:1 + ZSM-5 30:1 post 2-hour aspirin adsorption. B) 
Commercial ZSM-5 Ammonium 30:1 + ZSM-5 30:1 post 4-hour aspirin adsorption. C) Commercial 
ZSM-5 Ammonium 30:1 + ZSM-5 30:1 post 6-hour aspirin adsorption. D) Commercial ZSM-5 
Ammonium 30:1 + ZSM-5 30:1 post 8-hour aspirin adsorption. E) Commercial ZSM-5 Ammonium 
30:1 + ZSM-5 30:1 post 10-hour aspirin adsorption. F) Commercial ZSM-5 Ammonium 30:1 + ZSM-
5 30:1 post 24-hour aspirin adsorption. G) Commercial ZSM-5 Ammonium 30:1 + ZSM-5 30:1 post 
48-hour aspirin adsorption. 
 
 
All seven patterns show differences between the original and the post adsorption 
pattern. This is most prominently shown in a reduction in the relative peak intensity 
in the first two major peaks at 7.91
o
 2-theta and 8.82
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 2-theta, with the commercial 
ZSM-5 having peak intensities of 11162 counts per second and 6111 counts per 
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that this change is negligible. 
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The data from the XRD patterns were used to determine the cell parameters to see 
how the cell structure changed to accommodate the adsorbed aspirin. A Pawley fit 
was done using a Chebyshev function background and Pseudo-Voight peak shape 
function, the zero background and unit cell parameters (a, b, c) were refined to 
determine errors. 
 
Table 12. Lattice parameters of commercial ZSM-5 30:1 pre-and post aspirin adsorption with 
errors included in brackets. 
Contact Time with 
Aspirin Solution 
(Hours) RWP 
a 
(Å) 
b 
(Å) 
c 
(Å) 
0 7.466 20.11848(3) 19.92388(2) 13.41704(2) 
2 9.063 20.11648(4) 19.93417(3) 13.42123(3) 
4 7.417 20.10842(4) 19.93362(3) 13.42091(3) 
6 7.931 20.11721(7) 19.93039(5) 13.41920(5) 
8 7.22 20.08936(4) 19.94652(3) 13.41488(2) 
10 6.976 20.11527(3) 19.93053(2) 13.42048(2) 
24 6.974 20.10132(6) 19.93409(5) 13.41659(4) 
48 7.616 20.10199(4) 19.92641(3) 13.41310(3) 
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Figure 23. A) Change in lattice parameter a against ZSM-5 30:1 contact time with aspirin. B) 
Change in lattice parameter b against ZSM-5 30:1 contact time with aspirin. C) Change in 
lattice parameter c against ZSM-5 30:1 contact time with aspirin. 
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Figure 23 shows the change in the lattice parameters of ZSM-5 pre and post aspirin 
adsorption and shows all three follow similar trends in relative size changes, 
parameter b and c having similar size changes from 0-6 hours, a and c both having a 
large reduction in size at 8 hours, a size change of -0.14% for parameter a and -
0.03% for parameter c, and then increase again at 10 hours, a size change of 0.13% 
for parameter a and 0.04% for parameter c, while parameter b the inverse happens for 
these contact times, increasing by 0.17% from 6-8 hours and reducing by 0.08% from 
8-10 hours, parameter a and c having a similar drop from 10-24 hours while 
parameter b increases in size, parameter a and c reducing by 0.07% and 0.03% 
respectively and parameter b increasing by 0.02%, and then a final reduction in size 
for parameters b and c from 24-48 hours, a reduction of 0.04% and 0.03% 
respectively, while parameter a increases in size during that time by 0.003%. These 
changes in lattice parameter size indicate that an increase in concentration of aspirin 
adsorbed by the zeolite leads to an increase in size of parameter a and c and reduction 
in size for parameter c as shown at 10 hours when the maximum concentration was 
adsorbed, 55.60%. This would seem to indicate that these two lattice parameters are 
expanding in size to accommodate the aspirin. Considering aspirin has a size of 7.1Å 
X 4.9Å
[44]
 it could easily fit into the 5.4 X 5.6Å and 5.1 X 5.5Å sized pores of ZSM-5 
as their upper limit for adsorption is larger than aspirin, being 9.1Å
[6]
, so it would be 
logical to conclude that some pore expansion would occur to allow for the aspirin to 
be adsorbed. The data indicates that ZSM-5 did remove aspirin from the solution and 
would be a viable option for its removal from water systems. 
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4. Results and Discussion – Adsorptions Using Commercial ZSM-
5 Ammonium 200-400:1 
4.1 – Introduction 
The data presented in this chapter has been taken from the adsorptions of 
paracetamol, aspirin and ibuprofen lysine by the commercial ZSM-5 200-400:1 used 
in these experiments. The Si:Al ratio has been increased to ascertain the effect the 
ammonium cation has on the adsorption rates of the drugs investigated as this 
increase will reduce the number of cations present. The ZSM-5 used for the 
experiments in this chapter has a Si:Al ratio of 200-400:1 and its charge balancing 
cation is ammonium. 
 
4.2 – Paracetamol 
The previous paracetamol HPLC calibration curve’s equation was used to calculate 
the concentration of the paracetamol left in the solution after the adsorptions. Table 
13 shows the HPLC data produced by the adsorption reactions between 2 and 48 
hours. Included are the concentration of the drug left in solution, the concentration of 
the drug that was adsorbed and the percentage of the overall concentration that was 
adsorbed. A plot showing concentration adsorbed by the zeolite against contact time 
is presented in figure 24.  
Table 13. HPLC results for the paracetamol adsorptions by commercial ZSM-5 ammonium 
200-400:1. 
Paracetamol 
Concentration 
Left in 
Solution (M) 
Peak 
Area 
(mVmin) 
Contact 
Time 
(Hours) 
Retention 
Time 
(mins) 
Height 
(mV) 
Concentration 
Adsorbed by 
the Zeolite 
(M) 
% 
Concentration 
Adsorbed 
0.00402 447.7846 2 3.553 2191.053 0.00098 19.6965 
0.00379 422.8537 4 3.532 2195.389 0.00121 24.1674 
0.00360 401.6719 6 3.531 2276.892 0.00140 27.9661 
0.00361 402.3755 8 3.534 2270.588 0.00139 27.8399 
0.00376 419.5940 10 3.520 2252.319 0.00124 24.7520 
0.00386 430.8252 24 3.324 2288.548 0.00114 22.7379 
0.00368 409.9684 48 3.388 2321.145 0.00132 26.4782 
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Figure 24. Graph depicting concentration of paracetamol adsorbed by commercial ZSM-5 
ammonium 200-400:1 against contact time. 
 
The concentration adsorbed stays fairly constant throughout as the percentage 
adsorbed only had a range of 19.70-27.97% with the contact time of 2 hours 
accounting for the lowest concentration adsorbed of 0.00098M and the highest 
occurring during the 6-hour adsorption of 0.0014M. From 2-6 hours, a steady 
increase in concentration adsorbed is observed followed by a 0.13% concentration 
adsorbed decrease from 6-8 hours before a drop of 5.1% from 8-24 hours. Between 
24-48 hours the concentration adsorbed increased by 3.7%, to 26.48%, this indicates 
that the equilibrium of concentration adsorbed is within the range of 22-28%. This 
overall decrease in the concentration adsorbed by ZSM-5 indicates that fewer 
ammonium cations present lowers the affinity of paracetamol for ZSM-5.  
 
To confirm that the paracetamol has been adsorbed into the pores of ZSM-5 and not 
absorbed on to the surface of the particles powder XRD was performed on the 
filtered solid after adsorption had occurred. As a basis, the commercial ZSM-5 
ammonium 200-400:1 XRD pattern is included in figure 25 and shall have the 
adsorption patterns overlaid onto it in any further XRD patterns in this chapter. 
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Figure 25. Commercial ZSM-5 ammonium 200-400:1 XRD pattern. 
 
The diffraction patterns for the post adsorption ZSM-5 is shown in figure 26 with the 
post adsorption pattern overlaid onto the pre-adsorption pattern. 
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Figure 26. A) Commercial ZSM-5 Ammonium 200-400:1 + ZSM-5 200-400:1 post 2-hour 
paracetamol adsorption. B) Commercial ZSM-5 Ammonium 200-400:1 + ZSM-5 200-400:1 post 4-
hour paracetamol adsorption. C) Commercial ZSM-5 Ammonium 200-400:1 + ZSM-5 200-400:1 post 
6-hour paracetamol adsorption. D) Commercial ZSM-5 Ammonium 200-400:1 + ZSM-5 200-400:1 
post 8-hour paracetamol adsorption. E) Commercial ZSM-5 Ammonium 200-400:1 + ZSM-5 200-
400:1 post 10-hour paracetamol adsorption. F) Commercial ZSM-5 Ammonium 200-400:1 + ZSM-5 
200-400:1 post 24-hour paracetamol adsorption. G) Commercial ZSM-5 Ammonium 200-400:1 + 
ZSM-5 200-400:1 post 48-hour paracetamol adsorption. 
 
All seven XRD patterns show some difference when compared to the original, 
commercial ZSM-5. All the patterns have some form of reduction in relative peak 
intensity in multiple peaks within the range of 5
o
-23
o
 2-theta. The biggest difference 
is seen in the first two peaks at 8.03
o
 2-theta and 8.90
o
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ZSM-5 pre-adsorption having peak intensities of 22321 counts per second and 9576 
counts per second respectively. Post adsorption these peaks were reduced to between 
10809-18329 counts per second and 6240-8945 counts per second with the lowest 
peaks being produced by the 6-hour adsorption and highest being produced by the 
10-hour adsorption. For the 6-hour adsorption there was also a notable reduction in 
relative peak intensity at the four peaks at 13.32
o
, 14.03
o
, 14.85
o
 and 15.99
o
 2-theta, 
with the commercial ZSM-5 pre-adsorption having peak intensities of 1737, 2026, 
2558 and 1937 counts per second respectively. Post adsorption these peaks were 
reduced to 659, 1137, 1211 and 955 counts per second respectively. This change in 
relative peak intensity indicates that the contents of the unit cell have changed in 
some way which would indicate that the adsorption of the paracetamol has been 
successful. Another indicator is that the post adsorption pattern for 10 hours has been 
shifted to the left by 0.1212
o
 2-theta. This shift towards a lower 2-theta value 
indicates an expansion of the zeolite unit cell is occurring. The zeolite framework has 
a high degree of flexibility and this peak position shift is a further indication that a 
species has been adsorbed into the pores of the zeolite, in this case paracetamol, 
though the relatively low level of shift occurring indicates that this change is 
negligible. I have not included the 4-hour adsorption XRD pattern into my discussion 
as I believe this to be an outlier result due to its inconsistent data with respect to the 
rest of the paracetamol XRD and HPLC results, going from the trend set by the other 
data it should have a similar XRD pattern to the 2 and 24 hour adsorptions. The loss 
of definite peaks within the range 16
o
-23
o
 2-theta indicates a loss of crystallinity in 
the zeolite but there doesn’t seem to be any other indication that this should be 
occurring. 
  
The HPLC and XRD data indicate that the paracetamol has been adsorbed by the 
commercial ZSM-5 200-400:1 and successfully removed from the solution. The data 
from the XRD patterns were used to determine the cell parameters to see how the cell 
structure changed to accommodate the adsorbed paracetamol. The unit cell 
parameters for commercial ZSM-5 200-400:1 pre-and post paracetamol adsorption 
were determined using Topas and J-edit and shown in table 14. A Pawley fit was 
done using a Chebyshev function background and Pseudo-Voight peak shape 
function, the zero background and unit cell parameters (a, b, c) were refined to 
determine errors.  
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Table 14. Lattice parameters of commercial ZSM-5 200-400:1 pre-and post paracetamol 
adsorption with errors included in brackets. 
Contact Time with 
Paracetamol 
Solution (Hours) RWP 
a 
(Å) 
b 
(Å) 
c 
(Å) 
0 14.083 20.11858(3) 19.87802(2) 13.38665(2) 
2 12.142 20.10968(6) 19.87911(5) 13.38614(5) 
4 10.364 20.12285(5) 19.89023(5) 13.41291(5) 
6 11.918 20.15622(4) 19.90739(3) 13.41809(4) 
8 10.93 20.12050(4) 19.89147(4) 13.39455(3) 
10 11.903 20.11053(4) 19.87947(3) 13.38668(3) 
24 11.263 20.10687(4) 19.87512(4) 13.38366(3) 
48 10.665 20.11650(4) 19.88051(4) 13.38748(3) 
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Figure 27. A) Change in lattice parameter a against ZSM-5 200-400:1 contact time with 
paracetamol. B) Change in lattice parameter b against ZSM-5 200-400:1 contact time with 
paracetamol. C) Change in lattice parameter c against ZSM-5 200-400:1 contact time with 
paracetamol. 
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Figure 27 shows the change in the lattice parameters of ZSM-5 pre-and post 
paracetamol adsorption and shows all three lattice parameter size changes follow the 
same pattern. All three increase from 0-6 hours where their size peaks, they then 
reduce in size between 6-24 hours before increasing in size gain from 24-48 hours. 
Their graphs are visually similar because of this with the main exception being 
parameter c having a larger relative increase in size from 2-4 hours due to a higher 4-
hour value, though as before the results for the 4-hour adsorption are not being 
considered with regards to the rest of the discussion as it seems to be an outlier with 
false XRD data. Taking that out then the lattice parameter sizes change in relation to 
the amount of paracetamol adsorbed by ZSM-5. The concentration adsorbed of 
paracetamol increased from 2-6 hours, peaking at 6 hours, and then decreasing from 
6-24 hours before increasing again from 24-48 hours, mirroring the lattice parameter 
sizes. Between 2-6 hours there is an increase in concentration adsorbed of 8.27% 
followed by a reduction of 5.23% concentration adsorbed between 6-24 hours and an 
increase of 3.74% concentration adsorbed between 24-48 hours. Similarly between 2-
6 hours there are increase in size of lattice parameters a, b and c of 0.23%, 0.14% and 
0.24% respectively, between 6-24 hours there is a reduction in size of lattice 
parameters a, b and c of 0.24%, 0.16% and 0.26% respectively, and between 24-48 
hours there is an increase in size of 0.05% for parameter a, 0.03% for parameters b 
and c. Paracetamol is 7.8Å X 4.2Å 
[41]
 in size, considering the pore sizes of ZSM-5 
are 5.4 X 5.6Å and 5.1 X 5.5Å it would be logical to conclude that some pore 
expansion would be required for paracetamol to be adsorbed and with the upper limit 
for molecule adsorption size for ZMS-5 being 9.1Å
[6]
 it is completely possible for 
paracetamol to be adsorbed. 
 
These changes in size corresponding with the changes in the concentration of 
paracetamol adsorbed indicate that these changes are due to the unit cell expanding to 
accommodate the paracetamol being adsorbed into the pores of ZSM-5 200-400:1, 
which confirms that the paracetamol is being adsorbed by the ZSM-5 200-400:1. 
However considering its overall amount of concentration removed from solution is 
reduced by over half of the ZSM-5 30:1 equivalent we would consider commercial 
ZSM-5 ammonium 200-400:1 appropriate for the removal of paracetamol from 
aqueous solution but to not use it if commercial ZSM-5 ammonium 30:1 is available. 
This would indicate that the lowered number of ammonium cations in the zeolite led 
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to the lowered affinity of paracetamol for ZSM-5 though it could also be due to the 
higher hydrophobicity of the ZSM-5 due to the increased Si:Al ratio. A change in 
charge balancing cation could help indicate which is more probable. 
 
4.3 – Ibuprofen Lysine 
The previous ibuprofen lysine HPLC calibration curve’s equation was used to 
calculate the concentration of the ibuprofen lysine left in the solution after the 
adsorptions. Table 15 shows the HPLC data produced by the adsorption reactions 
between 2 and 48 hours. Included are the concentration of the drug left in solution, the 
concentration of the drug that was adsorbed and the percentage of the overall 
concentration that was adsorbed. A plot showing concentration adsorbed by the 
zeolite against contact time is presented in figure 28.  
Table 15. HPLC results for the paracetamol adsorptions by commercial ZSM-5 ammonium 
200-400:1. 
Ibuprofen 
Lysine 
Concentration 
Left in 
Solution (M) 
Peak Area 
(mVmin) 
Contact 
Time 
(Hours) 
Retention 
Time (mins) 
Height 
(mV) 
Concentration 
Adsorbed by 
the Zeolite 
(M) 
% 
Concentration 
Adsorbed 
0.00210 167.0034 2 12.812 355.352 0.000* 0.0000 
0.00214 170.0308 4 10.996 312.878 0.000* 0.0000 
0.00205 162.6876 6 10.973 308.117 0.000* 0.0000 
0.00204 162.3697 8 11.058 310.110 0.000* 0.0000 
0.00204 162.3697 10 8.709 313.649 0.000* 0.0000 
0.00211 167.7182 24 13.023 297.059 0.000* 0.0000 
0.00213 169.4421 48 11.000 317.040 0.000* 0.0000 
*These values have been normalised to zero as HPLC data came out with a negative 
concentration 
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Figure 28. Graph depicting concentration of ibuprofen lysine adsorbed by ZSM-5 ammonium 
200-400:1 against contact time. 
 
Due to its low concentration and the low relative solubility of ibuprofen lysine in 
general the HPLC machine may have picked up a higher result than possible, if only 
slightly, causing negative results to appear. These adsorptions were repeated to check 
validity and consistent results were produced. For the purposes of this research any 
negative concentration results have been changed to indicate that no ibuprofen lysine 
was adsorbed, though some may have been the amount is negligible. Since all the 
results presented produced higher results than possible they were all normalised to 
zero. This indicates that the increase in the Si:Al ratio, and therefore the decrease in 
the amount of ammonium ions present, decreases the affinity of ibuprofen lysine 
towards ZSM-5 considerably. The incongruous retention time of the 10 hour 
adsorption is due to this adsorption being ran in a different batch of mobile phase to 
the rest of the adsorptions and was repeated to confirm its validity. 
 
To ascertain that ibuprofen lysine had been adsorbed into the pores of the zeolite and 
not the surface of the particles XRD was carried out and the data analysed using 
Pawley fits. The post adsorption XRD patterns overlaid onto the commercial ZSM-5 
200-400:1 XRD pattern, shown in figure 25, are plotted in figure 29 below. 
 
0.00000
0.10000
0.20000
0.30000
0.40000
0.50000
0.60000
0.70000
0.80000
0.90000
1.00000
2 4 6 8 10 24 48
C
o
n
ce
n
tr
at
io
n
 (
M
) 
Contact Time (Hours) 
73 
 
  
 
 
0
5000
10000
15000
20000
25000
5 15 25 35 45
In
te
n
si
ty
 (
C
o
u
n
ts
 p
er
 S
ec
o
n
d
) 
2-Theta (Degrees) 
Commercial ZSM-5
Ammonium 200-400:1
2 Hour Adsorption
0
5000
10000
15000
20000
25000
5 15 25 35 45
In
te
n
si
ty
 (
C
o
u
n
ts
 p
er
 S
ec
o
n
d
) 
2-Theta (Degrees) 
Commercial ZSM-5
Ammonium 200-400:1
4 Hour Adsorption
0
5000
10000
15000
20000
25000
5 15 25 35 45
In
te
n
si
ty
 (
C
o
u
n
ts
 p
er
 S
ec
o
n
d
) 
2-Theta (Degrees) 
Commercial ZSM-5
Ammonium 200-400:1
6 Hour Adsorption
A 
B 
C 
74 
 
  
 
 
0
5000
10000
15000
20000
25000
5 15 25 35 45
In
te
n
si
ty
 (
C
o
u
n
ts
 p
er
 S
ec
o
n
d
) 
2-Theta (Degrees) 
Commercial ZSM-5
Ammonium 200-400:1
8 Hour Adsorption
0
5000
10000
15000
20000
25000
5 15 25 35 45
In
te
n
si
ty
 (
C
o
u
n
ts
 p
er
 S
ec
o
n
d
) 
2-Theta (Degrees) 
Commercial ZSM-5
Ammonium 200-400:1
10 Hour Adsorption
0
5000
10000
15000
20000
25000
5 15 25 35 45
In
te
n
si
ty
 (
C
o
u
n
ts
 p
er
 S
ec
o
n
d
) 
2-Theta (Degrees) 
Commercial ZSM-5
Ammonium 200-400:1
24 Hour Adsorption
E 
D 
F 
75 
 
 
Figure 29. A) Commercial ZSM-5 Ammonium 200-400:1 + ZSM-5 200-400:1 post 2-hour ibuprofen 
lysine adsorption. B) Commercial ZSM-5 Ammonium 200-400:1 + ZSM-5 200-400:1 post 4-hour 
ibuprofen lysine adsorption. C) Commercial ZSM-5 Ammonium 200-400:1 + ZSM-5 200-400:1 post 
6-hour ibuprofen lysine adsorption. D) Commercial ZSM-5 Ammonium 200-400:1 + ZSM-5 200-
400:1 post 8-hour ibuprofen lysine adsorption. E) Commercial ZSM-5 Ammonium 200-400:1 + ZSM-
5 200-400:1 post 10-hour ibuprofen lysine adsorption. F) Commercial ZSM-5 Ammonium 200-400:1 
+ ZSM-5 200-400:1 post 24-hour ibuprofen lysine adsorption. G) Commercial ZSM-5 Ammonium 
200-400:1 + ZSM-5 200-400:1 post 48-hour ibuprofen lysine adsorption. 
 
All seven XRD patterns show some slight difference when compared to the original, 
commercial ZSM-5. All the patterns have some form of reduction in relative peak 
intensity in multiple peaks within the range of 5
o
-23
o
 2-theta. The biggest difference 
is seen in the first two peaks at 8.03
o
 2-theta and 8.90
o
 2-theta, with the commercial 
ZSM-5 pre-adsorption having peak intensities of 22321 counts per second and 9576 
counts per second respectively. Post adsorption these peaks were reduced to between 
19814-20874 counts per second and 9579-8438 counts per second with the lowest 
peaks being produced by the 4-hour adsorption and highest being produced by the 
10-hour adsorption. This change in relative peak intensity indicates that the contents 
of the unit cell have changed in some way which would indicate that the adsorption 
of the ibuprofen lysine has been successful, but considering the HPLC results these 
changes are most likely due to the negligible concentration of ibuprofen lysine 
adsorbed which would explain the relatively small reduction in relative peak 
intensity. All seven of the XRD patterns show some shifting towards the left, a shift 
of 0.0606-0.1212 2-theta with the smallest shift being produced by the 24-hour 
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adsorption and the largest shift being produced by the 2, 6, 8, 10 and 48-hour 
adsorption. This shift towards a lower 2-theta value indicates an expansion of the 
zeolite unit cell is occurring. The zeolite framework has a high degree of flexibility 
and this peak position shift is a further indication that a species has been adsorbed 
into the pores of the zeolite, in this case ibuprofen lysine, though the relatively low 
level of shift occurring indicates that this change is negligible.  
 
The HPLC and XRD data indicate that the ibuprofen lysine has not been adsorbed by 
the commercial ZSM-5 200-400:1 and unsuccessfully removed from the solution. 
The data from the XRD patterns were used to determine the cell parameters to see 
how the cell structure changed to accommodate the adsorbed ibuprofen lysine. The 
unit cell parameters for commercial ZSM-5 200-400:1 pre-and post ibuprofen lysine 
adsorption were determined using Topas and J-edit and shown in table 16. A Pawley 
fit was done using a Chebyshev function background and Pseudo-Voight peak shape 
function, the zero background and unit cell parameters (a, b, c) were refined to 
determine errors.  
 
 
Table 16. Lattice parameters of commercial ZSM-5 200-400:1 pre-and post ibuprofen lysine 
adsorption with errors included in brackets. 
Contact Time with 
Ibuprofen Lysine 
Solution (Hours) RWP 
a 
(Å) 
b 
(Å) 
c 
(Å) 
0 14.083 20.11858(3) 19.87802(2) 13.38665(2) 
2 12.741 20.11985(3) 19.88012(3) 13.38896(3) 
4 13.965 20.12178(4) 19.87836(3) 13.38860(3) 
6 11.918 20.13450(4) 19.89147(3) 13.39826(3) 
8 12.164 20.12244(4) 19.88052(3) 13.39051(3) 
10 12.601 20.12215(4) 19.88367(3) 13.38941(3) 
24 12.117 20.12277(4) 19.88158(4) 13.38950(3) 
48 12.255 20.12666(4) 19.89167(3) 13.39527(3) 
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Figure 30. A) Change in lattice parameter a against ZSM-5 200-400:1 contact time with 
ibuprofen lysine. B) Change in lattice parameter b against ZSM-5 200-400:1 contact time 
with ibuprofen lysine. C) Change in lattice parameter c against ZSM-5 200-400:1 contact 
time with ibuprofen lysine. 
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Figure 30 shows the change in the lattice parameters of ZSM-5 pre-and post 
ibuprofen lysine adsorption and shows all three lattice parameter size changes follow 
the same pattern. All three plateau from 0-4 hours then increase in size between 4-6 
hours before decreasing in size from 6-8 hours, they then plateau from 8-24 hours 
before a final increase from 24-48 hours. Their graphs are visually similar because of 
this with the main exception being parameter b and c having an increase between 0-2 
hours and parameter b having an increase between 8-10 hours before reducing back 
down to a similar relative size as the other two parameters. The largest increase, from 
4-6 hours, accounts for an increase of 0.06% for parameter a, 0.07% for parameter b 
and c. This change in size would indicate that some ibuprofen lysine was adsorbed 
into the zeolite, but coupled with the HPLC, XRD and low increase in overall size it 
would be safe to assume that the amount adsorbed was so small as to be negligible. 
Ibuprofen lysine is 8.9Å X 3.8Å
[42] 
in size, considering the pore sizes of ZSM-5 are 
5.4 X 5.6Å and 5.1 X 5.5Å it would be logical to conclude that some pore expansion 
would be required for ibuprofen lysine to be adsorbed and with the upper limit for 
molecule adsorption size for ZMS-5 being 9.1Å
[6]
 it is completely possible for 
ibuprofen lysine to be adsorbed but considering that the previous ibuprofen lysine 
adsorption had produced a maximum lattice parameter increase of 0.43% the 0.07% 
maximum from this adsorption would indicate that not enough expansion has 
occurred for adsorption to occur. This lines up with the HPLC data showing that no 
adsorption did occur. 
 
This data indicates that ZSM-5 200-400:1 ammonium is not an appropriate 
compound for the removal of ibuprofen lysine from aqueous solution. This may be 
due to the lower number of ammonium cations present due to the higher Si:Al ratio 
or could be due to the increased hydrophobicity a higher Si:Al ratio produces. A 
change in the charge balancing cation could help determine which is more probable. 
 
 
4.4 – Aspirin  
The previous aspirin HPLC calibration curve’s equations for aspirin peak 1 and 2 was 
used to calculate the concentration of the aspirin left in the solution after the 
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adsorptions by combining the concentrations. Table 17 shows the HPLC data 
produced by the adsorption reactions between 2 and 48 hours for peak 1, table 18 
shows peak 2 and table 19 are the two sets of concentrations combined. Included are 
the concentration of the drug left in solution, the concentration of the drug that was 
adsorbed and the percentage of the overall concentration that was adsorbed. A plot 
showing the aspirin combined concentration adsorbed by the zeolite against contact 
time is presented in figure 31.  
Table 17. Aspirin peak 1 HPLC results 
Aspirin Tablet 
Samples Peak 1 
Concentration 
Left in Solution 
(M) 
Peak Area 
(mVmin) 
Contact Time 
(Hours) 
Retention 
Time (min) 
Height 
(mV) 
0.00138 13.5547 2 7.203 49.615 
0.00145 14.2320 4 7.235 50.566 
0.00200 19.5517 6 7.235 68.437 
0.00196 19.1874 8 7.185 66.860 
0.00160 15.6785 10 7.200 55.619 
0.00156 15.3361 24 7.141 54.115 
0.00077 7.5558 48 7.253 27.495 
. 
Table 18. Aspirin peak 2 HPLC results. 
Aspirin Tablet 
Samples Peak 2 
Concentration 
Left in Solution 
(M) 
Peak Area 
(mVmin) 
Contact Time 
(Hours) 
Retention 
Time (mins) 
Height 
(mV) 
0.00069 6.1941 2 10.841 14.979 
0.00074 6.6261 4 10.922 16.209 
0.00063 5.6723 6 10.906 13.671 
0.00060 5.4208 8 10.826 12.894 
0.00060 5.4059 10 10.828 13.434 
0.00050 4.4691 24 10.732 11.234 
0.00115 10.3435 48 10.987 24.786 
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Table 19. Aspirin combined concentrations HPLC results. 
Aspirin Tablet 
Samples 
Combined 
Concentrations 
Left in Solution 
(M) 
Contact 
Time 
Concentration 
Adsorbed by the 
Zeolite % Concentration Adsorbed 
0.00207 2 0.00293 58.5294 
0.00219 4 0.00281 56.1842 
0.00263 6 0.00237 47.4531 
0.00256 8 0.00244 48.7572 
0.00220 10 0.00280 55.9518 
0.00206 24 0.00294 58.7387 
0.00192 48 0.00308 61.5237 
 
Figure 31. Graph depicting concentration of aspirin adsorbed by ZSM-5 ammonium 200-
400:1 against contact time. 
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adsorbed only had a range of 47.45-61.52% with the contact time of 6 hours 
accounting for the lowest concentration adsorbed of 0.0024M and the highest 
occurring during the 48-hour adsorption of 0.0031M. An equilibrium seems to have 
been found at around 56-61%, 2 and 4 hours being within this range before dropping 
down to 47.45% at 6 hours. From 6-8 hours, there is a slight increase in percentage 
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steadily, going from 48.76% to the maximum of 61.52% and seemingly the 
equilibrium point. This overall relative increase in the concentration adsorbed by 
ZSM-5 indicates that fewer ammonium cations present increases the affinity of 
aspirin for ZSM-5.  
 
To confirm that the aspirin has been adsorbed into the pores of ZSM-5 and not 
absorbed on to the surface of the particles powder XRD was performed on the 
filtered solid after adsorption had occurred. As a basis, the commercial ZSM-5 
ammonium 200-400:1 XRD pattern is included in figure 25 and the diffraction 
patterns for the post adsorption ZSM-5 is shown in figure 32 with the post adsorption 
pattern overlaid onto the pre-adsorption pattern. 
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Figure 32. A) Commercial ZSM-5 Ammonium 200-400:1 + ZSM-5 200-400:1 post 2-hour aspirin 
adsorption. B) Commercial ZSM-5 Ammonium 200-400:1 + ZSM-5 200-400:1 post 4-hour aspirin 
adsorption. C) Commercial ZSM-5 Ammonium 200-400:1 + ZSM-5 200-400:1 post 6-hour aspirin 
adsorption. D) Commercial ZSM-5 Ammonium 200-400:1 + ZSM-5 200-400:1 post 8-hour aspirin 
adsorption. E) Commercial ZSM-5 Ammonium 200-400:1 + ZSM-5 200-400:1 post 10-hour aspirin 
adsorption. F) Commercial ZSM-5 Ammonium 200-400:1 + ZSM-5 200-400:1 post 24-hour aspirin 
adsorption. G) Commercial ZSM-5 Ammonium 200-400:1 + ZSM-5 200-400:1 post 48-hour aspirin 
adsorption. 
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relative peak intensity, with the commercial ZSM-5 pre-adsorption having peak 
intensities of 22321 counts per second and 9576 counts per second respectively. Post 
adsorption these peaks were reduced to between 7205-14430 counts per second and 
4415-7702 counts per second with the lowest peaks being produced by the 8-hour 
adsorption and highest being produced by the 6-hour adsorption. There was also 
notable reduction in relative peak intensity at the four peaks at 13.32
o
, 14.03
o
, 14.85
o
 
and 15.99
o
 2-theta, with the commercial ZSM-5 pre-adsorption having peak 
intensities of 1737, 2026, 2558 and 1937 counts per second respectively. Post 
adsorption these peaks were reduced to ranges of 330-762 counts per second for 
13.32
o
,
 
the largest being produced by the 6-hour adsorption and lowest the 10-hour 
adsorption, 1042-1714 counts per second for 14.03
o
, 1036-1759 counts per second 
for 14.85
o
 and 994-1521 counts per second for 15.99
o
, these last three points having 
their largest peak intensity produced by the 6-hour adsorption and their lowest by the 
8-hour adsorption. The last two notable changes occur at the peaks at 23.15
o
 and 
24.02
o
 2-theta, with the commercial ZSM-5’s pre-adsorption peak intensities being 
8304 and 5395 counts per second respectively. These became 3790-8565 counts per 
second for 23.15
o
, with the largest peak intensity produced by the 6-hour adsorption 
and the lowest by the 8-hour adsorption, and 1504-3225 counts per second for 24.02
o
, 
the largest peak intensity being produced by the 6-hour adsorption and the lowest the 
48-hour adsorption. This change in relative peak intensity indicates that the contents 
of the unit cell have changed in some way which would indicate that the adsorption 
of the aspirin has been successful. Another indicator is that the all the patterns show 
some shift either towards the left or right to a greater or lesser degree. The largest of 
these shifts occurs in the 6-hour adsorption as it is shifted to the left by 0.1414
o
 2-
theta. This shift towards a lower 2-theta value indicates an expansion of the zeolite 
unit cell is occurring. The rest of the patterns show a shift towards the higher 2-theta 
values which indicates a contraction of the zeolite unit cell is occurring. The zeolite 
framework has a high degree of flexibility and this peak position shift is a further 
indication that a species has been adsorbed into the pores of the zeolite, in this case 
aspirin, though the relatively low level of shift occurring indicates that this change is 
negligible. I have not included the 2-hour adsorption XRD pattern into my discussion 
as I believe this to be an outlier result due to its inconsistent data with respect to the 
rest of the aspirin XRD and HPLC results, going from the trend set by the other data 
it should have a similar XRD pattern to the 4 and 24 hour adsorptions but its relative 
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peak intensities are much lower than these two. The loss of definite peaks within the 
range 16
o
-23
o
 2-theta indicates a loss of crystallinity in the zeolite but there doesn’t 
seem to be any other indication that this should be occurring. 
  
The HPLC and XRD data indicate that the aspirin has been adsorbed by the 
commercial ZSM-5 200-400:1 and successfully removed from the solution. The data 
from the XRD patterns were used to determine the cell parameters to see how the cell 
structure changed to accommodate the adsorbed aspirin. The unit cell parameters for 
commercial ZSM-5 200-400:1 pre-and post aspirin adsorption were determined using 
Topas and J-edit and shown in table 20. A Pawley fit was done using a Chebyshev 
function background and Pseudo-Voight peak shape function, the zero background 
and unit cell parameters (a, b, c) were refined to determine errors.  
 
 
Table 20. Lattice parameters of commercial ZSM-5 200-400:1 pre-and post aspirin 
adsorption with errors included in brackets. 
Contact Time with 
Paracetamol 
Solution (Hours) RWP 
a 
(Å) 
b 
(Å) 
c 
(Å) 
0 14.083 20.11858(3) 19.87802(2) 13.38665(2) 
2 8.422 20.09008(19) 19.85840(17) 13.39895(14) 
4 12.619 20.15887(5) 19.90917(4) 13.40750(3) 
6 11.089 20.12000(6) 19.94505(3) 13.37450(3) 
8 9.749 20.13646(5) 19.94842(4) 13.42013(4) 
10 10.557 20.12037(7) 19.95905(4) 13.40383(4) 
24 10.585 20.07175(6) 19.95104(4) 13.39697(3) 
48 11.859 20.10364(7) 19.96116(4) 13.38733(4) 
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Figure 33. A) Change in lattice parameter a against ZSM-5 200-400:1 contact time with 
aspirin. B) Change in lattice parameter b against ZSM-5 200-400:1 contact time with aspirin. 
C) Change in lattice parameter c against ZSM-5 200-400:1 contact time with aspirin. 
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Figure 33 shows the change in the lattice parameters of ZSM-5 pre-and post aspirin 
adsorption and all three lattice parameters do not follow a similar path to one another. 
Lattice parameter a and b both decrease in size from 0-2 hours but lattice parameter a 
then peaks at 4 hours while b steadily increases until 6 hours where it then plateaus 
till its peak at 48 hours. Between 0 hours to its peak at 48 there is an increase of 
0.42%. Lattice parameter a decreases from its peak at 4 hours to 6 hours before rising 
slightly at 8 hours. It then drops from 8-24 hours before a slight increase at 48 hours. 
Overall there is shown to be a 0.07% reduction in lattice parameter a’s size from 0-48 
hours. Lattice parameter c shows a steady increase in size from 0-4 hours before a 
large drop at 6 hours. It then jumps back up at 8 hours before steady decline in size 
between 8-48 hours. Overall there was a 0.01% increase in lattice parameter c’s size 
from 0-48 hours. Considering aspirin has a size of 7.1Å X 4.9Å
[44]
 it could easily fit 
into the 5.4 X 5.6Å and 5.1 X 5.5Å sized pores of ZSM-5 as their upper limit for 
adsorption is larger than aspirin, being 9.1Å
[6]
, so it would be logical to conclude that 
some pore expansion would occur to allow for the aspirin to be adsorbed. At the 
maximum concentration adsorbed, the 48-hour adsorption, lattice parameter b and c 
show an increase in size whereas a shows a decrease in size. This trend is shown 
throughout the data as the amount adsorbed is relatively stable and high. 
 
These changes in size corresponding with the changes in the concentration of aspirin 
adsorbed indicate that these changes are due to the unit cell expanding and 
contracting to accommodate the aspirin being adsorbed into the pores of ZSM-5 200-
400:1, which confirms that the aspirin is being adsorbed by the ZSM-5 200-400:1. 
ZSM-5 200-400:1 shows a higher concentration adsorbed than ZSM-5 30:1, an 
increase of 5.9% adsorbed at maximum. From this the conclusion that ZSM-5 200-
400:1 ammonium would be an appropriate compound for the removal of aspirin from 
aqueous solution, more so than ZSM-5 30:1. This increase in affinity after an 
increase in the Si:Al ratio indicates that the charge balancing cation had a large effect 
on aspirin’s affinity for ZSM-5 as a reduction in this cation increased it. A change in 
the charge balancing cation may produce similar results and shall be explored later in 
this research. It could also be due to the increase hydrophobic tendencies of ZSM-5 
with an increase amount of silicon, the change in the charge balancing cation will 
indicate whether this is probable or not. 
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5. Results and Discussion – Adsorptions Using Fe Ion Exchanged 
ZSM-5 30:1  
5.1 – Introduction 
The data presented in this chapter has been taken from the adsorptions of 
paracetamol, aspirin and ibuprofen lysine by the commercial ZSM-5 30:1 after it had 
undergone an ion exchange reaction using Fe(II)Cl2. The charge balancing cation has 
been changed to see if this would change the investigated drug’s affinity for ZSM-5 
and whether this change in cation will have a positive effect on their adsorption. The 
ZSM-5 used for the experiments in this chapter has a Si:Al ratio of 30:1 and its 
charge balancing cation is Fe
3+
. To confirm that a successful ion exchange had 
occurred SEM EDX spectroscopy was ran before and after the reaction. The results 
of this are presented in table 21 below, five sets of EDX were run on different areas 
of the zeolite and an average was found. These results show that successful ion 
exchange has occurred and this allowed me to carry on with my adsorption reactions. 
 
Table 21. ZSM-5 30:1 EDX Wt% data before and after Fe ion exchange reaction. 
Sample Analysed 
Silicon Wt% 
(%) 
Aluminium 
Wt% (%) 
Oxygen Wt% 
(%) 
Nitrogen Wt% 
(%) 
Iron Wt% 
(%) 
ZSM-5 30:1 NH4 #1 47.62 3.30 46.79 2.30 0.00 
ZSM-5 30:1 NH4 #2 34.61 2.75 52.84 9.80 0.00 
ZSM-5 30:1 NH4 #3 46.89 3.42 44.06 5.63 0.00 
ZSM-5 30:1 NH4 #4 49.10 3.74 43.28 3.87 0.00 
ZSM-5 30:1 NH4 #5 54.25 4.08 38.55 3.12 0.00 
Average 46.49 3.46 45.10 4.94 0.00 
ZSM-5 30:1 FeCl2 
Ion Exchange #1 35.83 3.26 47.49 0.00 13.42 
ZSM-5 30:1 FeCl2 
Ion Exchange #2 47.50 3.93 47.13 0.00 1.45 
ZSM-5 30:1 FeCl2 
Ion Exchange #3 42.89 3.20 51.95 0.00 1.95 
ZSM-5 30:1 FeCl2 
Ion Exchange #4 45.97 3.52 48.29 0.00 2.22 
ZSM-5 30:1 FeCl2 
Ion Exchange #5 42.96 3.40 52.48 0.00 1.16 
Average 43.03 3.46 49.47 0.00 4.04 
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5.2 – Paracetamol 
The previous paracetamol HPLC calibration curve’s equation was used to calculate 
the concentration of the paracetamol left in the solution after the adsorptions. Table 
22 shows the HPLC data produced by the adsorption reactions between 2 and 48 
hours. Included are the concentration of the drug left in solution, the concentration of 
the drug that was adsorbed and the percentage of the overall concentration that was 
adsorbed. A plot showing concentration adsorbed by the zeolite against contact time 
is presented in figure 34.  
Table 22. HPLC results for the paracetamol adsorptions by Fe ion exchanged ZSM-5 30:1. 
Paracetamol 
Concentration 
Left in 
Solution (M) 
Peak 
Area 
(mVmin) 
Contact 
Time 
(Hours) 
Retention 
Time 
(mins) 
Height 
(mV) 
Concentration 
Adsorbed by 
the Zeolite (M) 
% Concentration 
Adsorbed 
0.00393 438.8005 2 3.512 2312.091 0.00107 21.3076 
0.00392 436.9443 4 3.496 2302.634 0.00108 21.6405 
0.00386 430.0410 6 3.484 2285.780 0.00114 22.8785 
0.00383 427.3773 8 3.482 2275.059 0.00117 23.3562 
0.00372 414.7077 10 3.493 2237.827 0.00128 25.6283 
0.00391 436.0245 24 3.490 2285.189 0.00109 21.8055 
0.00390 435.0501 48 3.483 2280.047 0.00110 21.9802 
 
 
Figure 34. Graph depicting concentration of paracetamol adsorbed by Fe ion exchanged 
ZSM-5 30:1 against contact time. 
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accounting for the lowest concentration adsorbed of 0.00107M and the highest 
occurring during the 10-hour adsorption of 0.00128M, indicating that 10 hours is the 
optimum contact time. The equilibrium seems to be between 21-22% as the 2, 4, 6, 
24 and 48 hour adsorptions all fall within this range. Overall this shows a decrease in 
the concentration adsorbed by ZSM-5 when compared to the ZSM-5 with ammonium 
as the charge balancing cation. This indicates that replacing the ammonium cations 
with iron cations lowers the affinity of paracetamol for ZSM-5.  
 
To confirm that the paracetamol has been adsorbed into the pores of ZSM-5 and not 
absorbed on to the surface of the particles powder XRD was performed on the 
filtered solid after adsorption had occurred. As a basis, the Fe ion exchanged ZSM-5 
30:1 pre-adsorption XRD pattern is included in figure 35 and shall have the 
adsorption patterns overlaid onto it in any further XRD patterns in this chapter. 
 
 
Figure 35. Fe ion exchanged ZSM-5 30:1 pre-adsorption XRD pattern. 
 
The diffraction patterns for the post adsorption ZSM-5 is shown in figure 36 with the 
post adsorption pattern overlaid onto the pre-adsorption pattern. 
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Figure 36. A) Fe ion exchanged ZSM-5 30:1 pre-adsorption + Fe ion exchanged ZSM-5 30:1 post 2-
hour paracetamol adsorption. B) Fe ion exchanged ZSM-5 30:1 pre-adsorption + Fe ion exchanged 
ZSM-5 30:1 post 4-hour paracetamol adsorption. C) Fe ion exchanged ZSM-5 30:1 pre-adsorption + 
Fe ion exchanged ZSM-5 30:1 post 6-hour paracetamol adsorption. D) Fe ion exchanged ZSM-5 30:1 
pre-adsorption + Fe ion exchanged ZSM-5 30:1 post 8-hour paracetamol adsorption. E) Fe ion 
exchanged ZSM-5 30:1 pre-adsorption + Fe ion exchanged ZSM-5 30:1 post 10-hour paracetamol 
adsorption. F) Fe ion exchanged ZSM-5 30:1 pre-adsorption + Fe ion exchanged ZSM-5 30:1 post 24-
hour paracetamol adsorption. G) Fe ion exchanged ZSM-5 30:1 pre-adsorption + Fe ion exchanged 
ZSM-5 30:1 post 48-hour paracetamol adsorption. 
 
All seven XRD patterns show some difference when compared to the pre-adsorption 
ZSM-5. All the patterns have some form of change in relative peak intensity in 
multiple peaks within the range of 5
o
-23
o
 2-theta. The most consistent difference is 
seen in the first two peaks at 7.93
o
 2-theta and 8.82
o
 2-theta, with the Fe ion 
exchanged ZSM-5 pre-adsorption having peak intensities of 8236 counts per second 
and 4700 counts per second respectively. Post adsorption these peaks were changed 
to between 8456-8999counts per second and 4675-5135 counts per second with the 
lowest peaks being produced by the 6-hour adsorption and highest being produced by 
the 48-hour adsorption. This change in relative peak intensity indicates that the 
contents of the unit cell have changed in some way which would indicate that the 
adsorption of the paracetamol has been successful. Another indicator is that all the 
post adsorption patterns have been shifted to the right by 0.0202
o
-0.0808
o
 2-theta 
with the 10-hour adsorption being shifted the most and the 8-hour adsorption the 
least. This shift towards a higher 2-theta value indicates a contraction of the zeolite 
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unit cell is occurring. The zeolite framework has a high degree of flexibility and this 
peak position shift is a further indication that a species has been adsorbed into the 
pores of the zeolite, in this case paracetamol, though the relatively low level of shift 
occurring indicates that this change is negligible.  
 
The HPLC and XRD data indicate that the paracetamol has been adsorbed by the Fe 
ion exchanged ZSM-5 30:1 and successfully removed from the solution. The data 
from the XRD patterns were used to determine the cell parameters to see how the cell 
structure changed to accommodate the adsorbed paracetamol. The unit cell 
parameters for Fe ion exchanged ZSM-5 30:1 pre-and post paracetamol adsorption 
were determined using Topas and J-edit and shown in table 23. A Pawley fit was 
done using a Chebyshev function background and Pseudo-Voight peak shape 
function, the zero background and unit cell parameters (a, b, c) were refined to 
determine errors.  
 
Table 23. Lattice parameters of Fe ion exchanged ZSM-5 30:1 pre-and post paracetamol 
adsorption with errors included in brackets. 
Contact Time with 
Paracetamol 
Solution (Hours) RWP 
a 
(Å) 
b 
(Å) 
c 
(Å) 
0 6.791 20.11923(4) 19.92074(2) 13.41776(2) 
2 6.294 20.12903(4) 19.92670(2) 13.41817(2) 
4 6.225 20.12127(3) 19.92243(2) 13.41232(2) 
6 6.156 20.13228(3) 19.92865(2) 13.42065(2) 
8 6.305 20.12280(6) 19.92317(2) 13.41237(2) 
10 6.221 20.13241(3) 19.93416(2) 13.42308(2) 
24 6.379 20.12665(3) 19.92374(2) 13.41350(2) 
48 6.457 20.11770(3) 19.91986(2) 13.41179(2) 
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Figure 37. A) Change in lattice parameter a against Fe ion exchanged ZSM-5 30:1 contact 
time with paracetamol. B) Change in lattice parameter b against Fe ion exchanged ZSM-5 
30:1 contact time with paracetamol. C) Change in lattice parameter c against Fe ion 
exchanged ZSM-5 30:1 contact time with paracetamol. 
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Figure 37 shows the change in the lattice parameters of ZSM-5 pre-and post 
paracetamol adsorption and shows all three lattice parameter size changes follow the 
same pattern. All three increase from 0-2 hours, they then reduce in size between 2-4 
hours, followed by another increase in size from 4-6 hours, they reduce in size from 
6-8 hours then increase in size from 8-10 hours and then a final reduction in size 
from 10-48 hours. Their graphs are visually similar because of this with only the 
relative size changes varying. These peaks and valleys do not seem to correlate with 
the steady yet small increase in concentration adsorbed shown in the HPLC data but 
there are some definite similarities. The concentration adsorbed of paracetamol 
increased steadily from 2-10 hours, peaking at 10 hours, and then decreasing from 
10-48 hours. Between 2-10 hours there is an increase in concentration adsorbed of 
4.32% followed by a reduction of 3.65% concentration adsorbed between 10-48 
hours. Similarly, between 0-10 hours there is an increase in size of lattice parameters 
a, b and c of 0.07%, 0.07% and 0.04% respectively, between 10-48 hours there is a 
reduction in size of lattice parameters a, b and c of 0.07%, 0.07% and 0.08% 
respectively. Paracetamol is 7.8Å X 4.2Å 
[41]
 in size, considering the pore sizes of 
ZSM-5 are 5.4 X 5.6Å and 5.1 X 5.5Å it would be logical to conclude that some pore 
expansion would be required for paracetamol to be adsorbed and with the upper limit 
for molecule adsorption size for ZMS-5 being 9.1Å
[6]
 it is completely possible for 
paracetamol to be adsorbed. 
 
These changes in size corresponding with the changes in the concentration of 
paracetamol adsorbed indicate that these changes are due to the unit cell expanding to 
accommodate the paracetamol being adsorbed into the pores of the Fe ion exchanged 
ZSM-5 30:1, which confirms that the paracetamol is being adsorbed by the Fe ion 
exchanged ZSM-5 30:1. However considering its overall amount of concentration 
removed from solution is reduced by over half of the commercial ZSM-5 30:1 
equivalent we would consider the Fe ion exchanged ZSM-5 30:1 appropriate for the 
removal of paracetamol from aqueous solution but to not use it if commercial ZSM-5 
ammonium 30:1 is available. This would indicate that the presence of iron cations 
instead of ammonium reduced paracetamol’s affinity for ZSM-5. From this we can 
infer that it is more likely that the reduction in adsorption of paracetamol by the 
commercial ZSM-5 ammonium 200-400:1 was due to the reduction of ammonium 
cations present rather than its increased hydrophobicity. 
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5.3 – Ibuprofen Lysine 
The previous ibuprofen lysine HPLC calibration curve’s equation was used to 
calculate the concentration of the ibuprofen lysine left in the solution after the 
adsorptions. Table 24 shows the HPLC data produced by the adsorption reactions 
between 2 and 48 hours. Included are the concentration of the drug left in solution, the 
concentration of the drug that was adsorbed and the percentage of the overall 
concentration that was adsorbed. A plot showing concentration adsorbed by the 
zeolite against contact time is presented in figure 38.  
Table 24. HPLC results for the ibuprofen lysine adsorptions by Fe ion exchanged ZSM-5 
30:1. 
Ibuprofen 
Lysine 
Concentration 
Left in 
Solution (M) 
Peak Area 
(mVmin) 
Contact 
Time 
(Hours) 
Retention 
Time (mins) 
Height 
(mV) 
Concentration 
Adsorbed by 
the Zeolite 
(M) 
% 
Concentration 
Adsorbed 
0.00205 162.9501 2 8.258 450.885 0.00000* 0.0000 
0.00214 170.3202 4 8.203 395.462 0.00000* 0.0000 
0.00151 120.1861 6 8.079 345.410 0.00049 24.4065 
0.00145 115.5099 8 8.070 331.811 0.00055 27.3477 
0.00147 117.2509 10 8.068 336.472 0.00053 26.2527 
0.00206 163.6923 24 8.234 457.206 0.00000* 0.0000 
0.00205 162.8823 48 8.243 451.870 0.00000* 0.0000 
*These values have been normalised to zero as HPLC data came out with a negative 
concentration 
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Figure 38. Graph depicting concentration of ibuprofen lysine adsorbed by Fe ion exchanged 
ZSM-5 30:1 against contact time. 
 
Due to its low concentration and the low relative solubility of ibuprofen lysine in 
general the HPLC machine may have picked up a higher result than possible, if only 
slightly, causing negative results to appear. These adsorptions were repeated to check 
validity and consistent results were produced. For the purposes of this research any 
negative concentration results have been changed to indicate that no ibuprofen lysine 
was adsorbed, though some may have been the amount is negligible. The amount 
adsorbed seems to be rather stable when it is adsorbed, being within the range of 
24.4-27.35%. This data would indicate that the optimum adsorption time is 8 hours as 
after this the concentration adsorbed starts to drop. This would indicate that while 
better than commercial ZSM-5 200-400:1, Fe ion exchanged ZSM-5 30:1 is not 
appropriate for the removal of ibuprofen lysine from aqueous solution if commercial 
ZSM-5 30:1 is available. 
 
To ascertain that ibuprofen lysine had been adsorbed into the pores of the zeolite and 
not the surface of the particles XRD was carried out and the data analysed using 
Pawley fits. The post adsorption XRD patterns overlaid onto the Fe ion exchanged 
ZSM-5 30:1 XRD pattern, shown in figure 35, are plotted in figure 39 below. 
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Figure 39. A) Fe Ion Exchanged ZSM-5 30:1 pre-adsorption + Fe Ion Exchanged ZSM-5 30:1 post 2-
hour ibuprofen lysine adsorption. B) Fe Ion Exchanged ZSM-5 30:1 pre-adsorption + Fe Ion 
Exchanged ZSM-5 30:1 post 4-hour ibuprofen lysine adsorption. C) Fe Ion Exchanged ZSM-5 30:1 
pre-adsorption + Fe Ion Exchanged ZSM-5 30:1 post 6-hour ibuprofen lysine adsorption. D) Fe Ion 
Exchanged ZSM-5 30:1 pre-adsorption + Fe Ion Exchanged ZSM-5 30:1 post 8-hour ibuprofen lysine 
adsorption. E) Fe Ion Exchanged ZSM-5 30:1 pre-adsorption + Fe Ion Exchanged ZSM-5 30:1 post 
10-hour ibuprofen lysine adsorption. F) Fe Ion Exchanged ZSM-5 30:1 pre-adsorption + Fe Ion 
Exchanged ZSM-5 30:1 post 24-hour ibuprofen lysine adsorption. G) Fe Ion Exchanged ZSM-5 30:1 
pre-adsorption + Fe Ion Exchanged ZSM-5 30:1 post 48-hour ibuprofen lysine adsorption. 
 
All seven XRD patterns show some slight difference when compared to the pre-
adsorption ZSM-5. All the patterns have some form of reduction in relative peak 
intensity in multiple peaks within the range of 5
o
-23
o
 2-theta. The biggest difference 
is seen in the first two peaks at 7.93
o
 2-theta and 8.82
o
 2-theta, with the commercial 
ZSM-5 pre-adsorption having peak intensities of 8236 counts per second and 4700 
counts per second respectively. Post adsorption these peaks were reduced to between 
5201-6777 counts per second and 3150-4058 counts per second with the lowest peaks 
being produced by the 6-hour adsorption and highest being produced by the 8 and 10 
hour adsorptions respectively. The 6-hour adsorption also has noticeable reductions 
in the peaks at 13.89
o
 2-theta, 14.75
o
 2-theta, 15.50
o
 2-theta, 15.90
o
 2-theta, 23.05
o
 2-
theta and 23.90
o
 2-theta. These initially had peak intensities of 1351, 1388, 1021, 
1196, 6652 and 3797 counts per second respectively. These were reduced to 902, 
917, 769, 836, 4998 and 2986 counts per second respectively. This change in relative 
peak intensity indicates that the contents of the unit cell have changed in some way 
which would indicate that the adsorption of the ibuprofen lysine has been successful. 
The 6-hour adsorption’s XRD pattern show some shifting towards the right, a shift of 
0.1212
o
 2-theta. This shift towards a higher 2-theta value indicates a contraction of 
the zeolite unit cell is occurring. The zeolite framework has a high degree of 
flexibility and this peak position shift is a further indication that a species has been 
adsorbed into the pores of the zeolite, in this case ibuprofen lysine, though the 
relatively low level of shift occurring indicates that this change is negligible. I have 
not included the 2, 4, 24 and 48-hour adsorption’s XRD patterns in my conclusions 
as the peaks they display are inconsistent with what would be expected and each 
other, 2 and 4 hours being similar to each other and 24 and 48 hours being similar but 
both sets being dissimilar to each other. This could be due to small amount of 
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ibuprofen lysine being adsorbed and the HPLC not picking it up properly but since 2 
and 4 hours have a similar pattern to the 6-hour adsorption and 24 and 48 hours have 
a similar pattern to the 10-hour adsorption it is still inconsistent. Any further analysis 
shall exclude these data points also. 
 
The HPLC and XRD data indicate that the ibuprofen lysine has been adsorbed at 
certain times by the Fe ion exchanged ZSM-5 30:1 and successfully removed from 
the solution. The data from the XRD patterns were used to determine the cell 
parameters to see how the cell structure changed to accommodate the adsorbed 
ibuprofen lysine. The unit cell parameters for Fe ion exchanged ZSM-5 30:1 pre-and 
post ibuprofen lysine adsorption were determined using Topas and J-edit and shown 
in table 25. A Pawley fit was done using a Chebyshev function background and 
Pseudo-Voight peak shape function, the zero background and unit cell parameters (a, 
b, c) were refined to determine errors.  
Table 25. Lattice parameters of Fe ion exchanged ZSM-5 30:1 pre-and post ibuprofen lysine 
adsorption with errors included in brackets. 
Contact Time with 
Ibuprofen Lysine 
Solution (Hours) RWP 
a 
(Å) 
b 
(Å) 
c 
(Å) 
0 6.791 20.11923(4) 19.92074(2) 13.41776(2) 
2 6.270 20.13753(4) 19.93231(2) 13.42492(3) 
4 6.170 20.12901(5) 19.92952(3) 13.42435(3) 
6 6.031 20.13959(4) 19.93073(3) 13.42675(3) 
8 5.939 20.13039(4) 19.93160(2) 13.42568(2) 
10 6.086 20.12244(4) 19.92341(2) 13.42254(2) 
24 6.565 20.12246(4) 19.92455(2) 13.42109(2) 
48 6.253 20.12771(4) 19.93093(2) 13.42469(2) 
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Figure 40. A) Change in lattice parameter a against Fe ion exchanged ZSM-5 30:1 contact 
time with ibuprofen lysine. B) Change in lattice parameter b against Fe ion exchanged ZSM-
5 30:1 contact time with ibuprofen lysine. C) Change in lattice parameter c against Fe ion 
exchanged ZSM-5 30:1 contact time with ibuprofen lysine. 
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Figure 40 shows the change in the lattice parameters of ZSM-5 pre-and post 
ibuprofen lysine adsorption and shows all three lattice parameter size changes follow 
a similar pattern. All three increase in size from 0-2 hours then reduce in size 
between 2-4 hours before increasing in size again from 4-6 hours. Then parameters a 
and c decrease in size from 6-10 hours, with parameter c further decreasing in size 
from 10-24 hours and parameter a plateauing at this point. Parameter b increases in 
size between 4-6 hours before dropping down from 8-10 hours followed by a slight 
increase in size from 10-24 hours. All three parameters then increase in size from 24-
48 hours. Disregarding the XRD data from 2, 4, 24 and 48 hours, as done previously, 
then it seems that all the parameters increase in size when ibuprofen lysine is 
adsorbed but that parameter b increases in size the higher the concentration is 
adsorbed while parameters a and c decrease in size. From 6-8 hours, there is an 
increase in adsorption by 2.94%, this produced an increase in size for parameter b of 
0.004% and reductions in size of parameters a and c by 0.046% and 0.008% 
respectively. All three behave inconsistently with this though at 10 hours, as there is 
a reduction in concentration so parameter b should reduce in size, as it does, but its 
reduction seems too large for the reduction in concentration that is occurring. 
Similarly, at 10 hours there should be an increase in size of parameters a and c as 
there is a reduction in concentration adsorbed but both are shown to decrease in size 
alongside parameter b. The concentration adsorbed is reduced by 1.10% and this 
leads to a reduction in size for parameters a, b and c of 0.039%, 0.041% and 0.023% 
respectively. These inconsistencies indicate that the lattice parameters were changing 
independently of the amount of ibuprofen lysine adsorbed and that they do not 
change to accommodate the ibuprofen lysine. Ibuprofen lysine is 8.9Å X 3.8Å
[42] 
in 
size, considering the pore sizes of ZSM-5 are 5.4 X 5.6Å and 5.1 X 5.5Å it would be 
logical to conclude that some pore expansion would be required for ibuprofen lysine 
to be adsorbed and with the upper limit for molecule adsorption size for ZMS-5 being 
9.1Å
[6]
 it is completely possible for ibuprofen lysine to be adsorbed, but due to the 
inconsistencies presented in the lattice parameters sizes it does not seem likely that 
the expansions occurring are purely due to the adsorption of ibuprofen lysine. 
  
This data indicates that Fe ion exchanged ZSM-5 30:1 is not an appropriate 
compound for the removal of ibuprofen lysine from aqueous solution. The presence 
of a lower amount of adsorption than that of commercial ZSM-5 ammonium 30:1 
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would indicate that the change to the iron charge balancing cation decreased the 
affinity of ibuprofen lysine for ZSM-5 and it is more likely that the reduction in the 
number of charge balancing cations and not the hydrophobicity of the commercial 
ZSM-5 200-400:1 that caused the reduction in ibuprofen lysine’s affinity for it. 
 
5.4 – Aspirin  
The previous aspirin HPLC calibration curve’s equations for aspirin peak 1 and 2 was 
used to calculate the concentration of the aspirin left in the solution after the 
adsorptions by combining the concentrations. Table 26 shows the HPLC data 
produced by the adsorption reactions between 2 and 48 hours for peak 1, table 27 
shows peak 2 and table 28 are the two sets of concentrations combined. Included are 
the concentration of the drug left in solution, the concentration of the drug that was 
adsorbed and the percentage of the overall concentration that was adsorbed. A plot 
showing the aspirin combined concentration adsorbed by the zeolite against contact 
time is presented in figure 41.  
Table 26. Aspirin peak 1 HPLC results 
Aspirin Tablet 
Samples Peak 1 
Concentration 
Left in Solution 
(M) 
Peak Area 
(mVmin) 
Contact Time 
(Hours) 
Retention 
Time (min) 
Height 
(mV) 
0.0014 13.7629 2 7.291 46.359 
0.0014 13.8948 4 7.212 46.576 
0.0019 18.6756 6 6.987 65.442 
0.0019 18.1783 8 6.872 62.975 
0.0008 7.8051 10 6.835 27.295 
0.0018 17.4385 24 6.802 60.180 
0.0010 9.4389 48 6.793 32.345 
. 
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Table 27. Aspirin peak 2 HPLC results. 
Aspirin Tablet 
Samples Peak 2 
Concentration 
Left in Solution 
(M) 
Peak Area 
(mVmin) 
Contact Time 
(Hours) 
Retention 
Time (mins) 
Height 
(mV) 
0.0014 12.8839 2 11.044 30.142 
0.0015 13.3165 4 10.927 30.141 
0.0013 11.9726 6 10.448 39.060 
0.0013 11.4244 8 10.304 38.590 
0.0017 15.1906 10 10.221 35.969 
0.0013 11.2748 24 10.148 28.011 
0.0019 17.2676 48 10.425 40.242 
 
Table 28. Aspirin combined concentrations HPLC results. 
Aspirin Tablet 
Samples 
Combined 
Concentrations 
Left in Solution 
(M) 
Contact 
Time 
Concentration 
Adsorbed by the 
Zeolite % Concentration Adsorbed 
0.0028 2 0.0022 43.1930 
0.0029 4 0.0021 41.9596 
0.0032 6 0.0018 35.1979 
0.0031 8 0.0019 37.4347 
0.0025 10 0.0025 50.2108 
0.0030 24 0.0020 39.2781 
0.0029 48 0.0021 42.2468 
 
Figure 41. Graph depicting concentration of aspirin adsorbed by Fe ion exchanged ZSM-5 
30:1 against contact time. 
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The concentration adsorbed stays fairly constant throughout as the percentage 
adsorbed only had a range of 35.20-50.21% with the contact time of 6 hours 
accounting for the lowest concentration adsorbed of 0.0018M and the highest 
occurring during the 10-hour adsorption of 0.0025M, indicating that this is the 
optimum adsorbance time. An equilibrium seems to have been found at around 41-
43%, 2 and 4 hours being within this range before dropping down to 35.20% at 6 
hours. From 6-8 hours, there is a slight increase in percentage adsorbed, from 35.20% 
to 37.43%, before increasing again between 8-10 hours, going from 37.43% to the 
maximum of 50.21% before dropping down to 39.28% at 24 hours. It then increases 
again to 42.25% at 48 hours, seemingly approaching the equilibrium once again. This 
overall relative decrease in the concentration adsorbed by ZSM-5 when compared the 
commercial ZSM-5 ammonium 30:1 indicates that changing the charge balancing 
cation to iron reduced aspirin’s affinity for ZSM-5. It also shows a relative decrease 
in the concentration adsorbed when compared to the commercial ZSM-5 ammonium 
200-400:1, this would indicate that aspirin’s increased affinity for ZSM-5 200-400:1 
was more likely due to its increased hydrophobicity than its reduced amount of 
ammonium cations. 
 
To confirm that the aspirin has been adsorbed into the pores of ZSM-5 and not 
absorbed on to the surface of the particles powder XRD was performed on the 
filtered solid after adsorption had occurred. As a basis, the Fe ion exchanged ZSM-5 
30:1 XRD pattern is included in figure 35 and the diffraction patterns for the post 
adsorption ZSM-5 is shown in figure 42 with the post adsorption pattern overlaid 
onto the pre-adsorption pattern. 
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Figure 42. A) Fe ion exchanged ZSM-5 30:1 pre-adsorption + Fe ion exchanged ZSM-5 30:1 post 2-
hour aspirin adsorption. B) Fe ion exchanged ZSM-5 30:1 pre-adsorption + Fe ion exchanged ZSM-5 
30:1 post 4-hour aspirin adsorption. C) Fe ion exchanged ZSM-5 30:1 pre-adsorption + Fe ion 
exchanged ZSM-5 30:1 post 6-hour aspirin adsorption. D) Fe ion exchanged ZSM-5 30:1 pre-
adsorption + Fe ion exchanged ZSM-5 30:1 post 8-hour aspirin adsorption. E) Fe ion exchanged ZSM-
5 30:1 pre-adsorption + Fe ion exchanged ZSM-5 30:1 post 10-hour aspirin adsorption. F) Fe ion 
exchanged ZSM-5 30:1 pre-adsorption + Fe ion exchanged ZSM-5 30:1 post 24-hour aspirin 
adsorption. G) Fe ion exchanged ZSM-5 30:1 pre-adsorption + Fe ion exchanged ZSM-5 30:1 post 48-
hour aspirin adsorption. 
 
All seven XRD patterns show noticeable difference when compared to pre-adsorption 
ZSM-5. All the patterns have some form of change in relative peak intensity in the 
first two peaks at 7.93
o
 2-theta and 8.82
o
 2-theta. These show a consistent increase in 
relative peak intensity, except for 6 hours which shows a reduction of relative peak 
intensity, with the commercial ZSM-5 pre-adsorption having peak intensities of 8236 
counts per second and 4700 counts per second respectively. Post adsorption these 
peaks were changed to between 7883-9663 counts per second and 4415-7702 counts 
per second with the lowest peaks being produced by the 6-hour adsorption and 
highest being produced by the 48-hour adsorption. This change in relative peak 
intensity indicates that the contents of the unit cell have changed in some way which 
would indicate that the adsorption of the aspirin has been successful. Another 
indicator is that the 24-hour adsorption pattern has been shifted to the right by a 
noticeable amount, being shifted by 0.0606
o
 2-theta. This shift towards a higher 2-
theta value indicates a contraction of the zeolite unit cell is occurring. The rest of the 
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patterns also show a shift towards the higher 2-theta values which indicating that a 
contraction of the zeolite unit cell is occurring there as well. The zeolite framework 
has a high degree of flexibility and this peak position shift is a further indication that 
a species has been adsorbed into the pores of the zeolite, in this case aspirin, though 
the relatively low level of shift occurring indicates that this change is negligible.  
  
The HPLC and XRD data indicate that the aspirin has been adsorbed by the Fe ion 
exchanged ZSM-5 30:1 and successfully removed from the solution. The data from 
the XRD patterns were used to determine the cell parameters to see how the cell 
structure changed to accommodate the adsorbed aspirin. The unit cell parameters for 
Fe ion exchanged ZSM-5 30:1 pre-and post aspirin adsorption were determined using 
Topas and J-edit and shown in table 29. A Pawley fit was done using a Chebyshev 
function background and Pseudo-Voight peak shape function, the zero background 
and unit cell parameters (a, b, c) were refined to determine errors.  
 
Table 29. Lattice parameters of Fe ion exchanged ZSM-5 30:1 pre-and post aspirin 
adsorption with errors included in brackets. 
Contact Time with 
Paracetamol 
Solution (Hours) RWP 
a 
(Å) 
b 
(Å) 
c 
(Å) 
0 6.791 20.11923(4) 19.92074(2) 13.41776(2) 
2 6.489 20.12965(3) 19.92964(2) 13.41955(2) 
4 6.418 20.11964(4) 19.92586(3) 13.41366(3) 
6 6.747 20.12342(4) 19.92081(3) 13.41465(3) 
8 6.809 20.11310(4) 19.92608(2) 13.41296(2) 
10 6.694 20.10625(4) 19.92351(2) 13.41111(2) 
24 6.444 20.11578(4) 19.92679(2) 13.41478(2) 
48 7.04 20.10644(4) 19.92032(2) 13.40841(3) 
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Figure 43. A) Change in lattice parameter a against Fe ion exchanged ZSM-5 30:1 contact 
time with aspirin. B) Change in lattice parameter b against Fe ion exchanged ZSM-5 30:1 
contact time with aspirin. C) Change in lattice parameter c against Fe ion exchanged ZSM-5 
30:1 contact time with aspirin. 
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Figure 43 shows the change in the lattice parameters of ZSM-5 pre-and post aspirin 
adsorption and all three lattice parameters do follow a similar path to one another. All 
three increase from 0-2 hours, lattice parameter a increasing by 0.05%, parameter b 
by 0.04% and parameter c by 0.1%. They then slowly decrease in size between 2-48 
hours with lattice parameter a reducing by 0.12%, lattice parameter b reducing by 
0.05% and lattice parameter c by 0.08%. These changes in size do not correlate to the 
change in concentration adsorbed by the zeolite, this indicates that the changes in 
lattice parameter’s sizes are independent and therefore they are not changing to 
accommodate adsorbing the aspirin. 
 
From this we conclude that Fe ion exchanged ZSM-5 30:1 would be an appropriate 
compound for the removal of aspirin from aqueous solution, though slightly less 
useful than commercial ZSM-5 30:1 ammonium and commercial ZSM-5 200-400:1 
ammonium. This reduction in affinity after changing the charge balancing cation to 
iron indicates that the charge balancing cation influences aspirin’s affinity for ZSM-
5, though this effect may be quite small as it isn’t that large a reduction in relative 
concentration adsorbed. Taken in conjunction with the increase in affinity for ZSM-5 
200-400:1 seems to indicate that it was more likely that the increase in aspirin’s 
affinity for ZSM-5 200-400:1 was due to the increase in its hydrophobicity rather 
than the reduction of the number of charge balancing cations present. Overall using 
Fe ion exchanged ZSM-5 30:1 to remove aspirin from aqueous solution is viable 
though unadvised if commercial ZSM-5 30:1 ammonium or commercial ZSM-5 200-
400:1 ammonium is available as these are preferable. 
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6. Results and Discussion – Adsorptions Using Na Ion Exchanged 
ZSM-5 30:1  
6.1 – Introduction 
The data presented in this chapter has been taken from the adsorptions of 
paracetamol, aspirin and ibuprofen lysine by the commercial ZSM-5 30:1 after it had 
undergone an ion exchange reaction using NaCl. The charge balancing cation has 
been changed to see if this would change the investigated drug’s affinity for ZSM-5. 
The ZSM-5 used for the experiments in this chapter has a Si:Al ratio of 30:1 and its 
charge balancing cation is
 
Na
+
. To confirm that a successful ion exchange had 
occurred SEM EDX spectroscopy was ran before and after the reaction. The results 
of this are presented in table 30 below, five sets of EDX were run on different areas 
of the zeolite and an average was found. These results show that successful ion 
exchange has occurred and this allowed me to carry on with my adsorption reactions. 
 
Table 30. ZSM-5 30:1 EDX Wt% data before and after Na ion exchange reaction. 
Sample Analysed 
Silicon Wt% 
(%) 
Aluminium 
Wt% (%) 
Oxygen Wt% 
(%) 
Nitrogen Wt% 
(%) 
Sodium 
Wt% (%) 
ZSM-5 30:1 NH4 #1 47.62 3.30 46.79 2.30 0.00 
ZSM-5 30:1 NH4 #2 34.61 2.75 52.84 9.80 0.00 
ZSM-5 30:1 NH4 #3 46.89 3.42 44.06 5.63 0.00 
ZSM-5 30:1 NH4 #4 49.10 3.74 43.28 3.87 0.00 
ZSM-5 30:1 NH4 #5 54.25 4.08 38.55 3.12 0.00 
Average 46.49 3.46 45.10 4.94 0.00 
ZSM-5 30:1 NaCl 
Ion Exchange #1 43.19 3.54 51.03 0.00 2.24 
ZSM-5 30:1 NaCl 
Ion Exchange #2 46.21 3.45 48.55 0.00 1.79 
ZSM-5 30:1 NaCl 
Ion Exchange #3 47.74 3.36 47.22 0.00 1.68 
ZSM-5 30:1 NaCl 
Ion Exchange #4 44.89 3.53 49.49 0.00 2.08 
ZSM-5 30:1 NaCl 
Ion Exchange #5 46.35 3.60 48.38 0.00 1.66 
Average 45.68 3.50 48.93 0.00 1.89 
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6.2 – Paracetamol 
The previous paracetamol HPLC calibration curve’s equation was used to calculate 
the concentration of the paracetamol left in the solution after the adsorptions. Table 
31 shows the HPLC data produced by the adsorption reactions between 2 and 48 
hours. Included are the concentration of the drug left in solution, the concentration of 
the drug that was adsorbed and the percentage of the overall concentration that was 
adsorbed. A plot showing concentration adsorbed by the zeolite against contact time 
is presented in figure 44.  
Table 31. HPLC results for the paracetamol adsorptions by Na ion exchanged ZSM-5 30:1. 
Paracetamol 
Concentration 
Left in 
Solution (M) 
Peak 
Area 
(mVmin) 
Contact 
Time 
(Hours) 
Retention 
Time 
(mins) 
Height 
(mV) 
Concentration 
Adsorbed by 
the Zeolite (M) 
% Concentration 
Adsorbed 
0.004007 446.8445 2 3.471 2307.533 0.000993 19.8651 
0.003971 442.8634 4 3.435 2270.959 0.001029 20.5790 
0.004127 460.2138 6 3.470 2325.131 0.000873 17.4675 
0.003935 438.8704 8 3.436 2274.801 0.001065 21.2951 
0.003943 439.7617 10 3.438 2271.731 0.001057 21.1352 
0.004022 448.5706 24 3.469 2303.159 0.000978 19.5555 
0.004111 458.5221 48 3.451 2311.202 0.000889 17.7708 
 
 
Figure 44. Graph depicting concentration of paracetamol adsorbed by Na ion exchanged 
ZSM-5 30:1 against contact time. 
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accounting for the lowest concentration adsorbed of 0.000873M and the highest 
occurring during the 8-hour adsorption of 0.001065M, indicating that 8 hours is the 
optimum contact time. The equilibrium seems to be between 19-21% as the 2, 4, 8, 
10 and 24 hour adsorptions all fall within this range. There is a drop at 6 hours, with 
a concentration adsorbed of 17.47%, and at 48 hours with a concentration at 17.77%. 
Overall this shows a decrease in the concentration adsorbed by ZSM-5 when 
compared to the ZSM-5 with ammonium as the charge balancing cation. This 
indicates that replacing the ammonium cations with sodium cations lowers the 
affinity of paracetamol for ZSM-5.  
 
To confirm that the paracetamol has been adsorbed into the pores of ZSM-5 and not 
absorbed on to the surface of the particles powder XRD was performed on the 
filtered solid after adsorption had occurred. As a basis, the Fe ion exchanged ZSM-5 
30:1 pre-adsorption XRD pattern is included in figure 45 and shall have the 
adsorption patterns overlaid onto it in any further XRD patterns in this chapter. 
 
 
Figure 45. Na ion exchanged ZSM-5 30:1 pre-adsorption XRD pattern. 
 
The diffraction patterns for the post adsorption ZSM-5 is shown in figure 46 with the 
post adsorption pattern overlaid onto the pre-adsorption pattern. 
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Figure 46. A) Na ion exchanged ZSM-5 30:1 pre-adsorption + Na ion exchanged ZSM-5 30:1 post 2-
hour paracetamol adsorption. B) Na ion exchanged ZSM-5 30:1 pre-adsorption + Na ion exchanged 
ZSM-5 30:1 post 4-hour paracetamol adsorption. C) Na ion exchanged ZSM-5 30:1 pre-adsorption + 
Na ion exchanged ZSM-5 30:1 post 6-hour paracetamol adsorption. D) Na ion exchanged ZSM-5 30:1 
pre-adsorption + Na ion exchanged ZSM-5 30:1 post 8-hour paracetamol adsorption. E) Na ion 
exchanged ZSM-5 30:1 pre-adsorption + Na ion exchanged ZSM-5 30:1 post 10-hour paracetamol 
adsorption. F) Na ion exchanged ZSM-5 30:1 pre-adsorption + Na ion exchanged ZSM-5 30:1 post 
24-hour paracetamol adsorption. G) Na ion exchanged ZSM-5 30:1 pre-adsorption + Na ion 
exchanged ZSM-5 30:1 post 48-hour paracetamol adsorption. 
 
All seven XRD patterns show some difference when compared to the pre-adsorption 
ZSM-5. All the patterns have some form of change in relative peak intensity in 
multiple peaks within the range of 5
o
-23
o
 2-theta. The most consistent differences are 
seen in the first two peaks at 7.93
o
 2-theta and 8.82
o
 2-theta, with the Na ion 
exchanged ZSM-5 pre-adsorption having peak intensities of 9961 counts per second 
and 5208 counts per second respectively, and the peaks at 23.05
o 
2-theta and 23.88
o
 
2-theta, with the Na ion exchanged ZSM-5 pre-adsorption having peak intensities of 
6498 counts per second and 3800 counts per second respectively. Post adsorption 
these peaks were changed to between 7699-9119 counts per second and 4369-5199 
counts per second for 7.93
o
 2-theta and 8.82
o
 2-theta respectively, with the lowest 
peaks being produced by the 10-hour adsorption and highest being produced by the 2 
and 8 hour adsorptions respectively. For the peaks at 23.05
o
 2-theta and 23.88
o
 2-
theta the post-adsorption peaks were changed to between 6627-7105 counts per 
second and 3770-4096 counts per second respectively with the lowest peaks being 
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produced by the 4-hour adsorption and the highest being produced by the 6-hour 
adsorption. This change in relative peak intensity indicates that the contents of the 
unit cell have changed in some way which would indicate that the adsorption of the 
paracetamol has been successful. Another indicator is that 4-hour adsorption pattern 
has been shifted to the right by 0.0808
o
 2-theta. This shift towards a higher 2-theta 
value indicates a contraction of the zeolite unit cell is occurring. The zeolite 
framework has a high degree of flexibility and this peak position shift is a further 
indication that a species has been adsorbed into the pores of the zeolite, in this case 
paracetamol, though this could be seen to be negligible due to the low levels.  
 
The HPLC and XRD data indicate that the paracetamol has been adsorbed by the Fe 
ion exchanged ZSM-5 30:1 and successfully removed from the solution. The data 
from the XRD patterns were used to determine the cell parameters to see how the cell 
structure changed to accommodate the adsorbed paracetamol. The unit cell 
parameters for Na ion exchanged ZSM-5 30:1 pre-and post paracetamol adsorption 
were determined using Topas and J-edit and shown in table 32. A Pawley fit was 
done using a Chebyshev function background and Pseudo-Voight peak shape 
function, the zero background and unit cell parameters (a, b, c) were refined to 
determine errors.  
 
Table 32. Lattice parameters of Na ion exchanged ZSM-5 30:1 pre-and post paracetamol 
adsorption with errors included in brackets. 
Contact Time with 
Paracetamol 
Solution (Hours) RWP 
a 
(Å) 
b 
(Å) 
c 
(Å) 
0 7.228 20.13230(3) 19.92958(2) 13.42249(2) 
2 6.892 20.12666(3) 19.92248(2) 13.41696(2) 
4 6.949 20.13635(3) 19.93184(2) 13.41977(2) 
6 6.999 20.12648(3) 19.92326(2) 13.41727(2) 
8 7.109 20.12705(4) 19.92628(2) 13.41622(2) 
10 6.499 20.13911(3) 19.93545(2) 13.42536(2) 
24 6.786 20.13384(3) 19.93107(2) 13.42559(2) 
48 6.824 20.13339(4) 19.93369(2) 13.42343(2) 
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Figure 47. A) Change in lattice parameter a against Na ion exchanged ZSM-5 30:1 contact 
time with paracetamol. B) Change in lattice parameter b against Na ion exchanged ZSM-5 
30:1 contact time with paracetamol. C) Change in lattice parameter c against Na ion 
exchanged ZSM-5 30:1 contact time with paracetamol. 
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Figure 47 shows the change in the lattice parameters of ZSM-5 pre-and post 
paracetamol adsorption and shows all three lattice parameter size changes follow a 
similar pattern. All three decrease in size from 0-2 hours, then increase in size 
between 2-4 hours, followed by another decrease in size from 4-6 hours, then an 
increase in size from 6-10 hours before a final decrease in size from 10-48 hours 
overall. Parameter c differs from this pattern in two ways, first having a decrease in 
size from 6-8 hours before the increase at 10 hours and second a small increase 
between 10-24 hours before the final decrease at 48 hours and parameter b increases 
in size between 24 and 48 hours instead of decreasing. From 2-48 hours, there is an 
overall increase of 0.03% for parameter a, a 0.06% increase for parameter b and a 
0.05% increase for parameter c. The data points seem to fit with the HPLC data, 
increasing from 2-4 hours and then decreasing from 4-6 hours in conjunction with the 
HPLC data. They differ however in that if they are directly proportional to one 
another then the peak point for size in all three parameters should be 8 hours but as 
shown it is 10 hours, and the increase from 8-10 hours is too large in comparison. 
From this we can conclude that overall the changes in the lattice parameters’ size are 
independent to the changes in concentration adsorbed and therefore do not change to 
accommodate the paracetamol adsorbed. 
 
The overall amount of concentration removed from solution is reduced by over half 
of the commercial ZSM-5 30:1 equivalent we would consider the Na ion exchanged 
ZSM-5 30:1 appropriate for the removal of paracetamol from aqueous solution but to 
not use it if commercial ZSM-5 ammonium 30:1 is available. This would indicate 
that the presence of sodium cations instead of ammonium reduced paracetamol’s 
affinity for ZSM-5. From this we can infer that it is more likely that the reduction in 
adsorption of paracetamol by the commercial ZSM-5 ammonium 200-400:1 was due 
to the reduction of ammonium cations present rather than its increased 
hydrophobicity. 
 
 
 
6.3 – Ibuprofen Lysine 
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The previous ibuprofen lysine HPLC calibration curve’s equation was used to 
calculate the concentration of the ibuprofen lysine left in the solution after the 
adsorptions. Table 33 shows the HPLC data produced by the adsorption reactions 
between 2 and 48 hours. Included are the concentration of the drug left in solution, the 
concentration of the drug that was adsorbed and the percentage of the overall 
concentration that was adsorbed. A plot showing concentration adsorbed by the 
zeolite against contact time is presented in figure 48.  
Table 33. HPLC results for the ibuprofen lysine adsorptions by Na ion exchanged ZSM-5 
30:1. 
Ibuprofen 
Lysine 
Concentration 
Left in 
Solution (M) 
Peak Area 
(mVmin) 
Contact 
Time 
(Hours) 
Retention 
Time (mins) 
Height 
(mV) 
Concentration 
Adsorbed by 
the Zeolite 
(M) 
% 
Concentration 
Adsorbed 
0.00206 163.3818 2 8.415 345.897 0.00000* 0.0000 
0.00199 158.2332 4 8.399 334.504 0.00001 0.4760 
0.00216 171.6196 6 8.315 346.323 0.00000* 0.0000 
0.00210 167.3168 8 8.304 336.573 0.00000* 0.0000 
0.00208 165.6775 10 8.283 333.887 0.00000* 0.0000 
0.00211 167.4967 24 8.377 352.131 0.00000* 0.0000 
0.00212 168.1853 48 8.287 337.790 0.00000* 0.0000 
*These values have been normalised to zero as HPLC data came out with a negative 
concentration 
  
Figure 48. Graph depicting concentration of ibuprofen lysine adsorbed by Na ion exchanged 
ZSM-5 30:1 against contact time. 
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Due to its low concentration and the low relative solubility of ibuprofen lysine in 
general the HPLC machine may have picked up a higher result than possible, if only 
slightly, causing negative results to appear. These adsorptions were repeated to check 
validity and consistent results were produced. For the purposes of this research any 
negative concentration results have been changed to indicate that no ibuprofen lysine 
was adsorbed, though some may have been the amount is negligible. The only 
contact time where any ibuprofen lysine was adsorbed was 4 hours, adsorbing 0.48% 
of the overall amount in solution. This would indicate that while marginally better 
than commercial ZSM-5 200-400:1, Na ion exchanged ZSM-5 30:1 is not appropriate 
for the removal of ibuprofen lysine from aqueous solution as the positive amount 
removed could itself be easily negligible. 
 
To ascertain that ibuprofen lysine had been adsorbed into the pores of the zeolite and 
not the surface of the particles XRD was carried out and the data analysed using 
Pawley fits. The post adsorption XRD patterns overlaid onto the Na ion exchanged 
ZSM-5 30:1 XRD pattern, shown in figure 45, are plotted in figure 49 below. 
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Figure 49. A) Na Ion Exchanged ZSM-5 30:1 pre-adsorption + Na Ion Exchanged ZSM-5 30:1 post 2-
hour ibuprofen lysine adsorption. B) Na Ion Exchanged ZSM-5 30:1 pre-adsorption + Na Ion 
Exchanged ZSM-5 30:1 post 4-hour ibuprofen lysine adsorption. C) Na Ion Exchanged ZSM-5 30:1 
pre-adsorption + Na Ion Exchanged ZSM-5 30:1 post 6-hour ibuprofen lysine adsorption. D) Na Ion 
Exchanged ZSM-5 30:1 pre-adsorption + Na Ion Exchanged ZSM-5 30:1 post 8-hour ibuprofen lysine 
adsorption. E) Na Ion Exchanged ZSM-5 30:1 pre-adsorption + Na Ion Exchanged ZSM-5 30:1 post 
10-hour ibuprofen lysine adsorption. F) Na Ion Exchanged ZSM-5 30:1 pre-adsorption + Na Ion 
Exchanged ZSM-5 30:1 post 24-hour ibuprofen lysine adsorption. G) Na Ion Exchanged ZSM-5 30:1 
pre-adsorption + Na Ion Exchanged ZSM-5 30:1 post 48-hour ibuprofen lysine adsorption. 
 
All seven XRD patterns show some differences when compared to the pre-adsorption 
ZSM-5. All the patterns have similar forms of change in relative peak intensity in 
multiple peaks within the range of 5
o
-23
o
 2-theta. The biggest differences are seen in 
the first two peaks at 7.93
o
 2-theta and 8.82
o
 2-theta, with the Na ion exchanged 
ZSM-5 pre-adsorption having peak intensities of 9961 counts per second and 5208 
counts per second respectively, and the peaks at 23.05
o 
2-theta and 23.88
o
 2-theta, 
with the Na ion exchanged ZSM-5 pre-adsorption having peak intensities of 6498 
counts per second and 3800 counts per second respectively. Post adsorption these 
peaks were reduced to between 6668-7593 counts per second and 4108-4542 counts 
per second, with the lowest peaks being produced by the 6-hour adsorption and 
highest being produced by the 4-hour adsorption. For the peaks at 23.05
o
 2-theta and 
23.88
o
 2-theta the post-adsorption peaks were changed to between 6511-7272 counts 
per second and 3519-4080 counts per second respectively with the lowest peaks 
being produced by the 6-hour adsorption and the highest being produced by the 8 and 
10 hour adsorptions respectively. This change in relative peak intensity indicates that 
the contents of the unit cell have changed in some way which would indicate that the 
adsorption of the ibuprofen lysine has been successful. The 6-hour adsorption’s XRD 
pattern show some shifting towards the right, a shift of 0.1212
o
 2-theta. This shift 
towards a higher 2-theta value indicates a contraction of the zeolite unit cell is 
occurring. The zeolite framework has a high degree of flexibility and this peak 
position shift is a further indication that a species has been adsorbed into the pores of 
the zeolite, in this case ibuprofen lysine, though considering the HPLC results it 
would indicate that the amounts adsorbed are negligible.  
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The HPLC and XRD data indicate that the ibuprofen lysine has not been adsorbed by 
the Na ion exchanged ZSM-5 30:1 and has not been successfully removed from the 
solution. The data from the XRD patterns were used to determine the cell parameters 
to see how the cell structure changed to accommodate the adsorbed ibuprofen lysine. 
The unit cell parameters for Na ion exchanged ZSM-5 30:1 pre-and post ibuprofen 
lysine adsorption were determined using Topas and J-edit and shown in table 34. A 
Pawley fit was done using a Chebyshev function background and Pseudo-Voight 
peak shape function, the zero background and unit cell parameters (a, b, c) were 
refined to determine errors.  
 
Table 34. Lattice parameters of Na ion exchanged ZSM-5 30:1 pre-and post ibuprofen lysine 
adsorption with errors included in brackets. 
Contact Time with 
Ibuprofen Lysine 
Solution (Hours) RWP 
a 
(Å) 
b 
(Å) 
c 
(Å) 
0 7.228 20.13230(3) 19.92958(2) 13.42249(2) 
2 6.854 20.12407(3) 19.93208(2) 13.42822(2) 
4 6.98 20.12411(4) 19.93551(2) 13.42837(2) 
6 6.048 20.14328(4) 19.94898(3) 13.44385(3) 
8 6.751 20.12614(3) 19.93327(2) 13.43024(2) 
10 6.75 20.12972(4) 19.93658(2) 13.43051(2) 
24 7.115 20.13689(4) 19.93856(2) 13.43180(3) 
48 6.45 20.12734(3) 19.93482(2) 13.43062(2) 
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Figure 50. A) Change in lattice parameter a against Na ion exchanged ZSM-5 30:1 contact 
time with ibuprofen lysine. B) Change in lattice parameter b against Na ion exchanged ZSM-
5 30:1 contact time with ibuprofen lysine. C) Change in lattice parameter c against Na ion 
exchanged ZSM-5 30:1 contact time with ibuprofen lysine. 
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mostly similar pattern. Parameter a decreases in size from 0-2 hours while parameters 
b and c increase during this time. All three then plateau between 2-4 hours and then 
increasing to their peak sizes at 6 hours before decreasing in size from 6-8 hours. All 
three then increase in size from 8-24 hours with parameter a showing the largest 
increase in this range, then there is a final reduction in size from 24-48 hours. The 
largest change in size is produced by the 6-hour adsorption accounting for an increase 
in size for lattice parameter a of 0.05%, for parameter b of 0.10% and parameter c of 
0.16% and these would indicate that it is expanding to accommodate ibuprofen lysine 
adsorption, but taking the HPLC data into account this is inconsistent and therefore 
the lattice parameters are independent and not altered by the adsorption of ibuprofen 
lysine. 
  
This data indicates that Na ion exchanged ZSM-5 30:1 is not an appropriate 
compound for the removal of ibuprofen lysine from aqueous solution as it is 
unsuccessful in doing so. The lack of any viable adsorption when compare with that 
of commercial ZSM-5 ammonium 30:1 would indicate that the change to the sodium 
charge balancing cation decreased the affinity of ibuprofen lysine for ZSM-5 and 
therefore it is more likely that the reduction in the number of charge balancing 
cations and not the hydrophobicity of the commercial ZSM-5 200-400:1 that caused 
the reduction in ibuprofen lysine’s affinity for it. 
 
6.4 – Aspirin  
The previous aspirin HPLC calibration curve’s equations for aspirin peak 1 and 2 was 
used to calculate the concentration of the aspirin left in the solution after the 
adsorptions by combining the concentrations. Table 35 shows the HPLC data 
produced by the adsorption reactions between 2 and 48 hours for peak 1, table 36 
shows peak 2 and table 37 are the two sets of concentrations combined. Included are 
the concentration of the drug left in solution, the concentration of the drug that was 
adsorbed and the percentage of the overall concentration that was adsorbed. A plot 
showing the aspirin combined concentration adsorbed by the zeolite against contact 
time is presented in figure 51.  
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Table 35. Aspirin peak 1 HPLC results 
Aspirin Tablet 
Samples Peak 1 
Concentration 
Left in Solution 
(M) 
Peak Area 
(mVmin) 
Contact Time 
(Hours) 
Retention 
Time (min) 
Height 
(mV) 
0.0040 38.8928 2 6.868 132.108 
0.0040 38.7591 4 6.789 128.004 
0.0039 37.9694 6 6.827 126.190 
0.0032 31.0207 8 6.892 98.752 
0.0031 30.0074 10 6.036 99.405 
0.0040 39.5102 24 6.761 130.499 
0.0031 30.8190 48 6.820 100.380 
 
Table 36. Aspirin peak 2 HPLC results. 
Aspirin Tablet 
Samples Peak 2 
Concentration 
Left in Solution 
(M) 
Peak Area 
(mVmin) 
Contact Time 
(Hours) 
Retention 
Time (mins) 
Height 
(mV) 
0.0007 5.9046 2 10.311 13.979 
0.0006 5.8091 4 10.200 13.266 
0.0008 6.9036 6 10.284 15.396 
0.0017 15.5030 8 10.402 34.673 
0.0016 14.2309 10 9.283 33.657 
0.0005 4.6416 24 10.140 10.580 
0.0018 16.1409 48 10.275 35.314 
 
Table 37. Aspirin combined concentrations HPLC results. 
Aspirin Tablet 
Samples 
Combined 
Concentrations 
Left in Solution 
(M) 
Contact 
Time 
Concentration 
Adsorbed by the 
Zeolite % Concentration Adsorbed 
0.00463 2 0.00037 7.4616 
0.00460 4 0.00040 7.9474 
0.00464 6 0.00036 7.1195 
0.00489 8 0.00011 2.1333 
0.00465 10 0.00035 7.0368 
0.00455 24 0.00045 9.0168 
0.00494 48 0.00006 1.1231 
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Figure 51. Graph depicting concentration of aspirin adsorbed by Na ion exchanged ZSM-5 
30:1 against contact time. 
 
The concentration adsorbed stays fairly constant throughout, with the exception for 8 
and 48 hours, as the percentage adsorbed has a range of 1.12-9.02% with the contact 
time of 48 hours accounting for the lowest concentration adsorbed of 0.00006M and 
the highest occurring during the 24-hour adsorption of 0.00045M, indicating that this 
is the optimum adsorbance time. 2-6 hours plateau, from 7.46% to 7.12%, before 
dropping down to 2.1% at 8 hours. From 8-24 hours, there is an increase of 6.9% up 
to the peak of 9.02% before the final reduction at 48 hours, reducing in concentration 
adsorbed by 7.9% to 1.1% adsorbed. The equilibrium is shown to be between 7.0-
7.9% as the 2, 4, 6 and 10 hour adsorptions fall into this range. This overall relative 
decrease in the concentration adsorbed by ZSM-5 when compared the commercial 
ZSM-5 ammonium 30:1 indicates that changing the charge balancing cation to 
sodium reduced aspirin’s affinity for ZSM-5. It also shows a relative decrease in the 
concentration adsorbed when compared to the commercial ZSM-5 ammonium 200-
400:1, this would indicate that aspirin’s increased affinity for ZSM-5 200-400:1 was 
more likely due to its increased hydrophobicity than its reduced amount of 
ammonium cations. Overall it has the lowest concentration adsorbed out of all the 
aspirin adsorptions ran. 
 
To confirm that the aspirin has been adsorbed into the pores of ZSM-5 and not 
absorbed on to the surface of the particles powder XRD was performed on the 
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filtered solid after adsorption had occurred. As a basis, the Na ion exchanged ZSM-5 
30:1 XRD pattern is included in figure 45 and the diffraction patterns for the post 
adsorption ZSM-5 is shown in figure 52 with the post adsorption pattern overlaid 
onto the pre-adsorption pattern. 
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Figure 52. A) Na ion exchanged ZSM-5 30:1 pre-adsorption + Na ion exchanged ZSM-5 30:1 post 2-
hour aspirin adsorption. B) Na ion exchanged ZSM-5 30:1 pre-adsorption + Na ion exchanged ZSM-5 
30:1 post 4-hour aspirin adsorption. C) Na ion exchanged ZSM-5 30:1 pre-adsorption + Na ion 
exchanged ZSM-5 30:1 post 6-hour aspirin adsorption. D) Na ion exchanged ZSM-5 30:1 pre-
adsorption + Na ion exchanged ZSM-5 30:1 post 8-hour aspirin adsorption. E) Na ion exchanged 
ZSM-5 30:1 pre-adsorption + Na ion exchanged ZSM-5 30:1 post 10-hour aspirin adsorption. F) Na 
ion exchanged ZSM-5 30:1 pre-adsorption + Na ion exchanged ZSM-5 30:1 post 24-hour aspirin 
adsorption. G) Na ion exchanged ZSM-5 30:1 pre-adsorption + Na ion exchanged ZSM-5 30:1 post 
48-hour aspirin adsorption. 
 
All seven XRD patterns show minor differences when compared to the original, 
commercial ZSM-5 30:1. All the patterns have similar forms of change in relative 
peak intensity in multiple peaks within the range of 5
o
-23
o
 2-theta. The biggest 
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differences are seen in the first two peaks at 7.93
o
 2-theta and 8.82
o
 2-theta, with the 
Na ion exchanged ZSM-5 pre-adsorption having peak intensities of 9961 counts per 
second and 5208 counts per second respectively, and the peaks at 23.05
o 
2-theta and 
23.88
o
 2-theta, with the Na ion exchanged ZSM-5 pre-adsorption having peak 
intensities of 6498 counts per second and 3800 counts per second respectively. Post 
adsorption these peaks were changed to between 8247-9450 counts per second and 
4849-5371 counts per second, with the lowest peaks being produced by the 48-hour 
adsorption and highest being produced by the 2 and 6 hour adsorptions respectively. 
For the peaks at 23.05
o
 2-theta and 23.88
o
 2-theta the post-adsorption peaks were 
changed to between 6844-7408 counts per second and 3441-3815 counts per second 
respectively with the lowest peaks being produced by the 48 and 24 hour adsorptions 
and the highest being produced by the 10 and 4 hour adsorptions respectively. This 
change in relative peak intensity indicates that the contents of the unit cell have 
changed in some way which would indicate that the adsorption of the aspirin has 
been successful. Another indicator is that the 48-hour adsorption pattern has been 
noticeably shifted to the right by 0.1010
o
 2-theta. This shift towards a higher 2-theta 
value indicates a contraction of the zeolite unit cell is occurring. The zeolite 
framework has a high degree of flexibility and this peak position shift is a further 
indication that a species has been adsorbed into the pores of the zeolite, in this case 
aspirin, though the relatively low shift indicates that this change is negligible.  
  
The HPLC and XRD data indicate that the aspirin has been adsorbed by the Na ion 
exchanged ZSM-5 30:1 and successfully removed from the solution, though 
minimally. The data from the XRD patterns were used to determine the cell 
parameters to see how the cell structure changed to accommodate the adsorbed 
aspirin. The unit cell parameters for Na ion exchanged ZSM-5 30:1 pre-and post 
aspirin adsorption were determined using Topas and J-edit and shown in table 38. A 
Pawley fit was done using a Chebyshev function background and Pseudo-Voight 
peak shape function, the zero background and unit cell parameters (a, b, c) were 
refined to determine errors.  
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Table 38. Lattice parameters of Na ion exchanged ZSM-5 30:1 pre-and post aspirin 
adsorption with errors included in brackets. 
Contact Time with 
Paracetamol 
Solution (Hours) RWP 
a 
(Å) 
b 
(Å) 
c 
(Å) 
0 7.228 20.13230(3) 19.92958(2) 13.42249(2) 
2 7.438 20.11644(4) 19.93599(2) 13.42100(3) 
4 8.100 20.09623(4) 19.92594(3) 13.41213(3) 
6 7.566 20.10042(4) 19.93219(3) 13.41678(3) 
8 7.954 20.09909(5) 19.93214(3) 13.41026(3) 
10 7.053 20.08977(4) 19.93816(3) 13.41048(3) 
24 7.260 20.11195(4) 19.94062(3) 13.41836(3) 
48 7.925 20.11052(4) 19.93882(3) 13.41660(3) 
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Figure 53. A) Change in lattice parameter a against Na ion exchanged ZSM-5 30:1 contact 
time with aspirin. B) Change in lattice parameter b against Na ion exchanged ZSM-5 30:1 
contact time with aspirin. C) Change in lattice parameter c against Na ion exchanged ZSM-5 
30:1 contact time with aspirin. 
 
Figure 53 shows the change in the lattice parameters of ZSM-5 pre-and post 
paracetamol adsorption with lattice parameters a and c following a similar path to 
20.06
20.07
20.08
20.09
20.1
20.11
20.12
20.13
20.14
0 2 4 6 8 10 24 48
La
tt
ic
e 
P
ar
am
et
er
 S
iz
e 
(Å
) 
Contact Time (Hours) 
A 
19.915
19.92
19.925
19.93
19.935
19.94
19.945
0 2 4 6 8 10 24 48
La
tt
ic
e 
P
ar
am
et
er
 S
iz
e 
(Å
) 
Contact Time (Hours) 
B 
13.404
13.406
13.408
13.41
13.412
13.414
13.416
13.418
13.42
13.422
13.424
0 2 4 6 8 10 24 48
La
tt
ic
e 
P
ar
am
et
er
 S
iz
e 
(Å
) 
Contact Time (Hours) 
C 
140 
 
one another while parameter b changes halfway. Parameters a and c decrease in size 
from 0-4 hours, increase in size from 4-6 hours and then decreasing in size from 6-10 
hours, though parameter c increases from 8-10 hours. They both increase in size from 
10-24 hours before a final decrease in size from 24-48 hours. Parameter b follows a 
similar path but does derivate at certain points. It increases in size from 0-2 hours and 
8-10 hours rather than decrease. Comparing these changes to the changes in 
concentration adsorbed shows some inconsistencies. The highest concentration 
adsorbed was at 24 hours, with 9.02% of the concentration being adsorbed. This is 
reflected in the increase in lattice parameter size from 10-24 hours with parameter a 
increasing by 0.11%, parameter b by 0.1% and parameter c by 0.06%. This increase 
would indicate that the lattice parameter size and concentration adsorbed are directly 
proportional to one another but all three parameters decrease in size from 2-4 hours 
when there is an increase in concentration adsorbed within this range. The 
concentration adsorbed is increased by 0.49% whereas there is a reduction in the size 
of lattice parameter a by 0.10%, lattice parameter b by 0.05% and lattice parameter c 
by 0.07%. This indicates that the changes in lattice parameters’ sizes are not related 
to the changes in concentration adsorbed and therefore the lattice parameters do not 
change to accommodate the aspirin that is adsorbed. 
 
From this we can conclude that Na ion exchanged ZSM-5 30:1 would be an 
inappropriate compound for the removal of aspirin from aqueous solution, as the 
concentration of aspirin it can remove from solution is much to low when compared 
commercial ZSM-5 30:1 ammonium and commercial ZSM-5 200-400:1 ammonium. 
This reduction in affinity after changing the charge balancing cation to sodium 
indicates that the charge balancing cation influences aspirin’s affinity for ZSM-5. 
Taken in conjunction with the increase in affinity for ZSM-5 200-400:1 seems to 
indicate that it was more likely that this increase was due to the increase in its 
hydrophobicity rather than the reduction of the number of charge balancing cations 
present. Overall using Na ion exchanged ZSM-5 30:1 to remove aspirin from 
aqueous solution is not viable though as the amount you would remove against time 
spent would not be cost effective.  
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7. Results and Discussion – Adsorptions of Reduced Paracetamol 
Concentrations Using Commercial ZSM-5 Ammonium 30:1 
7.1 Introduction 
The data presented in this chapter has been taken from the adsorptions of paracetamol 
with the reduced concentrations of 0.0025M and 0.00125M, a half and a quarter of 
the original adsorptions, by commercial ZSM-5 30:1. The ZSM-5 used for the 
experiments in this chapter has a Si:Al ratio of 30:1 and its charge balancing cation is 
ammonium. 
 
7.2 – Paracetamol 0.0025M 
The previous paracetamol HPLC calibration curve’s equation was used to calculate 
the concentration of the paracetamol left in the solution after the adsorptions. Table 39 
shows the HPLC data produced by the adsorption reactions between 2 and 48 hours. 
Included are the concentration of the drug left in solution, the concentration of the 
drug that was adsorbed and the percentage of the overall concentration that was 
adsorbed. A plot showing concentration adsorbed by the zeolite against contact time 
is presented in figure 54.  
Table 39. HPLC results for the 0.0025M paracetamol adsorptions by commercial ZSM-5 
ammonium 30:1. 
Paracetamol 
Concentration 
Left in 
Solution (M) 
Peak Area 
(mVmin) 
Contact Time 
(Hours) 
Retention 
Time (mins) Height (mV) 
Concentration 
Adsorbed by 
the Zeolite 
(M) 
% 
Concentration 
Adsorbed 
0.002409 268.7025 2 3.351 1071.962 0.000091 3.6244 
0.002461 274.4252 4 3.447 1159.051 0.000039 1.5718 
0.002419 269.7596 6 3.427 1078.407 0.000081 3.2452 
0.002464 274.8350 8 3.438 1140.841 0.000036 1.4248 
0.002415 269.3480 10 3.425 1097.696 0.000085 3.3928 
0.002451 273.3517 24 3.405 1082.383 0.000049 1.9568 
0.002447 272.9518 48 3.430 1135.358 0.000053 2.1003 
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Figure 54. Graph depicting concentration of 0.0025M paracetamol adsorbed by commercial 
ZSM-5 ammonium 30:1 against contact time. 
 
The overall concentration adsorbed is small in comparison to the previous ZSM-5 
30:1 paracetamol adsorption, only having a maximum of 0.000091M, 3.62% of the 
overall concentration. This is much lower than the 0.005M paracetamol ZSM-5 30:1 
adsorption which had a maximum adsorption of 0.0032M, 64.39% of its overall 
concentration. The concentration adsorbed seems to fluctuate within the range of 
1.43-3.62%, which would put its equilibrium somewhere in this range though it 
doesn’t reach it. This low amount of concentration adsorbed seems to indicate that 
commercial ZSM-5 ammonium 30:1’s ability to adsorb paracetamol from solution is 
reduced considerably at lower concentrations making it impractical for the removal of 
concentrations of this level from wastewater. 
 
 To confirm that the paracetamol has been adsorbed into the pores of ZSM-5 and not 
absorbed on to the surface of the particles powder XRD was performed on the filtered 
solid after adsorption had occurred. As a basis, the commercial ZSM-5 ammonium 
30:1 XRD pattern is included in figure 8. The diffraction patterns for the post 
adsorption ZSM-5 is shown in figure 55 with the post adsorption pattern overlaid onto 
the pre-adsorption pattern. 
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Figure 55. A) Commercial ZSM-5 Ammonium 30:1 + ZSM-5 30:1 post 2 hour 0.0025M paracetamol 
adsorption. B) Commercial ZSM-5 Ammonium 30:1 + ZSM-5 30:1 post 4 hour 0.0025M paracetamol 
adsorption. C) Commercial ZSM-5 Ammonium 30:1 + ZSM-5 30:1 post 6 hour 0.0025M paracetamol 
adsorption. D) Commercial ZSM-5 Ammonium 30:1 + ZSM-5 30:1 post 8 hour 0.0025M paracetamol 
adsorption. E) Commercial ZSM-5 Ammonium 30:1 + ZSM-5 30:1 post 10 hour 0.0025M 
paracetamol adsorption. F) Commercial ZSM-5 Ammonium 30:1 + ZSM-5 30:1 post 24 hour 
0.0025M paracetamol adsorption. G) Commercial ZSM-5 Ammonium 30:1 + ZSM-5 30:1 post 48 
hour 0.0025M paracetamol adsorption. 
 
All seven XRD patterns show some slight differences when compared to the original, 
commercial ZSM-5. All the patterns have some form of reduction in relative peak 
intensity in multiple peaks within the range of 5
o
-23
o
 2-theta. The most notable 
differences are seen in the first two peaks at 7.91
o
 2-theta and 8.82
o
 2-theta, with the 
commercial ZSM-5 having peak intensities of 11162 counts per second and 6111 
counts per second respectively. Post adsorption these peaks were reduced to between 
9460-10985 counts per second and 5448-6019 counts per second with the lowest 
peaks being produced by the 4-hour adsorption and highest being produced by the 
24-hour adsorption. This change in relative peak intensity indicates that the contents 
of the unit cell have changed in some way which would indicate that the adsorption 
of the paracetamol has been successful. Another indicator is that the 2, 6 and 8-hour 
adsorption patterns are shifted to the right by 0.0606
o
 2-theta. This shift towards a 
higher 2-theta value indicates a contraction of the zeolite unit cell is occurring. The 
zeolite framework has a high degree of flexibility and this peak position shift is a 
further indication that a species has been adsorbed into the pores of the zeolite, in this 
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case paracetamol, though the relatively low shift indicates that this change is 
negligible. 
  
The HPLC and XRD data indicate that the paracetamol has been adsorbed by the 
commercial ZSM-5 30:1 and successfully removed from the solution. The data from 
the XRD patterns were used to determine the cell parameters to see how the cell 
structure changed to accommodate the adsorbed paracetamol. The unit cell 
parameters for commercial ZSM-5 30:1 pre-and post paracetamol adsorption were 
determined using Topas and J-edit and shown in table 40. A Pawley fit was done 
using a Chebyshev function background and Pseudo-Voight peak shape function, the 
zero background and unit cell parameters (a, b, c) were refined to determine errors. 
 
Table 40. Lattice parameters of commercial ZSM-5 30:1 pre-and post 0.0025M paracetamol 
adsorption with errors included in brackets. 
Contact Time with 
Paracetamol 
Solution (Hours) RWP 
a 
(Å) 
b 
(Å) 
c 
(Å) 
0 7.466 20.11848(3) 19.92388(2) 13.41704(2) 
2 7.113 20.12973(3) 19.93565(2) 13.42620(2) 
4 7.345 20.11167(4) 19.92043(2) 13.41578(2) 
6 7.105 20.12197(3) 19.92777(2) 13.41839(2) 
8 7.520 20.11178(3) 19.91999(2) 13.41566(2) 
10 6.881 20.11458(4) 19.92679(3) 13.42030(3) 
24 7.461 20.11642(3) 19.92676(2) 13.42089(2) 
48 7.220 20.11410(3) 19.92328(2) 13.41619(2) 
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Figure 56. A) Change in lattice parameter a against ZSM-5 30:1 contact time with 0.0025M 
paracetamol. B) Change in lattice parameter b against ZSM-5 30:1 contact time with 
0.0025M paracetamol. C) Change in lattice parameter c against ZSM-5 30:1 contact time 
with 0.0025M paracetamol. 
 
Figure 56 shows the change in the lattice parameters of ZSM-5 pre-and post 
paracetamol adsorption and shows all three lattice parameter size changes are related 
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to each other. All three lattice parameters increase in size from 0-2 hours, reduce in 
size from 2-4 hours, increase in size from 4-6 hours, reduce in size from 6-8 hours 
and then increase in size from 8-10 hours. Parameters a and c both increase in size 
from 10-24 hours while parameter b has a slight reduction before all three reduce in 
size from 24-48 hours. This pattern seems to match the pattern of the concentration 
adsorbed, except for parameter b at 24 hours. Disregarding this one point, the data 
indicates that lattice parameter size and concentration adsorbed are directionally 
proportional to one another. They both share the same position for their maximums, 
the 2-hour contact time accounting for adsorbing 3.62% of the overall concentration 
and a 0.06% increase in size for lattice parameters a and b, and an increase of 0.07% 
for c. This overall directional proportionality indicates that the lattice parameters 
increased in size to accommodate for the paracetamol to be adsorbed, confirming that 
paracetamol has been adsorbed. 
 
Commercial ZSM-5 ammonium 30:1 is not a viable compound for the adsorption of 
0.0025M paracetamol, though it does remove paracetamol from the solution it 
doesn’t remove enough to make it cost effective or a viable choice for it. 
 
7.3 – Paracetamol 0.00125M 
The previous paracetamol HPLC calibration curve’s equation was used to calculate 
the concentration of the paracetamol left in the solution after the adsorptions. Table 41 
shows the HPLC data produced by the adsorption reactions between 2 and 48 hours. 
Included are the concentration of the drug left in solution, the concentration of the 
drug that was adsorbed and the percentage of the overall concentration that was 
adsorbed. A plot showing concentration adsorbed by the zeolite against contact time 
is presented in figure 57.  
 
 
 
Table 41. HPLC results for the 0.00125M paracetamol adsorptions by commercial ZSM-5 
ammonium 30:1. 
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Paracetamol 
Concentration 
Left in 
Solution (M) 
Peak Area 
(mVmin) 
Contact Time 
(Hours) 
Retention 
Time (mins) Height (mV) 
Concentration 
Adsorbed by 
the Zeolite 
(M) 
% 
Concentration 
Adsorbed 
0.00097 108.0052 2 3.350 414.969 0.00028 22.5235 
0.00109 121.5950 4 3.430 493.509 0.00016 12.7749 
0.00110 122.4508 6 3.430 486.657 0.00015 12.1610 
0.00111 124.2864 8 3.425 501.281 0.00014 10.8443 
0.00106 118.0431 10 3.423 476.616 0.00019 15.3229 
0.00105 116.6749 24 3.401 452.057 0.00020 16.3043 
0.00108 120.9125 48 3.421 484.394 0.00017 13.2645 
 
 
Figure 57. Graph depicting concentration of 0.00125M paracetamol adsorbed by commercial 
ZSM-5 ammonium 30:1 against contact time. 
 
The overall concentration adsorbed is less when compared to the 0.005M commercial 
ZSM-5 ammonium 30:1 adsorption but higher than its 0.0025M counterpart. This 
seems inconsistent as an even lower base concentration should lead to a lower amount 
of concentration adsorbed. This makes sense however when taken in tandem with the 
ibuprofen lysine HPLC results. Those results produced negative concentrations 
adsorbed due to a lack of clarity in the HPLC machine producing higher than possible 
results because the original concentration was so small, 0.002M in that case. If that 
was happening here also it would make the higher than expected HPLC results make 
sense, as some of the concentration is being adsorbed though the actual exact amount 
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is unknown due to the inaccuracy of the analytical machine. The overall pattern the 
adsorptions follow will be useful for later analysis though.  
 
 To confirm that the paracetamol has been adsorbed into the pores of ZSM-5 and not 
absorbed on to the surface of the particles powder XRD was performed on the filtered 
solid after adsorption had occurred. As a basis, the commercial ZSM-5 ammonium 
30:1 XRD pattern is included in figure 8. The diffraction patterns for the post 
adsorption ZSM-5 is shown in figure 58 with the post adsorption pattern overlaid onto 
the pre-adsorption pattern. 
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Figure 58. A) Commercial ZSM-5 Ammonium 30:1 + ZSM-5 30:1 post 2 hour 0.00125M paracetamol 
adsorption. B) Commercial ZSM-5 Ammonium 30:1 + ZSM-5 30:1 post 4 hour 0.00125M 
paracetamol adsorption. C) Commercial ZSM-5 Ammonium 30:1 + ZSM-5 30:1 post 6 hour 
0.00125M paracetamol adsorption. D) Commercial ZSM-5 Ammonium 30:1 + ZSM-5 30:1 post 8 
hour 0.00125M paracetamol adsorption. E) Commercial ZSM-5 Ammonium 30:1 + ZSM-5 30:1 post 
10 hour 0.00125M paracetamol adsorption. F) Commercial ZSM-5 Ammonium 30:1 + ZSM-5 30:1 
post 24 hour 0.00125M paracetamol adsorption. G) Commercial ZSM-5 Ammonium 30:1 + ZSM-5 
30:1 post 48 hour 0.00125M paracetamol adsorption. 
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commercial ZSM-5 having peak intensities of 11162 counts per second and 6111 
counts per second respectively. Post adsorption these peaks were reduced to between 
9703-10774 counts per second and 5368-5942 counts per second with the lowest 
peaks being produced by the 8-hour adsorption and highest being produced by the 4-
hour adsorption. This change in relative peak intensity indicates that the contents of 
the unit cell have changed in some way which would indicate that the adsorption of 
the paracetamol has been successful, though due to small overall differences when 
compared to other paracetamol adsorptions the amount adsorbed would be very small 
almost negligible.  
 
The HPLC and XRD data indicate that the paracetamol has been adsorbed by the 
commercial ZSM-5 30:1 and successfully removed from the solution, though how 
much has exactly been removed is unknown. The data from the XRD patterns were 
used to determine the cell parameters to see how the cell structure changed to 
accommodate the adsorbed paracetamol. The unit cell parameters for commercial 
ZSM-5 30:1 pre-and post paracetamol adsorption were determined using Topas and 
J-edit and shown in table 42. A Pawley fit was done using a Chebyshev function 
background and Pseudo-Voight peak shape function, the zero background and unit 
cell parameters (a, b, c) were refined to determine errors. 
 
Table 42. Lattice parameters of commercial ZSM-5 30:1 pre-and post 0.00125M paracetamol 
adsorption with errors included in brackets. 
Contact Time with 
Paracetamol 
Solution (Hours) RWP 
a 
(Å) 
b 
(Å) 
c 
(Å) 
0 7.466 20.11848(3) 19.92388(2) 13.41704(2) 
2 7.353 20.11611(3) 19.92765(2) 13.42184(2) 
4 7.239 20.12049(3) 19.92811(2) 13.42222(2) 
6 7.043 20.11800(4) 19.92906(3) 13.42155(3) 
8 6.768 20.12637(3) 19.93390(2) 13.42717(2) 
10 7.54 20.11106(3) 19.92344(2) 13.41694(2) 
24 7.317 20.12267(3) 19.92729(2) 13.42270(2) 
48 7.368 20.11206(3) 19.92033(2) 13.41717(2) 
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Figure 59. A) Change in lattice parameter a against ZSM-5 30:1 contact time with 0.00125M 
paracetamol. B) Change in lattice parameter b against ZSM-5 30:1 contact time with 
0.00125M paracetamol. C) Change in lattice parameter c against ZSM-5 30:1 contact time 
with 0.00125M paracetamol. 
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Figure 59 shows the change in the lattice parameters of ZSM-5 pre-and post 
paracetamol adsorption and shows all three lattice parameter size changes follow an 
overall similar pattern.  Lattice parameter a decreases in size from 0-2 hours while 
parameters b and c increases in size at this time. Then all three parameters increase in 
size from 2-4 hours before parameters a and c decrease in size while parameter b 
increases in size. After this all three follow the same path, an increase in size from 6-
8 hours, a reduction in size from 8-10 hours, an increase in size from 10-24 hours and 
a final reduction in size 24-48 hours. The maximum concentration adsorption was 
produced at 2 hours and the minimum at 8 hours. The maximum size of the lattice 
parameters is produced at 8 hours, this would indicate that the lattice parameter size 
and concentration adsorbed are inversely proportional but this is not reflected in the 
rest of the data, the smallest lattice parameter sizes being produced by 13.26% 
concentration adsorbed, which seems to be in the middle of the pattern rather than the 
top. This indicates that there is no correlation between ZSM-5 lattice parameter’s size 
and the concentration of paracetamol adsorbed and that the lattice parameters are not 
changing in size to accommodate the adsorption of paracetamol. 
 
Commercial ZSM-5 ammonium 30:1 is not a viable compound for the adsorption of 
0.00125M paracetamol, though it does remove paracetamol from the solution the low 
base concentration and inaccuracy of the HPLC machine mean that it is not certain 
how much exactly it did adsorb and so it is not a viable adsorbent and very low 
concentrations. 
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8. – Conclusions and Further Research 
 
Commercial ZSM-5 ammonium 30:1 was found to be the optimum form of ZSM-5 
investigated for the adsorption of paracetamol from aqueous solution. Eight hours was 
its optimum contact time for adsorption, accounting for the removal of 64.39% of the 
paracetamol concentration. The aspect of ZSM-5 that most affected the affinity of 
paracetamol for ZSM-5 was the charge balancing ammonium cation. A reduction in 
concentration adsorbed was observed when the charge balancing cation was changed 
and when the number of charge balancing cations present were reduced by increasing 
the Si:Al ratio. Commercial ZSM-5 ammonium 30:1 is not appropriate for the 
removal of lower concentrations of paracetamol as the percentage of concentration 
adsorbed dropped to a maximum of 3.62% when the batch concentration was halved. 
Overall commercial ZSM-5 ammonium 30:1 is the most viable form of ZSM-5 
investigated for the removal of paracetamol from aqueous solution and therefore it is 
viable for removing paracetamol from waste water, though further research is required 
into its use at lower concentrations. 
 
Commercial ZSM-5 ammonium 30:1 was also found to be the optimum form of 
ZSM-5 investigated for the adsorption of ibuprofen lysine from aqueous solution. At 
2 hours, it adsorbed its maximum of 56.82% of the ibuprofen in the solution, making 
this the optimum contact time for adsorption. Similarly, to paracetamol the aspect of 
ZSM-5 that most affected the adsorption was the ammonium cation, as a reduction in 
the concentration adsorbed was observed when the charge balancing cation was 
changed and when the number of charge balancing cations present were reduced by 
increasing the Si:Al ratio, these changes leading to almost no ibuprofen lysine getting 
adsorbed at all. Overall we conclude that, though commercial ZSM-5 ammonium 30:1 
is viable for the removal of ibuprofen lysine from solution, its tendency to desorb all 
the ibuprofen lysine back at certain contact times makes it harder to implement for 
ibuprofen lysine’s removal from waste water. 
 
Commercial ZSM-5 ammonium 200-400:1 was also found to be the optimum form of 
ZSM-5 investigated for the adsorption of aspirin from aqueous solution. It had an 
optimum contact time of 48 hours, removing 61.52% of the aspirin from the solution 
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in this time. Conversely to the other two analgesics it was the hydrophobicity caused 
by the increase in the Si:Al ratio that had the greatest positive effect on the amount of 
concentration adsorbed by ZSM-5. This conclusion was arrived at due to the data 
showing that a decrease in the number of ammonium cations present increased 
aspirin’s affinity for ZSM-5 while the change in charge balancing cation reduced it. 
This makes commercial ZSM-5 ammonium 200-400:1 viable for the removal of 
aspirin from aqueous solution and therefore viable for aspirin’s removal from waste 
water. 
 
ZSM-5 overall was found to be an appropriate compound for the removal of the 
analgesics investigated from aqueous solutions though further research into its affinity 
for other analgesics and pharmaceutical compounds is required. Similarly, further 
investigation into the effects of a varied temperature and pH of the system on the 
affinity of the analgesics investigated would be advisable, as would considering the 
effects other charge balancing cations, such as calcium and potassium, if reducing the 
Si:Al ratio of ZSM-5 would have a positive effect on the adsorption of paracetamol 
and ibuprofen lysine by ZSM-5 and the ability of ZSM-5 to adsorb analgesics from a 
mixed solution. 
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